Rank,OrgStudyId,StudyType,ArmGroupType,InterventionType,DesignInterventionModel,DesignObservationalModel,TargetDuration,SamplingMethod,Phase
1,BTX-BCI-016-PRT,Observational,,Diagnostic Test,,Case-Only,5 Years,Non-Probability Sample,
2,2018-TJ-BCD,Observational,,"Diagnostic Test, Diagnostic Test",,Case-Control,,Non-Probability Sample,
3,Breast cancer,Observational,,"Genetic, Other",,Case-Control,,Probability Sample,
4,BC-BOMET,Observational,,"Other, Other",,Case-Control,,Non-Probability Sample,
5,241391,Observational,,Diagnostic Test,,Cohort,1 Year,Non-Probability Sample,
6,IL-TM-B1-01,Observational,,"Diagnostic Test, Diagnostic Test",,Cohort,,Non-Probability Sample,
7,FH-Risk 2.0 Research Protocol,Observational,,Other,,Other,,Non-Probability Sample,
8,ID-RPSBC-01-20201012,Observational,,Diagnostic Test,,Case-Control,3 Months,Probability Sample,
9,IRST174.22,Interventional,"No Intervention, Experimental, Experimental",Diagnostic Test,Parallel Assignment,,,,Not Applicable
10,ANILERGÄ°NN,Observational,,Diagnostic Test,,Cohort,10 Years,Probability Sample,
11,32155120.7.0000.0072,Observational,,Behavioral,,Cohort,,Probability Sample,
12,GCO 17-2188,Interventional,Other,Behavioral,Single Group Assignment,,,,Not Applicable
13,233756,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
14,D16196,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
15,LNs Staging of Breast cancer,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
16,UMCC 2021.087,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
17,RO1912-30902,Interventional,"Other, Experimental",Radiation,Parallel Assignment,,,,Not Applicable
18,SA18i0002,Interventional,"Active Comparator, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
19,494936,Interventional,Experimental,Genetic,Single Group Assignment,,,,Not Applicable
20,042210,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
21,Yuan Shifang-1,Observational,,Device,,Cohort,,Probability Sample,
22,(818)109A-57,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
23,21 SEIN 01,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
24,18-181,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
25,catheter guided chemo-infusion,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
26,2020/132,Interventional,"Experimental, No Intervention",Behavioral,Single Group Assignment,,,,Not Applicable
27,17-689,Interventional,Experimental,"Device, Device",Single Group Assignment,,,,Not Applicable
28,831804,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
29,PI-2842,Observational,,Behavioral,,Cohort,,Probability Sample,
30,260281,Observational,,"Other, Other",,Cohort,,Non-Probability Sample,
31,NCC2985,Observational,,Procedure,,Cohort,,Non-Probability Sample,
32,Amr Ahmed,Interventional,"Experimental, Experimental",Combination Product,Parallel Assignment,,,,Early Phase 1
33,154/2019,Interventional,"Experimental, Other",Other,Parallel Assignment,,,,Not Applicable
34,V1 11.12. 2020 (C.I.R.E.C.),Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
35,CLM-INS-004,Observational,,Other,,Cohort,,Probability Sample,
36,miRNA in breast cancer,Observational,,Diagnostic Test,,Case-Control,,Non-Probability Sample,
37,2022-11-076-002,Interventional,"Experimental, Experimental",Diagnostic Test,Crossover Assignment,,,,Not Applicable
38,Health Literacy of Breast Ca,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
39,MC1933,Observational,,Procedure,,Case-Only,,Probability Sample,
40,RADIOVAL,Observational,,Other,,Cohort,,Non-Probability Sample,
41,CE21096B,Observational,,Procedure,,Case-Control,,Non-Probability Sample,
42,ZY(2018-2020)-CCCX-2005-04,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
43,MicroRNA in breast cancer,Observational,,Diagnostic Test,,Case-Control,,Probability Sample,
44,GEICAM/2016-04,Observational,,,,Case-Only,,Probability Sample,
45,22IC7498,Interventional,"Active Comparator, Experimental, Experimental","Behavioral, Behavioral, Other",Parallel Assignment,,,,Not Applicable
46,BMIBC,Observational,,,,Case-Control,,Probability Sample,
47,3.0840453,Observational,,Other,,Case-Control,,Probability Sample,
48,HKG-KZ-BrCa-101,Observational,,,,Case-Control,,Non-Probability Sample,
49,Hibiscuss,Observational,,Device,,Other,,Probability Sample,
50,18 SEIN 11,Interventional,Experimental,Other,Single Group Assignment,,,,Phase 2
51,SNAPS Breast Cancer,Observational,,Diagnostic Test,,Case-Control,,Probability Sample,
52,Pro00107118,Observational,,Procedure,,Cohort,1 Year,Probability Sample,
53,ZCHBC022,Observational,,Drug,,Cohort,,Non-Probability Sample,
54,R.18.02.34.R1.R2,Observational,,,,Case-Control,,Non-Probability Sample,
55,17-447,Interventional,Experimental,"Drug, Device",Single Group Assignment,,,,Phase 1
56,22-509,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
57,ID-BCRPS-02-20220913,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
58,17-01549,Interventional,"Active Comparator, Active Comparator","Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
59,112991,Observational,,Radiation,,Cohort,,Non-Probability Sample,
60,202101073,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
61,TET-21-001,Observational,,,,Case-Control,,Probability Sample,
62,"estPerMed 1, Breast",Interventional,"Active Comparator, Active Comparator, No Intervention",Diagnostic Test,Parallel Assignment,,,,Not Applicable
63,68824072019,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
64,3055,Observational,,Other,,Cohort,,Non-Probability Sample,
65,20220303swj0211,Interventional,"Experimental, Other",Behavioral,Parallel Assignment,,,,Not Applicable
66,RC20_0532,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
67,Breast Cancer Risk,Observational,,,,Cohort,,Non-Probability Sample,
68,KMUHIRB-E(I)-20200041,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
69,VGHKS18-CT11-17,Observational,,Device,,Cohort,,Non-Probability Sample,
70,832165,Observational,,Drug,,Case-Only,,Non-Probability Sample,
71,LCCC2207,Observational,,Behavioral,,Ecologic or Community,,Non-Probability Sample,
72,ICO-2019-08,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
73,biomarkers in breast cancer,Observational,,Diagnostic Test,,Case-Control,,Probability Sample,
74,GEICAM/2017-07,Observational,,,,Case-Only,,Non-Probability Sample,
75,MCC-21448,Observational,,Diagnostic Test,,Case-Only,,Non-Probability Sample,
76,4452,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Sequential Assignment,,,,Not Applicable
77,UPCC 19121,Observational,,Other,,Case-Control,,Non-Probability Sample,
78,autotaxin1,Interventional,"Active Comparator, Sham Comparator",Biological,Parallel Assignment,,,,Not Applicable
79,2017-0588,Observational,,Other,,Cohort,,Non-Probability Sample,
80,SK-421-BRCA,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
81,DS8201-A-U302,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
82,LQ005,Observational,,Drug,,Cohort,,Probability Sample,
83,21-480,Observational,,"Behavioral, Behavioral",,Cohort,,Non-Probability Sample,
84,CCR 5113,Interventional,"No Intervention, No Intervention, Experimental, Experimental, Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
85,ICO-N-2017-02,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
86,medicin,Interventional,"Experimental, Placebo Comparator","Diagnostic Test, Radiation, Diagnostic Test, Diagnostic Test, Radiation, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Other, Other",Parallel Assignment,,,,Not Applicable
87,METCZ20200211,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
88,2021LC2210,Observational,,"Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",,Case-Only,,Probability Sample,
89,2020-A00058-31,Interventional,"Other, Other, Other",Other,Parallel Assignment,,,,Not Applicable
90,NCC3299,Observational,,Other,,Other,,Non-Probability Sample,
91,17-581,Observational,,Other,,Other,,Probability Sample,
92,ESR-21-21505,Observational,,Other,,Other,,Probability Sample,
93,2014P002688a,Observational,,Other,,Cohort,,Non-Probability Sample,
94,PekingUPH10B004,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
95,351-19,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
96,ODELIA,Observational,,Other,,Cohort,,Non-Probability Sample,
97,LUMHS/REC/-17,Observational,,Other,,Cohort,,Non-Probability Sample,
98,CD3-MUC1 in breast cancer,Interventional,"Experimental, Active Comparator, No Intervention","Biological, Procedure",Parallel Assignment,,,,Phase 2
99,LCCC 1829,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
100,2022-080,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
101,20218,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
102,2017-03-002A,Observational,,Radiation,,Cohort,40 Weeks,Non-Probability Sample,
103,2018-TJ-BCP,Observational,,"Other, Other",,Other,,Non-Probability Sample,
104,LA LEAST,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
105,2015-004027-31,Interventional,"Other, Other",Radiation,Parallel Assignment,,,,Not Applicable
106,1905795920,Observational,,,,Cohort,,Non-Probability Sample,
107,4-2018-0254,Observational,,Procedure,,Cohort,,Non-Probability Sample,
108,495077,Interventional,"Other, Other",Other,Parallel Assignment,,,,Not Applicable
109,CCR4684,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
110,211753,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
111,22-136,Interventional,Experimental,"Diagnostic Test, Radiation, Procedure",Single Group Assignment,,,,Phase 1
112,BREACE,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
113,1705018188,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
114,CDK-HeCOG-2019,Observational,,,,Cohort,,Non-Probability Sample,
115,RECO_CT29B,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
116,2020-0327,Observational,,"Drug, Diagnostic Test, Diagnostic Test",,Cohort,,Non-Probability Sample,
117,D8531C00002,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
118,SOLTI-1910,Interventional,"Experimental, Active Comparator",Drug,Parallel Assignment,,,,Phase 2
119,SH ABCD,Observational,,Other,,Cohort,5 Years,Non-Probability Sample,
120,1905202-3,Observational,,,,Case-Only,,Probability Sample,
121,2022-8048-23560,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
122,Targeted axillary dissection,Interventional,Experimental,Procedure,Single Group Assignment,,,,Phase 4
123,2021-0215,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
124,2019-A01861-56,Observational,,Other,,Cohort,,Probability Sample,
125,GFY202001,Observational,,,,Cohort,,Non-Probability Sample,
126,18-634,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
127,IRB # 21-0026,Observational,,Other,,Cohort,,Non-Probability Sample,
128,IRB00002991,Observational,,Radiation,,Cohort,,Probability Sample,
129,LCCC 1954,Observational,,Other,,Cohort,,Probability Sample,
130,20 KHCC 202,Observational,,,,Cohort,,Probability Sample,
131,ESR-17-12934,Observational,,Diagnostic Test,,Case-Control,,Probability Sample,
132,69HCL22_0613,Observational,,Other,,Cohort,,Non-Probability Sample,
133,17-398,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
134,LCCC2213,Observational,,Behavioral,,Ecologic or Community,,Non-Probability Sample,
135,IC 2018-01,Interventional,"Experimental, Experimental","Diagnostic Test, Diagnostic Test",Sequential Assignment,,,,Not Applicable
136,IC 2020 08,Interventional,"Experimental, Experimental","Diagnostic Test, Diagnostic Test",Sequential Assignment,,,,Not Applicable
137,PI17/00834,Interventional,,Other,Single Group Assignment,,,,Not Applicable
138,FMASUMD232/2021,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
139,PekingUMCH-FAPI-BC-2,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
140,PekingUMCH-FAPI-BC-1,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
141,Breast immune checkpoint,Observational,,Diagnostic Test,,Case-Control,2 Weeks,Non-Probability Sample,
142,180034,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
143,IRB17-0721,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
144,REO 027,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug, Drug, Drug",Parallel Assignment,,,,Early Phase 1
145,CentroHLO_EFBreastCancer,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
146,BCL IDE,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
147,2018-177-IMP-EXP-4,Observational,,Other,,Case-Control,,Non-Probability Sample,
148,elastography in breast cancer,Observational,,Device,,Cohort,,Non-Probability Sample,
149,V3-MOMMO-01,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 2
150,PROICM 2020-01 OST,Observational,,Other,,Cohort,,Probability Sample,
151,077-2019,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
152,84434789,Observational,,,,Case-Crossover,,Probability Sample,
153,CBS-PIK3CA,Observational,,Diagnostic Test,,Other,,Probability Sample,
154,JuÃ§ara Phd Thesis,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
155,2021-004,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
156,18-281,Observational,,Other,,Other,,Probability Sample,
157,2021-A02676-35,Observational,,Other,,Cohort,,Probability Sample,
158,ARNA Breast 2021,Observational,,Diagnostic Test,,Case-Control,,Probability Sample,
159,18 SEIN 08,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
160,SNP-17-001,Observational,,,,Cohort,,Probability Sample,
161,2021-012,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
162,2394,Observational,,,,Cohort,,Probability Sample,
163,69HCL18_0769,Observational,,Other,,Ecologic or Community,,Non-Probability Sample,
164,2020-KY-064,Observational,,"Drug, Drug, Drug, Drug, Drug, Drug",,Cohort,,Probability Sample,
165,CASE12119,Interventional,"Experimental, Active Comparator","Genetic, Genetic, Other, Other, Device",Parallel Assignment,,,,Not Applicable
166,18-124,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
167,EFC16133,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
168,964635,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
169,3049,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
170,18-461,Observational,,Behavioral,,Case-Only,,Non-Probability Sample,
171,82944089,Observational,,,,Case-Crossover,,Probability Sample,
172,NewGiza University Protocol 1,Observational,,Drug,,Case-Control,,Non-Probability Sample,
173,s66248,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
174,2019402,Interventional,"Experimental, Experimental, Other","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
175,Protocol EMIT-1,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
176,19-003085,Observational,,Genetic,,Cohort,,Non-Probability Sample,
177,SCCC-11118; STU-2018-0015,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
178,RADIO-SLEEP,Interventional,Experimental,"Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
179,3/19,Observational,,Other,,Cohort,,Non-Probability Sample,
180,2017/1356,Observational,,,,Case-Only,,Non-Probability Sample,
181,17/09/621_Myosin VI,Observational,,Other,,Other,,Non-Probability Sample,
182,left breast cancer,Observational,,,,Case-Control,,Non-Probability Sample,
183,IC 2016-07,Observational,,Other,,Cohort,,Non-Probability Sample,
184,180212-1,Observational,,Radiation,,Cohort,5 Years,Non-Probability Sample,
185,19-001,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
186,UCaenNormandie,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
187,CTRP6 in Breast Cancer,Observational,,Other,,Case-Control,,Probability Sample,
188,CESM in breast cancer,Observational,,,,Cohort,,Probability Sample,
189,SOLTI-1903,Observational,,Other,,Other,,Probability Sample,
190,Vitamin D in breast cancer,Observational,,Diagnostic Test,,Case-Only,,Non-Probability Sample,
191,17-552,Interventional,"Active Comparator, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
192,STUDY00011606,Interventional,"Experimental, Experimental, Experimental, Experimental, No Intervention","Other, Other, Other, Other",Factorial Assignment,,,,Not Applicable
193,CCR5348,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
194,19HLSEIN02,Observational,,Other,,Cohort,,Probability Sample,
195,200056,Interventional,"Experimental, Experimental, Experimental","Biological, Drug, Biological, Biological",Sequential Assignment,,,,Phase 1
196,03/21,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
197,AHQU-2021007,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
198,D8530C00003,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
199,2019-05-157,Interventional,Other,Diagnostic Test,Sequential Assignment,,,,Not Applicable
200,182-20-CA,Interventional,"Experimental, Experimental",Diagnostic Test,Parallel Assignment,,,,Phase 2
201,KY20192114-C-1,Observational,,"Diagnostic Test, Procedure",,Cohort,,Non-Probability Sample,
202,STUDY19060359,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
203,2019.089,Observational,,,,Case-Only,4 Years,Probability Sample,
204,NeoRadUKD,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Phase 3
205,004181,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
206,Shengjing-LCG008,Interventional,"Experimental, Other","Drug, Drug",Parallel Assignment,,,,Phase 3
207,Xist,Observational,,Genetic,,Case-Control,,Probability Sample,
208,HERMIONE 13,Observational,,,,Case-Only,,Non-Probability Sample,
209,NL75855.091.21,Observational,,Device,,Cohort,,Probability Sample,
210,CASE5118,Observational,,"Other, Other",,Cohort,,Non-Probability Sample,
211,UEM0002,Interventional,"Experimental, Experimental, Placebo Comparator","Other, Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
212,21 SEIN 09,Interventional,Other,"Other, Other",Single Group Assignment,,,,Not Applicable
213,CINEICC-3-IAT,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
214,Bakircay University,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
215,STANDPOINT,Observational,,"Procedure, Drug",,Case-Only,,Probability Sample,
216,21149002,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
217,21-528,Observational,,Other,,Cohort,,Non-Probability Sample,
218,HR-HER2-RWS-01,Observational,,Drug,,Cohort,,Non-Probability Sample,
219,AAAU1629,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
220,DS8201-0002-EAP-MA,Observational,,Drug,,Cohort,,Non-Probability Sample,
221,2020-12/898,Observational,,"Drug, Procedure, Drug",,Cohort,,Probability Sample,
222,01-BR-003,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
223,PI-0538-2017,Observational,,,,Case-Control,,Probability Sample,
224,2020[84],Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Early Phase 1
225,IRB202100182 -N,Interventional,"Experimental, Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
226,BC-NEO-IIT-SHR1316-SHR6390-RT,Interventional,"Experimental, Experimental","Drug, Drug, Radiation",Parallel Assignment,,,,Not Applicable
227,121K686,Interventional,"Experimental, Active Comparator, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
228,CHIR-07-Sentimag,Observational,,"Procedure, Procedure, Procedure",,Case-Only,,Non-Probability Sample,
229,2019-KY-001-003,Interventional,Experimental,Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
230,06-2020,Observational,,,,Case-Only,,Non-Probability Sample,
231,CHUBX 2016/19,Observational,,Other,,Case-Only,,Non-Probability Sample,
232,AbantIBU,Interventional,"Experimental, Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
233,Breast Cancer,Interventional,"Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
234,21/4657,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
235,URomLS Prot.0930/2021Rif. 6528,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
236,BSU,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
237,NADOPTIC,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
238,2020-0724,Observational,,"Procedure, Procedure, Other",,Case-Control,,Non-Probability Sample,
239,17-PP-19,Observational,,Other,,Case-Control,,Probability Sample,
240,Pro00020917,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
241,LCCC 1749,Interventional,Experimental,"Behavioral, Other",Single Group Assignment,,,,Not Applicable
242,22-x145,Interventional,"Experimental, Active Comparator, Other, Experimental","Device, Procedure",Parallel Assignment,,,,Not Applicable
243,SOLTI-1716,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
244,2015-4-6-003,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
245,GIMI-IRB-20005,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
246,147/19,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
247,STUDY00001641,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
248,MD 177/2021,Observational,,,,Cohort,,Non-Probability Sample,
249,PetrovRIO,Interventional,"Experimental, Experimental",Procedure,Single Group Assignment,,,,Not Applicable
250,FIRST,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
251,19-001004,Observational,,,,Case-Control,,Non-Probability Sample,
252,A5481177,Observational,,,,Cohort,,Non-Probability Sample,
253,PUMCH-BREAST-ctDNA screening,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
254,2017-KY-19,Observational,,Other,,Cohort,,Probability Sample,
255,19049,Observational,,Other,,Other,,Probability Sample,
256,Z211100002921033,Observational,,Drug,,Cohort,,Non-Probability Sample,
257,Radiotherapy in breast cancer,Observational,,Radiation,,Cohort,,Non-Probability Sample,
258,Breast cancer neoadjuvant,Observational,,Diagnostic Test,,Case-Only,,Non-Probability Sample,
259,CFDAIIUASABFDOBC,Observational,,Diagnostic Test,,Other,,Non-Probability Sample,
260,SYSEC-KY-2018-018,Observational,,Procedure,,Cohort,,Non-Probability Sample,
261,852-20,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
262,2020-KY-063,Observational,,,,Cohort,,Probability Sample,
263,PROICM 2019-16-BCU,Observational,,Other,,Other,,Probability Sample,
264,wanghaibo,Interventional,Experimental,Biological,Single Group Assignment,,,,Early Phase 1
265,IBCSG 59-19,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
266,PUMCH-BC502,Observational,,,,Cohort,,Non-Probability Sample,
267,33293720.9.0000.5505,Interventional,"Experimental, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
268,19-045,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
269,199080,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
270,SCHBCC-N024,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
271,SOLTI-1907,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
272,4817,Observational,,Genetic,,Cohort,,Non-Probability Sample,
273,EEBC,Observational,,"Procedure, Drug",,Cohort,,Non-Probability Sample,
274,symptom of breast cancer,Observational,,"Behavioral, Behavioral",,Cohort,,Non-Probability Sample,
275,APHP211502,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
276,IEO 0761/,Observational,,,,Case-Only,,Non-Probability Sample,
277,SDS-HER-01-2018,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
278,ISTMET-BHWGI2022-1,Observational,,Radiation,,Cohort,5 Years,Non-Probability Sample,
279,SLN SPECT,Interventional,"Active Comparator, Active Comparator","Device, Device",Sequential Assignment,,,,Not Applicable
280,Cpetptmrbc,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
281,Tiresias,Observational,,Diagnostic Test,,Cohort,5 Years,Probability Sample,
282,RWD_abemaciclib,Observational,,,,Cohort,30 Months,Non-Probability Sample,
283,ML40952,Observational,,,,Cohort,,Non-Probability Sample,
284,CELC-G-301,Interventional,"Experimental, Experimental, Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
285,CARMA-2101,Observational,,,,Cohort,,Non-Probability Sample,
286,A5481125,Observational,,,,Cohort,,Non-Probability Sample,
287,20-1789.cc,Observational,,Behavioral,,Cohort,,Probability Sample,
288,DBCG Proton trial,Interventional,"Active Comparator, Experimental",Radiation,Parallel Assignment,,,,Not Applicable
289,710/2021,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
290,OOTR-N016/KBCRN-B-003/HT-PAB,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
291,19-003028,Observational,,Procedure,,Case-Control,,Non-Probability Sample,
292,V2_16-04-2020,Observational,,Device,,Cohort,,Probability Sample,
293,N19ASC,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
294,SNBvsPET/MRI 2,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
295,dingxwyh01,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Not Applicable
296,KL166-IIS-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
297,SNUH_FMI,Interventional,Other,Genetic,Single Group Assignment,,,,Not Applicable
298,RF-2013-02358165,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
299,2022/0035986,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
300,dingxwyh02,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Not Applicable
301,18-516,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
302,17/0765,Observational,,Procedure,,Cohort,,Non-Probability Sample,
303,AURORA,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
304,2022106,Observational,,Drug,,Cohort,,Non-Probability Sample,
305,BR02/03/21,Interventional,Experimental,Device,Sequential Assignment,,,,Phase 1
306,19-147,Interventional,Experimental,"Diagnostic Test, Other",Single Group Assignment,,,,Phase 1
307,1186,Observational,,Genetic,,Cohort,,Probability Sample,
308,19 SEIN 14,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
309,01-2021,Observational,,"Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",,Cohort,,Non-Probability Sample,
310,2018-9529,Interventional,"Other, Other","Device, Procedure",Parallel Assignment,,,,Not Applicable
311,REaCT-HER TIME,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
312,FLA 18-057,Observational,,Procedure,,Cohort,,Non-Probability Sample,
313,HERdi PREDICT,Observational,,Other,,Cohort,,Non-Probability Sample,
314,SOLTI-1911,Interventional,"Experimental, Other","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
315,D9673R00011,Observational,,,,Cohort,,Probability Sample,
316,IC 2018-08,Interventional,Experimental,"Genetic, Genetic, Behavioral",Single Group Assignment,,,,Not Applicable
317,Breast Cancer,Observational,,Diagnostic Test,,Case-Control,,Non-Probability Sample,
318,APHP211593,Observational,,Other,,Other,,Non-Probability Sample,
319,AHQU-2021006,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
320,V2011201,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
321,Shengjing-LCG009,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
322,HCB-ONC001 (ML41519),Interventional,"Experimental, No Intervention",Biological,Single Group Assignment,,,,Phase 2
323,IAyas2,Observational,,,,Case-Control,,Non-Probability Sample,
324,IRB-300002157,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
325,SOC.04/20-21,Observational,,Other,,Cohort,,Probability Sample,
326,BC001,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
327,OTT-19-06,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
328,A5481176,Observational,,,,Cohort,,Non-Probability Sample,
329,20210312,Observational,,Drug,,Cohort,,Probability Sample,
330,19-509,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
331,Sentinel lymph node biopsy,Observational,,Procedure,,Cohort,,Non-Probability Sample,
332,UT BCS ECS Study,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
333,oddie2,Observational,,Device,,Cohort,,Probability Sample,
334,FMASU R61/2020,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
335,UW 20-064,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
336,18-109,Observational,,Drug,,Cohort,,Probability Sample,
337,19-277,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
338,FAST feasibility in CU,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
339,UC-0105/1701,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
340,20-1039,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
341,BRAR1,Observational,,Diagnostic Test,,Case-Control,,Non-Probability Sample,
342,18-1025,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
343,IRB16-0396,Observational,,"Diagnostic Test, Diagnostic Test",,Cohort,,Non-Probability Sample,
344,09.2019.984,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Not Applicable
345,O4M-B001,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
346,STGKS001,Interventional,"Active Comparator, Experimental","Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
347,TaiHao TVGH2020-07-006AC#1,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
348,CNER 202107/05,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
349,Optimune Trial,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
350,19-086,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
351,Emotional security&mastectomy,Observational,,,,Case-Only,,Non-Probability Sample,
352,1808019498,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Radiation, Drug, Biological",Parallel Assignment,,,,Phase 2
353,HYGEE,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,,,,Not Applicable
354,Breast Audit,Observational,,,,Other,,Non-Probability Sample,
355,STU-2018-0370,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
356,A5481115,Observational,,,,Cohort,,Non-Probability Sample,
357,Prix Ruban Rose/2021/FF-01,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
358,MRI in breast cancer,Observational,,Device,,Other,,Non-Probability Sample,
359,Pyrotinib neoadjuvant,Interventional,"Experimental, Active Comparator","Combination Product, Combination Product",Parallel Assignment,,,,Phase 2
360,SMC 2021-02-102,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
361,BSMMU/2019/8874,Interventional,"No Intervention, Active Comparator",Drug,Parallel Assignment,,,,Not Applicable
362,FUSCC-OMIT,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
363,20210601,Observational,,Procedure,,Cohort,3 Years,Non-Probability Sample,
364,Telemonitoring BCS,Interventional,"Experimental, Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
365,CCTG MA.39,Interventional,"Active Comparator, Active Comparator","Radiation, Other",Parallel Assignment,,,,Phase 3
366,99mTc-ADAPT6 vs 99mTc-DARPinG3,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Not Applicable
367,2021-1116,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 3
368,2490,Observational,,Diagnostic Test,,Case-Control,,Non-Probability Sample,
369,IRB-2022-166,Observational,,Other,,Other,,Non-Probability Sample,
370,19/317-2101,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Phase 3
371,s66248-aim2,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
372,SPT-2021-002,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 4
373,Cardiac safety study,Observational,,Drug,,Cohort,,Non-Probability Sample,
374,BGB-290-201,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
375,EORTC 1745-ETF-BCG,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
376,10038,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological",Sequential Assignment,,,,Phase 1
377,Pro00085352,Interventional,Experimental,Biological,Single Group Assignment,,,,Early Phase 1
378,4523,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
379,01AB21- PIK3CA,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
380,Optimune Trial Add-on,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
381,2018396H,Interventional,"Experimental, Active Comparator",Drug,Parallel Assignment,,,,Phase 2
382,2004-261-112,Observational,,Diagnostic Test,,Cohort,2 Years,Non-Probability Sample,
383,ICO-N-2017-12,Interventional,"Experimental, Experimental, Experimental","Procedure, Biological, Behavioral",Parallel Assignment,,,,Not Applicable
384,17-455,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Crossover Assignment,,,,Phase 2
385,69HCL18_0310,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
386,IJB-NERABRAIN-ODN-007,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
387,APHP190505,Observational,,Other,,Case-Control,,Probability Sample,
388,19-066,Interventional,"Experimental, Experimental, No Intervention, Experimental",Device,Parallel Assignment,,,,Not Applicable
389,GEICAM/2019-01,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
390,MA-BC-â¡-040,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
391,PROICM 2020-05 SKY,Interventional,"Experimental, Placebo Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
392,EH18-203,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
393,2019-1183,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 1
394,A211801,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Other",Parallel Assignment,,,,Phase 3
395,BakircayU,Observational,,"Other, Other, Other, Other, Other, Other, Other, Other, Other",,Cohort,,Non-Probability Sample,
396,SGK-SFC-001,Observational,,,,Other,10 Years,Non-Probability Sample,
397,22-280,Observational,,"Other, Diagnostic Test, Diagnostic Test",,Cohort,,Non-Probability Sample,
398,SOC.03/20-21,Observational,,"Other, Other, Diagnostic Test",,Cohort,,Probability Sample,
399,CAAE: 39277420.8.0000.5313,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
400,5354-CL-1201,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 2
401,800646,Interventional,"Experimental, No Intervention",Behavioral,Sequential Assignment,,,,Not Applicable
402,D361DC00001,Interventional,"Experimental, Placebo Comparator, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
403,2019-228,Interventional,"No Intervention, Experimental",Radiation,Parallel Assignment,,,,Not Applicable
404,PekingUMCH-NM25,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
405,MO39485,Observational,,"Drug, Drug, Drug, Drug, Drug, Drug",,Cohort,,Probability Sample,
406,BCP28,Observational,,,,Cohort,,Probability Sample,
407,DARE,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
408,NP 1521/19,Interventional,"Experimental, Active Comparator","Drug, Other",Parallel Assignment,,,,Not Applicable
409,NOV2016PhD818,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
410,M2020 UK01,Observational,,Device,,Other,,Probability Sample,
411,TRA05-GEFPICS,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
412,ATADEK-2021/14/16,Observational,,Other,,Case-Control,,Probability Sample,
413,[2019]52,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
414,EudraCT 2020-005200-19,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
415,GEICAM/2017-01_IBCSG 62-20_BIG,Interventional,"Experimental, Experimental, Active Comparator","Biological, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
416,J21125,Interventional,Other,"Other, Other, Behavioral, Behavioral, Other, Other, Behavioral, Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
417,PekingUMCH-FES-BC-1,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
418,D9673C00007,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 3
419,GCO 17-00563,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
420,LY2022-028-B,Observational,,Drug,,Cohort,,Probability Sample,
421,18ON009,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
422,MD.21.09.521.R,Observational,,Procedure,,Other,6 Months,Probability Sample,
423,TQB3616-III-03,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
424,20190283,Interventional,Experimental,Radiation,Sequential Assignment,,,,Not Applicable
425,SPHIC-TR-BCa2022-01,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 1
426,UBRS20139,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
427,2018-9567,Observational,,"Diagnostic Test, Diagnostic Test",,Other,,Non-Probability Sample,
428,FISH in breast cancer,Observational,,,,Case-Control,,Non-Probability Sample,
429,20 SEIN 13,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
430,201819010.4,Observational,,"Genetic, Drug",,Cohort,,Non-Probability Sample,
431,DBCG RT Recon,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
432,NCC3075,Interventional,"Experimental, Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 2
433,CSPC-DMS-BC-13,Observational,,,,Case-Control,,Non-Probability Sample,
434,2018NTLS176,Observational,,Radiation,,Cohort,,Non-Probability Sample,
435,ChanghaiHTB,Interventional,"Experimental, Experimental, Experimental, Experimental","Procedure, Procedure, Drug",Sequential Assignment,,,,Not Applicable
436,BrIMA,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
437,PROICM 2019-11 PRA,Interventional,"Experimental, Placebo Comparator","Drug, Other, Radiation",Parallel Assignment,,,,Phase 3
438,19900601,Interventional,"Experimental, No Intervention",Behavioral,Factorial Assignment,,,,Not Applicable
439,FDRT-BC009,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
440,SRMBCNabP2022,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
441,BCHRD201,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
442,21-3576.cc,Observational,,,,Cohort,,Probability Sample,
443,MCC-20897,Interventional,Experimental,"Biological, Biological",Sequential Assignment,,,,Phase 1
444,C3441020,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
445,IIT2018-01-McArthur-IPI,Interventional,Experimental,"Drug, Drug, Procedure, Procedure",Single Group Assignment,,,,Phase 2
446,18-223,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
447,2018-00838; ch20Weber2,Interventional,"Active Comparator, Active Comparator","Procedure, Radiation, Radiation",Parallel Assignment,,,,Not Applicable
448,2019/FO244363,Observational,,,,Cohort,,Non-Probability Sample,
449,KYJJ-2021-186,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
450,UC-0107/1903,Interventional,"Other, Other, No Intervention","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
451,AB-MR for Second Breast Cancer,Observational,,,,Cohort,,Non-Probability Sample,
452,WSG-AM09,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
453,18-058,Observational,,"Behavioral, Other, Other, Other, Procedure",,Cohort,,Non-Probability Sample,
454,PANONC-1 Version: 1.1,Observational,,"Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",,Cohort,10 Years,Non-Probability Sample,
455,AHQU-2021005,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
456,BC-2019,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
457,SP00049673,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
458,BCSCO003,Observational,,,,Cohort,,Non-Probability Sample,
459,DSCN-EHT-NIS-BC001,Observational,,Other,,Cohort,,Non-Probability Sample,
460,19-188,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
461,LC2019L06,Interventional,"Experimental, No Intervention","Drug, Drug",Parallel Assignment,,,,Phase 2
462,SCBCS025,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
463,17-512,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
464,Breast Screening with DWI,Observational,,,,Cohort,,Non-Probability Sample,
465,19-239,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
466,ICO-2019-03,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
467,GEICAM/2016-03,Observational,,,,Cohort,,Non-Probability Sample,
468,HNCH-BC003,Interventional,"Experimental, Active Comparator","Combination Product, Other",Parallel Assignment,,,,Phase 2
469,State University of SÃ£o Paulo,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
470,02AB21-TucErBit,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
471,21-183,Observational,,Procedure,,Cohort,,Non-Probability Sample,
472,IRB-48150,Interventional,Experimental,"Drug, Procedure, Procedure, Device",Single Group Assignment,,,,"Phase 1, Phase 2"
473,Breast Cancer Screening,Observational,,,,Cohort,1 Year,Non-Probability Sample,
474,Soh-Med-23-01-07,Observational,,Diagnostic Test,,Case-Only,,Probability Sample,
475,D133FR00138,Observational,,,,Other,18 Months,Non-Probability Sample,
476,IUSCC-0613,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,Phase 1
477,21-440,Interventional,"Experimental, Experimental","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
478,GEICAM/2020-08,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
479,2023-09,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
480,16-145,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,,,,Not Applicable
481,ZNJC201935,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
482,YM107109E,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
483,A5481144,Observational,,,,Cohort,,Non-Probability Sample,
484,grid.412416.4,Observational,,,,Other,,Probability Sample,
485,MA-BC-II-024,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
486,18-333,Interventional,Experimental,"Device, Device",Single Group Assignment,,,,Not Applicable
487,ARV-471-BC-201,Interventional,"Experimental, Active Comparator","Drug, Drug, Procedure",Parallel Assignment,,,,Phase 2
488,2018-09-007A,Observational,,Procedure,,Cohort,,Probability Sample,
489,ML42450,Observational,,,,Cohort,,Probability Sample,
490,intestinal flora study,Observational,,Drug,,Case-Only,,Non-Probability Sample,
491,Microbiome_BC&PnC,Observational,,"Drug, Drug, Drug, Drug, Drug",,Cohort,,Probability Sample,
492,DS8201-A-U301,Interventional,"Experimental, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
493,M18DMB,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
494,2017MayPR898,Observational,,Other,,Cohort,,Probability Sample,
495,MUKDEN-09,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
496,R148/2021,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
497,SSGJ-302H-mBC-IIT-01,Interventional,"Active Comparator, Experimental",Drug,Parallel Assignment,,,,Phase 4
498,SCHBCC0N026,Interventional,"Active Comparator, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
499,21-003046,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,,,,Phase 2
500,GNC-035-103,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
501,KY2019-070,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 3
502,NCC 2019-0098,Observational,,Other,,Case-Only,,Probability Sample,
503,NACAGEP,Observational,,Diagnostic Test,,Other,,Non-Probability Sample,
504,CINDERELLA,Interventional,"Experimental, Other",Device,Parallel Assignment,,,,Not Applicable
505,310-17-SZMC,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
506,CCR5214,Interventional,"Experimental, Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
507,K2022-025-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
508,PUMCH-MUSD,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
509,1R01CA236860-01A1,Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
510,D8530C00001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
511,RGT-419B_01-101,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
512,APHP191059,Observational,,,,Cohort,,Non-Probability Sample,
513,BT006,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
514,2017-01282 (BASEC),Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
515,MCC-21757,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Phase 2
516,A5481155,Observational,,,,Cohort,,Non-Probability Sample,
517,21822,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
518,CTNZ-2017-01,Interventional,"Other, Other","Drug, Drug",Crossover Assignment,,,,Phase 2
519,2020-08-06R,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
520,0720222005,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Phase 3
521,20-649,Interventional,Experimental,"Drug, Drug, Radiation",Single Group Assignment,,,,Phase 2
522,D967UC00001,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
523,Qassim QDs-VELD,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 1
524,COV-19 BUMDC,Observational,,Procedure,,Case-Only,18 Months,Non-Probability Sample,
525,PLEASURABLE,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
526,HR-BLTN-III-EBC,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
527,14-833-02,Interventional,"Active Comparator, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
528,CLUE-BCL,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
529,C3441055,Observational,,Drug,,Cohort,,Non-Probability Sample,
530,2020-A01423-36,Observational,,,,Cohort,,Probability Sample,
531,Radiotherapy in Breast Cancer,Interventional,"Experimental, Active Comparator",Radiation,Parallel Assignment,,,,Phase 3
532,CRF-NHI01,Observational,,,,Cohort,,Non-Probability Sample,
533,STML-ELA-0222,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
534,17-519,Interventional,Experimental,"Drug, Procedure",Single Group Assignment,,,,Phase 2
535,nihan25,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
536,H-41818,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
537,PRO00034502,Observational,,Other,,Case-Crossover,,Non-Probability Sample,
538,SCLND0919,Interventional,"Experimental, Active Comparator","Procedure, Radiation",Parallel Assignment,,,,Not Applicable
539,2020-0927,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
540,2020FES,Interventional,Experimental,Radiation,Single Group Assignment,,,,"Phase 1, Phase 2"
541,AHQU-2021001,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
542,PUMA-NER-6203,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
543,Breast cancer in females,Observational,,Other,,Other,,Non-Probability Sample,
544,ADA,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
545,KBCSG-24,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
546,2018LS148,Interventional,"Experimental, Active Comparator","Procedure, Behavioral",Parallel Assignment,,,,Not Applicable
547,CentroHLOBreastUnit,Interventional,"Experimental, No Intervention, Other, Other",Drug,Parallel Assignment,,,,Phase 4
548,PekingUMCH-BCa093,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,"Phase 1, Phase 2"
549,DBCG RT Natural Trial,Interventional,"Active Comparator, No Intervention",Radiation,Parallel Assignment,,,,Not Applicable
550,Fenofibrate in Breast Cancer,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
551,514-0213/21-5000,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Not Applicable
552,AHQU-2021003,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
553,SYSEC-KY-KS-2021-182,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
554,GCO 21-0699,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
555,IPNCb-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
556,003-2017,Interventional,Experimental,Radiation,Sequential Assignment,,,,Not Applicable
557,CCR4965,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
558,CASE6119,Interventional,"Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,Early Phase 1
559,E19137,Observational,,,,Case-Control,,Non-Probability Sample,
560,55791222.0.0000.5313,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
561,CSPC-KAL-BC-12,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
562,NCC2018M-042,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
563,STU00201961A,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
564,18-561,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
565,Breast cancer treatment,Interventional,"Placebo Comparator, Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
566,UF-BRE-002,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
567,348455,Interventional,Other,Behavioral,Single Group Assignment,,,,Not Applicable
568,Vitamin D and breast cancer,Interventional,"No Intervention, Experimental",Drug,Parallel Assignment,,,,"Phase 2, Phase 3"
569,LR19/011/50551,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
570,CTO-IUSCCC-0803,Observational,,,,Case-Only,,Probability Sample,
571,Zz123456.,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
572,GBG102 - SASCIA,Interventional,"Experimental, Other","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
573,SYSKY-2022-030-01,Observational,,Other,,Cohort,,Non-Probability Sample,
574,KX-ORAX-CN-007,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
575,PROICM 2018-05 BCU,Observational,,Other,,Other,,Probability Sample,
576,18-010602,Observational,,Device,,Case-Only,,Non-Probability Sample,
577,CCH-IRB-190414-P,Interventional,"Experimental, Active Comparator, Active Comparator","Device, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
578,CLEE011O12301C,Interventional,"Experimental, Active Comparator","Drug, Other",Parallel Assignment,,,,Phase 3
579,BREAST-SK-001,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
580,UI-ROD-OCTU02,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
581,HIRSLANDEN 01 SAKK 23/18,Interventional,Experimental,Procedure,Sequential Assignment,,,,Not Applicable
582,CAAE: 91570318.5.0000.5149,Observational,,Other,,Cohort,,Probability Sample,
583,18-641,Interventional,"Experimental, Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
584,FWA00015574/6-01-2019/korany,Interventional,"Experimental, Other","Drug, Drug",Parallel Assignment,,,,Phase 2
585,SOLTI-2101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
586,PN-301-21,Interventional,"Experimental, Active Comparator","Biological, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
587,KY20182079-F-1,Observational,,"Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",,Case-Only,,Probability Sample,
588,KY20202075-F-2,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
589,GIM21 - LiqERBcept,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
590,4-2018-0160,Observational,,"Radiation, Radiation",,Cohort,,Non-Probability Sample,
591,SOLTI-1805,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Early Phase 1
592,ROCK,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
593,Radiation in breast cancer,Observational,,Radiation,,Cohort,,Non-Probability Sample,
594,iOM-110383,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
595,06805118.2.1001.5404,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
596,ID4060,Observational,,Drug,,Cohort,,Non-Probability Sample,
597,MedOPP293,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
598,IRST174.25,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
599,AN.MCME.CR.12,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
600,EUROPA,Interventional,"Experimental, Active Comparator","Radiation, Drug",Parallel Assignment,,,,Phase 3
601,UF-BRE-007,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
602,0023041/i,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
603,2017-0499,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Phase 1
604,HM022BC3C01,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
605,CASE13119,Interventional,"Experimental, Placebo Comparator","Biological, Other",Parallel Assignment,,,,Not Applicable
606,SOLTI-2103,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
607,2020_61,Observational,,Other,,Cohort,,Non-Probability Sample,
608,SOLTI-1503,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,Early Phase 1
609,UPCC 17120,Interventional,Experimental,"Behavioral, Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
610,LQ009,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
611,IRB-57723,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
612,BGB-900-2001-IIT,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
613,115858,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
614,CLEE011H2301,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
615,D8530C00006,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
616,Shengjing_002,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
617,IIT-UM2018001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
618,ONAWA (SOLTI-1802),Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
619,Shengjing-LJY04,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
620,1,Interventional,"Experimental, No Intervention",Radiation,Parallel Assignment,,,,Not Applicable
621,ZX-2021-FES-ESTROTIMP-4,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
622,CCH-IRB-190414-R,Interventional,"Experimental, Active Comparator, Active Comparator","Device, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
623,STUDY00010776,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
624,3764,Interventional,Experimental,Radiation,Single Group Assignment,,,,Early Phase 1
625,2019-004559-35,Interventional,Experimental,"Drug, Drug, Drug, Drug, Procedure",Single Group Assignment,,,,Phase 2
626,UCCS20110,Interventional,Experimental,Other,Single Group Assignment,,,,Phase 1
627,RP-20-013,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,,,,Phase 4
628,KARMA Kontrast,Interventional,Other,Combination Product,Single Group Assignment,,,,Not Applicable
629,STUDY2019000317,Observational,,Radiation,,Cohort,5 Years,Non-Probability Sample,
630,STUDY00001225,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Phase 2
631,BREAST,Observational,,,,Cohort,2 Years,Non-Probability Sample,
632,2020-535,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
633,ACE-Breast-03,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
634,FirstHCMU_CB_001,Observational,,"Drug, Drug, Drug, Drug, Drug",,Other,,Probability Sample,
635,CCR5119,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
636,FMBSUREC/10102021/Rabie,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,"Phase 2, Phase 3"
637,GEICAM/2017-04,Observational,,,,Case-Only,,Probability Sample,
638,dAGEs,Observational,,Other,,Cohort,,Non-Probability Sample,
639,21-271,Observational,,"Diagnostic Test, Diagnostic Test, Diagnostic Test",,Cohort,,Non-Probability Sample,
640,1808-42,Observational,,Other,,Cohort,,Non-Probability Sample,
641,3475-756,Interventional,"Experimental, Placebo Comparator","Biological, Drug, Drug, Drug, Drug, Drug, Drug, Radiation, Procedure",Parallel Assignment,,,,Phase 3
642,2022-0055,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
643,WEFITTER,Interventional,"Active Comparator, No Intervention",Device,Parallel Assignment,,,,Not Applicable
644,A5481178,Observational,,,,Cohort,,Non-Probability Sample,
645,ARO-2015-1,Interventional,"No Intervention, Experimental",Radiation,Parallel Assignment,,,,Not Applicable
646,20-124,Interventional,"Experimental, Experimental, Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
647,DKFZ-2019-008,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, No Intervention","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
648,EF141,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
649,SHPD005,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 2
650,20170328,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
651,HNCH-MBC11,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
652,NIR-THERMA-02,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
653,Pro00020138,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
654,SOLTI-1507,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
655,E7389-M082-602,Observational,,Drug,,Cohort,,Probability Sample,
656,18-394,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
657,LaPemERLA,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
658,123123,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
659,2019SABE028,Interventional,"Experimental, Active Comparator","Procedure, Other",Parallel Assignment,,,,Not Applicable
660,IIBSP-PRO-2021-10,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
661,2021/193780(REK),Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
662,CP7-005,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
663,STUDY00001233,Observational,,Device,,Cohort,,Non-Probability Sample,
664,SYSUCC-015,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
665,INCASE0518,Observational,,Other,,Cohort,,Non-Probability Sample,
666,CIMS-4FMFES-2021-3966,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Phase 2
667,2019.429,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
668,REO 026-1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
669,HLX11-BC301,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
670,JTU-6H-20211011001,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
671,Stage 2 compression therapy,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
672,INST 1607,Observational,,Other,,Cohort,,Non-Probability Sample,
673,Yunwei Wei 2019-09-13,Observational,,Drug,,Case-Control,,Probability Sample,
674,SOLTI-1718,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
675,Tacrolimus_2020,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
676,CL1-81694-003,Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
677,PROICM 2020-07 VIS,Interventional,Other,"Other, Other",Single Group Assignment,,,,Not Applicable
678,Zoledronic Acid In Breast Ca,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 3
679,CASE5120,Interventional,"Experimental, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
680,2020.KB.SAG.069,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
681,6788,Observational,,,,Cohort,,Non-Probability Sample,
682,KSRAD001,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
683,20-157,Interventional,"Experimental, Experimental, Experimental","Radiation, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
684,INNOVBC,Interventional,"Experimental, Other",Behavioral,Parallel Assignment,,,,"Phase 2, Phase 3"
685,NCC1824,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
686,Shengjing-LCG005,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
687,WO39391,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
688,HunanCH-BC-001,Observational,,Drug,,Case-Only,,Non-Probability Sample,
689,GENEXAN,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
690,2-102-21,Observational,,"Diagnostic Test, Biological",,Case-Control,,Probability Sample,
691,GRO-06-001,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
692,R20-003,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
693,DS8201-A-U305,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
694,2021.693,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
695,HSC20160245H,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
696,MedOPP319,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
697,NCC1867,Observational,,Other,,Other,,Non-Probability Sample,
698,2000025837,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
699,Shengjing_001,Observational,,Drug,,Case-Only,,Probability Sample,
700,16D.674,Interventional,Other,"Procedure, Other, Other",Single Group Assignment,,,,Not Applicable
701,REC-H-PHBSU-21010,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
702,PREDIX II HER2,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
703,Melody_002,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
704,Neveen,Observational,,,,Case-Control,,Non-Probability Sample,
705,PCS-001,Observational,,Procedure,,Cohort,,Non-Probability Sample,
706,YOUNGBC-22,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
707,2018.016,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
708,18-603,Interventional,"Experimental, Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
709,R.20.05.834,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
710,17/209,Interventional,Other,Radiation,Single Group Assignment,,,,Not Applicable
711,ATADEK 2022-17/27,Interventional,"Active Comparator, Experimental","Device, Other",Parallel Assignment,,,,Not Applicable
712,SMC-2019-05-021 (2),Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
713,2018.08.ST,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
714,2020/33,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
715,HE071-CSP-021,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
716,2021-0170,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
717,SMC- 5725-18,Interventional,"Experimental, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
718,ORIN1001-001,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
719,CHIR-01-sentinel,Interventional,"Experimental, Experimental, Experimental, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
720,D3615C00001,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
721,MCC-20902,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
722,1563/2018,Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
723,YYS-20200305,Interventional,"Placebo Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
724,HNCH-BC010,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
725,PUMCH-SBSBC,Interventional,"Experimental, Other","Drug, Behavioral",Parallel Assignment,,,,Phase 3
726,PUMCH-BC501,Observational,,,,Cohort,,Non-Probability Sample,
727,Breast Cancer-RISS,Interventional,"Active Comparator, No Intervention",Drug,Parallel Assignment,,,,Phase 4
728,MACSSI (ET18-150),Observational,,Other,,Cohort,,Non-Probability Sample,
729,B27IB3856,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
730,C3441053,Observational,,Drug,,Cohort,,Non-Probability Sample,
731,CAN04CLIN005,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
732,LCCC2105,Observational,,Behavioral,,Case-Only,,Non-Probability Sample,
733,"2016-051-000001, 2563",Interventional,"Other, Other, Other","Other, Other, Other",Parallel Assignment,,,,Not Applicable
734,YOUNGBC-7,Observational,,,,Cohort,,Non-Probability Sample,
735,LUN_MMG_121,Observational,,Radiation,,Cohort,,Probability Sample,
736,STML-ELA-0322,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
737,H-50349,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
738,MIES-BCNAT,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
739,NCC2019-0142,Observational,,,,Cohort,,Non-Probability Sample,
740,20G.605,Interventional,Experimental,"Procedure, Drug, Procedure",Single Group Assignment,,,,Early Phase 1
741,RJrapidplan,Observational,,Radiation,,Cohort,,Non-Probability Sample,
742,NIS12501,Observational,,,,Cohort,,Non-Probability Sample,
743,eMOUVOIR-1901,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
744,LACUDY,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Not Applicable
745,2-049-18,Observational,,,,Case-Control,,Probability Sample,
746,UT BCS Sleep Study,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
747,22SCH740,Interventional,Other,Drug,Single Group Assignment,,,,Phase 2
748,B002-101,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
749,19-002792,Interventional,"Active Comparator, Experimental",Procedure,Parallel Assignment,,,,Not Applicable
750,919PP17,Interventional,"No Intervention, Experimental",Drug,Parallel Assignment,,,,Phase 2
751,MCC-21378,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Drug, Drug, Biological",Sequential Assignment,,,,Phase 1
752,2022-7735,Interventional,"Experimental, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
753,2021-0358,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
754,20210504,Observational,,,,Cohort,,Probability Sample,
755,010006,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
756,UC-0105/1815,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
757,18-2444.cc,Observational,,Other,,Cohort,,Non-Probability Sample,
758,NCC3340,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
759,YOMA,Interventional,"Experimental, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
760,C4891023,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,Phase 2
761,CSPC-DMS-BC-17,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
762,GS-US-595-6184,Interventional,"Experimental, Active Comparator","Biological, Biological, Drug",Parallel Assignment,,,,Phase 3
763,SYSU-2022-02,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
764,HR-BLTN-008,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
765,HR BLTN 014,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
766,IRB00130428,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Phase 2
767,GO40987,Interventional,"Experimental, Experimental, Experimental","Drug, Procedure",Parallel Assignment,,,,Phase 1
768,HNCH-MBC08-BM02,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
769,19-003532,Observational,,,,Case-Only,,Non-Probability Sample,
770,TRICIA,Observational,,Other,,Cohort,,Probability Sample,
771,1780,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
772,STU00206180,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
773,MA-BC-II-006,Interventional,Experimental,"Biological, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
774,HR-TNBC-HN100,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
775,SNF4,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
776,PALBOCOMP,Observational,,Drug,,Cohort,,Non-Probability Sample,
777,17/013,Interventional,"Active Comparator, Active Comparator","Radiation, Drug",Parallel Assignment,,,,Phase 2
778,2020 - 176,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
779,OkanU2,Observational,,Other,,Other,2 Years,Non-Probability Sample,
780,LACOG 0221,Observational,,,,Cohort,,Non-Probability Sample,
781,SNF3,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
782,EC/TMC/108/17,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
783,2019-09-09,Interventional,"Active Comparator, Experimental, Experimental, Experimental",Procedure,Parallel Assignment,,,,Not Applicable
784,2018-68-1461,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
785,YANWQ002,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
786,SGRT-BC,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,"Phase 2, Phase 3"
787,MR-01,Observational,,Other,,Cohort,,Non-Probability Sample,
788,PALBOSPAIN,Observational,,Drug,,Cohort,,Non-Probability Sample,
789,CMUH108-REC3-090,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
790,UBRS20013,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
791,HR-BLTN-014,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
792,EBaran,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
793,SPI-POZ-101,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
794,OstacoliMIND&BC,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
795,2019-0088,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
796,261\\2021,Interventional,"No Intervention, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
797,RC48-C012,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
798,R20-030,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
799,SYSA1901-002,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
800,OTT 18-02,Interventional,"Active Comparator, Active Comparator",Combination Product,Parallel Assignment,,,,Phase 4
801,CYH33-G103,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
802,ERIBRAIN-IPC 2017-014,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
803,2019/2452,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
804,CMUH106-REC3-137,Interventional,"Experimental, Experimental, Experimental",Drug,Crossover Assignment,,,,Not Applicable
805,NL77000.029.21,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
806,HR-BLTN-010,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
807,MUKDEN 07,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
808,NCC3286,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,,,,Phase 2
809,YBCSG-21-03,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
810,20-104,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
811,99mTc-ADAPT6,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
812,STUDY00022698,Observational,,"Other, Other, Other, Other, Other",,Other,,Non-Probability Sample,
813,SMX 22-002,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
814,SCAN-B-rec,Observational,,Diagnostic Test,,Cohort,10 Years,Non-Probability Sample,
815,DS8201-A-U303,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
816,20F.259,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,,,,"Phase 2, Phase 3"
817,9745,Observational,,Device,,Case-Crossover,,Non-Probability Sample,
818,LMengmeng,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
819,2010134480,Interventional,"Other, Other","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
820,SLNB-ACP,Observational,,,,Cohort,6 Years,Non-Probability Sample,
821,NCC1888,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
822,H18-02581,Interventional,Experimental,"Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
823,J1836,Interventional,"Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
824,K171005J,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
825,X-XJTU1AFLSY-93,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
826,HCI131027,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
827,D967JC00001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
828,18-371,Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
829,AI-BMRI,Observational,,Other,,Cohort,,Probability Sample,
830,SCHBCC-N030,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 2
831,CLEE011AUS64,Observational,,"Drug, Drug, Drug",,Cohort,,Probability Sample,
832,ERC/2020/10/11 (26/10/2020),Interventional,"No Intervention, Experimental","Device, Other, Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
833,19-055,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Phase 1
834,BC-P29,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
835,2021/32,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
836,XZP-3287-3002,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
837,R21-072,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
838,SCHBCC-N025,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
839,OMICS Mark,Observational,,Drug,,Case-Control,5 Years,Non-Probability Sample,
840,Smart,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
841,RS-NAT01,Interventional,"Active Comparator, No Intervention, Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
842,TeMP 2021,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
843,MC220301,Interventional,Experimental,"Procedure, Drug, Other, Procedure",Single Group Assignment,,,,Phase 2
844,BOMB,Interventional,"Experimental, Active Comparator","Procedure, Radiation, Other",Parallel Assignment,,,,Not Applicable
845,SMX 20-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
846,2019/1318,Interventional,"Experimental, No Intervention, Other",Behavioral,Parallel Assignment,,,,Not Applicable
847,D931CC00001,Interventional,"Experimental, Experimental","Drug, Combination Product",Parallel Assignment,,,,Phase 2
848,Stage 1 Compression Therapy,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
849,XuzhouMedSch3,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
850,FUSCC-TNBC-BLIS,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
851,20-371,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
852,SMC 2018-07-014-011,Observational,,Drug,,Case-Only,12 Months,Non-Probability Sample,
853,2019-KY-051,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
854,WuhanU,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
855,2022-017,Observational,,"Other, Other",,Cohort,,Probability Sample,
856,K3_K1_2,Interventional,"Experimental, Other","Behavioral, Other",Parallel Assignment,,,,Not Applicable
857,HBMUFH-101,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
858,4298,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
859,018-745,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
860,GEICAM/2018-03,Observational,,,,Cohort,10 Years,Non-Probability Sample,
861,213355,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
862,GCX-BCT-06,Interventional,"Active Comparator, No Intervention",Drug,Parallel Assignment,,,,Not Applicable
863,2022-0056,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
864,MEDOPP437,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
865,handan1,Observational,,Diagnostic Test,,Case-Control,3 Years,Probability Sample,
866,20192755,Interventional,"No Intervention, Active Comparator",Drug,Parallel Assignment,,,,Phase 2
867,42127,Observational,,Genetic,,Cohort,,Non-Probability Sample,
868,SYSKY-2023-129-01,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
869,ACR A4707,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
870,PREBCA,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
871,Melody_001,Observational,,Other,,Cohort,,Non-Probability Sample,
872,BC-P31,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
873,UW20035,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
874,D9670C00001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
875,2-025-19,Observational,,Procedure,,Case-Control,,Probability Sample,
876,SaglikBilimleriU_DU,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
877,20-09022641,Interventional,"Active Comparator, Active Comparator","Radiation, Drug, Drug",Parallel Assignment,,,,Phase 2
878,R868/18-IEO 916,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
879,EORTC-1550-BCG,Observational,,Procedure,,Cohort,,Non-Probability Sample,
880,I3Y-NS-O003,Observational,,Drug,,Case-Only,,Probability Sample,
881,OTT 20-11 (IT-02),Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
882,IOM-120465,Observational,,Drug,,Cohort,,Non-Probability Sample,
883,OBU-SC-BB-BC-II-010,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
884,309424,Observational,,Radiation,,Case-Control,,Non-Probability Sample,
885,D9673R00025,Observational,,Other,,Other,,Non-Probability Sample,
886,19-1812.cc,Observational,,,,Cohort,,Probability Sample,
887,mTPVB SPPB Ver 2,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
888,SNB vs PET/MRI 1,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
889,NIHR 128311,Interventional,"Experimental, Active Comparator","Procedure, Radiation, Radiation",Parallel Assignment,,,,Not Applicable
890,2019-053,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
891,ID-TMS-02-20201012,Interventional,"Experimental, No Intervention",Drug,Single Group Assignment,,,,Not Applicable
892,CABC012,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
893,STUDY00000023,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
894,20_RIPH3_06,Observational,,Other,,Cohort,,Probability Sample,
895,ACE-Breast-07,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
896,Pro00104868,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
897,GMI-1359-210,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
898,2021C0128,Observational,,,,Cohort,,Non-Probability Sample,
899,MA-BC-II-023,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
900,ICO-A-2018-10,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
901,AITIC,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
902,RG_16-108,Observational,,Procedure,,Cohort,,Probability Sample,
903,2022/0132,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
904,0494-22-RMB,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
905,20-001670,Observational,,Procedure,,Cohort,,Non-Probability Sample,
906,SHERO,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
907,YU-FTR-ST-01,Observational,,,,Case-Only,,Non-Probability Sample,
908,IBCSG 55-17,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
909,REG-074-2020,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
910,CSIIT-C39,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
911,HCC 22-003,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
912,CSIIT-C03,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
913,99mTc-ZHER2,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
914,Woman health,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
915,FAST-F-PG01,Observational,,Radiation,,Cohort,,Non-Probability Sample,
916,NRG-BR007,Interventional,"Active Comparator, Active Comparator","Other, Drug",Parallel Assignment,,,,Phase 3
917,CLP0008,Interventional,"Experimental, No Intervention",Combination Product,Parallel Assignment,,,,Phase 2
918,2022-05093-02,Interventional,"No Intervention, Experimental",Radiation,Parallel Assignment,,,,Not Applicable
919,NCCH2113,Observational,,,,Cohort,3 Years,Probability Sample,
920,WO42633,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
921,GEICAM/2018-06,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
922,Soh-Med-23-01-34,Observational,,,,Other,,Probability Sample,
923,UPCC 01121,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
924,SA20I0060,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
925,26272819.3.0000.0068,Interventional,"Active Comparator, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
926,COSMOPOLITAN,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
927,18-040,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 1
928,Molecular imaging of HER2,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
929,21-VIN-0166/SAN-0647,Interventional,"Experimental, Active Comparator","Drug, Drug",Crossover Assignment,,,,Phase 1
930,IFG-08-2019,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 4
931,OP-1250-002,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
932,MUKDEN 06,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
933,1094/2020,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
934,WO42133,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 2
935,HR-BLTN-002,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
936,110-163-F,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
937,19-524,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
938,E19059,Observational,,,,Cohort,,Probability Sample,
939,KN035-TH-HER2,Interventional,Experimental,"Biological, Biological, Drug",Single Group Assignment,,,,Phase 2
940,CTO-IUSCC-0684,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,Phase 1
941,HNCH-MBC09-BM03,Observational,,,,Cohort,,Non-Probability Sample,
942,0063-17,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
943,D9673R00028,Observational,,,,Cohort,,Non-Probability Sample,
944,NCT20210157-AI-ROL,Observational,,Other,,Cohort,,Non-Probability Sample,
945,Tele-Relax,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
946,M16-735,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
947,ISB 1302-103,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological, Biological, Biological, Biological, Biological, Biological, Biological",Parallel Assignment,,,,"Phase 1, Phase 2"
948,KCSG BR18-16,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
949,NCC1865,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
950,20-503,Interventional,Experimental,"Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
951,A5481126,Interventional,"Other, Other",Device,Single Group Assignment,,,,Not Applicable
952,BC-Genetics,Observational,,,,Cohort,,Probability Sample,
953,UMMCHTNBC,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
954,BTCRC-BRE18-337,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
955,2019/2632,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
956,LY01005/CT-CHN-303,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
957,19-09020752,Interventional,"Active Comparator, Active Comparator","Radiation, Drug, Drug",Parallel Assignment,,,,Phase 2
958,XZP-3287-3001,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
959,160178,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
960,20-2338,Interventional,"Other, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
961,J18138,Interventional,Other,"Procedure, Device",Single Group Assignment,,,,Not Applicable
962,GEP,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
963,MRG002-004,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
964,ACTRN1261000928213,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
965,PGG-BCA2121 / MK-3475-C99,Interventional,Experimental,"Biological, Biological",Single Group Assignment,,,,Phase 2
966,NCC2021291,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
967,RC31/21/0368,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
968,Pro2020002182,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
969,Shengjing-LJY07,Interventional,"Experimental, Experimental, Experimental",Procedure,Parallel Assignment,,,,Not Applicable
970,CNIL-2033408,Observational,,,,Cohort,,Non-Probability Sample,
971,F2017000 (UAB 17112),Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
972,BTCRC-BRE19-409,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
973,BC-Pyrotinib-NVB,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
974,2022-A02271-42,Observational,,Other,,Cohort,,Non-Probability Sample,
975,REG-028-2021,Observational,,Other,,Cohort,12 Months,Probability Sample,
976,SYSUCC-016,Interventional,"Experimental, Other","Drug, Drug",Parallel Assignment,,,,Phase 3
977,HMPL-012-SPRING-R103,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
978,CA209-7FL,Interventional,"Experimental, Placebo Comparator","Biological, Drug, Other, Drug, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 3
979,2020-0342,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
980,22-5307,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
981,19-396,Interventional,Other,"Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
982,CEP0431/2018 arm 2,Interventional,"Active Comparator, Active Comparator, Active Comparator","Procedure, Procedure, Drug",Parallel Assignment,,,,Not Applicable
983,PMD-026-1-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
984,201801559A3,Observational,,Combination Product,,Cohort,,Non-Probability Sample,
985,2022/0226,Observational,,"Other, Other, Other, Other, Other, Other, Other, Other",,Case-Control,,Probability Sample,
986,MA-BC-II-035,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
987,22040,Interventional,Experimental,"Drug, Behavioral",Single Group Assignment,,,,Phase 2
988,SYSUCC-011,Observational,,,,Cohort,,Probability Sample,
989,D0816R00025,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
990,CAAE 42627521600005274,Interventional,"Experimental, Experimental, No Intervention, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
991,ZYYY-BC-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
992,25IB-0023,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
993,CAAE: 82691818.0.0000.5154,Interventional,"Other, Experimental, Experimental, Experimental","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
994,MedOPP238,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
995,CTMS 17-0037,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
996,CMTNCMB,Observational,,Combination Product,,Other,,Probability Sample,
997,18-002,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Phase 1
998,919PP18,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
999,2020-KY-140,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1000,18432,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other, Other, Other, Behavioral",Parallel Assignment,,,,Not Applicable
1001,CRE2018013,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1002,RS1637/21,Observational,,Other,,Cohort,24 Months,Non-Probability Sample,
1003,SPHIC-TR-BCa2022-02,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
1004,SURVIVE,Interventional,"Active Comparator, Placebo Comparator","Diagnostic Test, Diagnostic Test, Diagnostic Test, Other",Parallel Assignment,,,,Not Applicable
1005,SYSUCC-008,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1006,S64752,Observational,,Diagnostic Test,,Case-Control,,Probability Sample,
1007,20201101.2,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1008,2020-KY-125,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1009,CDR0000643461,Observational,,"Other, Procedure",,Case-Only,,Non-Probability Sample,
1010,4352,Interventional,"Experimental, Experimental, Sham Comparator","Other, Behavioral, Other",Parallel Assignment,,,,Not Applicable
1011,IRB_00137018,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
1012,OSU-21065,Observational,,"Procedure, Procedure, Other",,Cohort,,Non-Probability Sample,
1013,MCC-19765,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Phase 1
1014,20-1866.cc,Observational,,Behavioral,,Cohort,,Probability Sample,
1015,IB 2015-01,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1016,2022-0353,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Phase 1
1017,2018/TMC/133/IRB/31,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
1018,LCCC 1931,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1019,ENDO-RESIST,Observational,,,,Cohort,,Probability Sample,
1020,BRE 354,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 2
1021,EORTC QLQ BR45,Observational,,,,Cohort,,Non-Probability Sample,
1022,21-325,Observational,,Procedure,,Cohort,,Non-Probability Sample,
1023,A5481167,Observational,,Drug,,Cohort,,Probability Sample,
1024,4-2018-0264,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1025,SYSUCC-017,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1026,2016-0537,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Other, Drug, Drug, Biological, Biological",Parallel Assignment,,,,"Phase 1, Phase 2"
1027,CCR4884,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
1028,IR-1.1,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1029,MEN1611-01,Interventional,Experimental,"Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
1030,A5481145,Observational,,"Drug, Drug",,Case-Only,,Non-Probability Sample,
1031,20-5215.0,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
1032,SGNTUC-028,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1033,UW16151,Observational,,"Drug, Drug, Drug, Drug, Drug",,Cohort,,Non-Probability Sample,
1034,STU-2022-0385,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Device, Procedure",Sequential Assignment,,,,"Phase 1, Phase 2"
1035,Concordance,Observational,,Procedure,,Cohort,,Non-Probability Sample,
1036,IMAP-CM,Interventional,"Experimental, Sham Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
1037,BC-RWS,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
1038,69HCL21_1085,Interventional,"Active Comparator, Experimental",Device,Parallel Assignment,,,,Not Applicable
1039,C4891001,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1040,SYSUCC-020,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1041,1234,Observational,,,,Case-Control,,Non-Probability Sample,
1042,BreastctDNA01,Observational,,Genetic,,Other,,Probability Sample,
1043,SGNTUC-025,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1044,KOTK/2022/12550,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1045,SRB_201808_163,Interventional,"Active Comparator, Experimental, No Intervention","Drug, Other",Parallel Assignment,,,,Phase 4
1046,3-2021-0026,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1047,BC-P26,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
1048,SCHBCC-N029,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1049,AIRC IG-23118,Interventional,Experimental,"Radiation, Radiation",Single Group Assignment,,,,"Phase 1, Phase 2"
1050,21-159,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1051,D8532C00001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1052,TMS01190510,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
1053,PUMCH-MIRC213,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,,,,Early Phase 1
1054,1752/20,Interventional,"No Intervention, Experimental","Radiation, Procedure, Other",Parallel Assignment,,,,Phase 2
1055,RG1121129,Interventional,"Experimental, Experimental, Experimental","Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1056,SBMASTER,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1057,SMC 2020-11-051,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
1058,6037248,Observational,,,,Cohort,,Non-Probability Sample,
1059,2016-A01344-47,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1060,1807187-2,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1061,21-123,Interventional,"Experimental, Experimental, Experimental","Dietary Supplement, Dietary Supplement, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1062,Ketogenic Diet,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
1063,TJ-IRB20211128,Observational,,,,Case-Only,,Probability Sample,
1064,20-172,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
1065,Lilly-I3Y-US-I026,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1066,FNF201830,Observational,,Genetic,,Other,,Non-Probability Sample,
1067,N-20180090,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
1068,A231901CD,Interventional,"Experimental, Active Comparator, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Active Comparator","Other, Other, Procedure, Other, Other, Other, Other, Other, Other",Factorial Assignment,,,,Not Applicable
1069,UC-BCG-2103,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1070,I236,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1071,D0816C00018,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 3
1072,CMUH108-REC1-113,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
1073,PRO00028602,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1074,2019-7-Non-NSU Health,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1075,ALT-P7,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
1076,PRO00028925,Interventional,"Other, Experimental","Other, Other",Parallel Assignment,,,,Phase 2
1077,HUB-PSI-CAMAD,Interventional,"Experimental, Experimental","Drug, Behavioral",Parallel Assignment,,,,Phase 2
1078,DRLCOLCT001,Observational,,Drug,,Cohort,,Non-Probability Sample,
1079,GCO 17-1585,Interventional,"Active Comparator, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1080,K160913J,Interventional,Experimental,"Genetic, Biological, Other",Single Group Assignment,,,,Not Applicable
1081,131916,Observational,,,,Cohort,,Non-Probability Sample,
1082,REP0121,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1083,BC-CIH-H-RWS,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
1084,YDPLD191016-I1-SYSU-001,Observational,,Other,,Cohort,1 Week,Probability Sample,
1085,LCCC1820,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1086,AMCI-001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1087,IRB15-1005,Interventional,"Experimental, Other, Other, Other, Other, Other","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1088,22/409-3611,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
1089,SYSEC-KY-KS-2022-056,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1090,FDRT-BC016,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
1091,Genetic study and TDM,Observational,,Drug,,Cohort,,Non-Probability Sample,
1092,2019.046,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1093,Fukui-2019-1,Interventional,"Active Comparator, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1094,UPCC 10117,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1095,GC101-21K177,Interventional,Experimental,Biological,Single Group Assignment,,,,Early Phase 1
1096,RF-2016-02363686,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
1097,2021-0768,Interventional,Experimental,"Procedure, Radiation, Procedure",Single Group Assignment,,,,Phase 2
1098,2020-0708,Interventional,"Active Comparator, Experimental, Experimental","Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1099,A5481136,Observational,,"Drug, Drug",,Cohort,,Probability Sample,
1100,4-2020-1453,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1101,TILS001 trial,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1102,V3002401,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1103,2020-004696-41,Interventional,"No Intervention, Experimental, Experimental, Experimental, No Intervention, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1104,BR01/02/21,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1105,69HCL16_0536,Observational,,Behavioral,,Other,,Non-Probability Sample,
1106,20-347,Interventional,Experimental,"Combination Product, Drug",Single Group Assignment,,,,Phase 2
1107,SCBCG-006,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 3
1108,S1709-101-888,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1109,21-600,Interventional,Experimental,"Device, Device",Single Group Assignment,,,,Not Applicable
1110,LCCC2241,Observational,,"Other, Other, Other, Other, Other",,Cohort,,Non-Probability Sample,
1111,6010121027,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
1112,MA-BC-II-020,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1113,FDRT-BC008,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
1114,YLiu,Observational,,Drug,,Cohort,,Probability Sample,
1115,2018-A02191-54,Observational,,,,Cohort,,Probability Sample,
1116,ICO 13-001,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Early Phase 1
1117,ARV-471-mBC-102,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1118,NL68820.091.19,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
1119,FS-1502-III1-01,Interventional,"Experimental, Active Comparator","Biological, Biological",Parallel Assignment,,,,Phase 3
1120,114,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
1121,IIT2018-17-McArthur-TCDRT,Interventional,"Active Comparator, Experimental","Drug, Radiation, Drug, Drug",Parallel Assignment,,,,Phase 2
1122,NCC2493,Interventional,"Active Comparator, Experimental","Drug, Radiation",Parallel Assignment,,,,Phase 3
1123,38341220.8.0000.0072,Interventional,"Active Comparator, Experimental, Experimental","Radiation, Radiation, Radiation",Parallel Assignment,,,,Not Applicable
1124,2018-A01128-47,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1125,CH-BC-059,Interventional,"Experimental, Active Comparator","Drug, Other, Genetic, Drug",Parallel Assignment,,,,Phase 3
1126,GRACE,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1127,2020-154,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,,,,Not Applicable
1128,20 KHCC 91,Interventional,Other,Radiation,Single Group Assignment,,,,Not Applicable
1129,LRP/PegGCSF/2016/004,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 4
1130,IIT-CRM2020001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1131,20-505,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Radiation",Parallel Assignment,,,,Phase 2
1132,SYSUCC-019,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1133,275078,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1134,Neo-ACT,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
1135,CA209-929,Interventional,"Experimental, Experimental, Experimental","Biological, Biological",Single Group Assignment,,,,Phase 2
1136,New theory(Tamoxifen&retinoic),Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Sham Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1137,CTO-IUSCC-0715,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1138,IIT-0026,Observational,,Radiation,,Case-Only,,Non-Probability Sample,
1139,Neo-program 2021.02.23,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Other",Parallel Assignment,,,,Not Applicable
1140,IIT-2017-NeoPACT,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1141,SP0048722,Interventional,"Experimental, Active Comparator, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1142,CLEE011ABR02,Observational,,Drug,,Cohort,,Non-Probability Sample,
1143,GO42784,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1144,145314,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,"Phase 1, Phase 2"
1145,REaCT-70,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Phase 4
1146,07102022_SR,Interventional,"Experimental, Active Comparator",Behavioral,Parallel Assignment,,,,Not Applicable
1147,RadiaAce001,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
1148,ARV-471-mBC-101,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1149,20-0140-A,Interventional,"Experimental, Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
1150,2021000247,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
1151,1216-4-011,Interventional,"Placebo Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
1152,GIM24-PALBO-BP,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1153,EUBREAST-01,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1154,BTCRC-BRE16-042,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1155,Glnz87?,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1156,TVD-101-002B,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1157,D9673R00004,Observational,,Other,,Cohort,,Non-Probability Sample,
1158,IBISCO Trial,Interventional,"Experimental, No Intervention",Radiation,Parallel Assignment,,,,Not Applicable
1159,SYSEC-KY-KS-2019-055-001,Observational,,Other,,Cohort,,Non-Probability Sample,
1160,SYSEC-KY-KS-2019-099,Observational,,"Drug, Drug, Drug, Drug, Drug, Drug",,Cohort,,Non-Probability Sample,
1161,18-115,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1162,201808046,Interventional,Experimental,"Radiation, Procedure",Single Group Assignment,,,,Not Applicable
1163,IC 2021-08,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1164,NBC Che001,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1165,6222/22.03.2017,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1166,18-217,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
1167,AI Yoga Study on Facebook - 1,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1168,ONC-010,Observational,,Other,,Case-Only,6 Years,Non-Probability Sample,
1169,CSPC-KAL-BC-16,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1170,21-161,Observational,,,,Case-Control,,Non-Probability Sample,
1171,TT420X2101,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
1172,OMERIC-1904,Interventional,,Procedure,Single Group Assignment,,,,Not Applicable
1173,CTO-IUSCCC-0781,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Phase 2
1174,178-2018,Observational,,Diagnostic Test,,Cohort,5 Years,Probability Sample,
1175,ACE-Breast-06,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1176,UPCC 15121,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral, Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
1177,CHLOBREASTASP,Interventional,"Placebo Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
1178,202207198RINB,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
1179,OMC2018/01,Observational,,,,Cohort,,Non-Probability Sample,
1180,NEXT-BRCA,Interventional,"Experimental, Experimental, No Intervention","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1181,REaCT-Wellness,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Phase 4
1182,CLEE011AFR01,Observational,,Other,,Cohort,,Non-Probability Sample,
1183,AB PoC 2021 RUS,Observational,,Diagnostic Test,,Case-Control,,Non-Probability Sample,
1184,VersiÃ³n 4- 20/09/2020,Interventional,Other,Drug,Single Group Assignment,,,,Phase 4
1185,HS-10352-102,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 1
1186,578-21-FB,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1187,LPM-008,Interventional,"Other, Experimental, Experimental","Combination Product, Drug",Sequential Assignment,,,,Phase 3
1188,2019.444,Observational,,Diagnostic Test,,Case-Only,,Probability Sample,
1189,MedOPP167,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 2
1190,BCSPilot01,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1191,IRB00048455,Observational,,"Procedure, Other, Other, Other",,Cohort,,Non-Probability Sample,
1192,DATOS-20220624-ASJF-Efecto car,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1193,2022-009,Interventional,"Experimental, Placebo Comparator, Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1194,1107210020,Observational,,,,Other,,Probability Sample,
1195,FZPL-â¢-303,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1196,NSABP FB-13,Interventional,Experimental,"Drug, Drug, Drug, Diagnostic Test",Single Group Assignment,,,,Phase 2
1197,SYSUCC 019,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1198,CCR5654,Observational,,Other,,Other,,Non-Probability Sample,
1199,107CS-6,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1200,KCT 005,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1201,DFP22-0020,Interventional,"Experimental, Experimental, Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
1202,BRE 381,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1203,2014CB543202-03,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
1204,G1T28-212,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Biological",Single Group Assignment,,,,Phase 2
1205,PI-2021-3,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
1206,2021-KY-124-001,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1207,SCHBCC-NO28,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1208,2022-YXZX-YX-08,Observational,,Other,,Case-Control,,Non-Probability Sample,
1209,NCKUH SLNB,Observational,,Procedure,,Case-Only,5 Years,Non-Probability Sample,
1210,ID-RCB 2022-A01488-35,Interventional,"No Intervention, Experimental",Device,Crossover Assignment,,,,Not Applicable
1211,CCM 1505,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1212,C4891006,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1213,MA-BC-â¡-021,Interventional,"Experimental, Experimental, Experimental","Procedure, Drug, Procedure",Parallel Assignment,,,,Phase 2
1214,042110,Interventional,"Active Comparator, Other","Drug, Other",Single Group Assignment,,,,Early Phase 1
1215,UKM14_0016,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
1216,PER.CIN.BN.95.III,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1217,21-5021,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1218,2021-0840,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1219,OV-121,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1220,RJBC-HFRNI,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Phase 3
1221,CTRIAL-IE 17-13,Interventional,Other,"Drug, Drug",Single Group Assignment,,,,Phase 1
1222,FDRT-BC017,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Phase 3
1223,2018-0601,Interventional,"Placebo Comparator, Experimental, Placebo Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1224,19-005860,Observational,,"Procedure, Other, Other",,Cohort,,Non-Probability Sample,
1225,BC-09638,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
1226,2020-495,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
1227,A231701CD,Interventional,"Active Comparator, Experimental","Other, Other",Crossover Assignment,,,,Not Applicable
1228,00005038,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
1229,OSU-22013,Interventional,"Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
1230,D967JC00002,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
1231,LB1802,Observational,,,,Case-Only,5 Years,Non-Probability Sample,
1232,18/028,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
1233,WO40324,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Procedure, Radiation, Drug",Parallel Assignment,,,,Phase 3
1234,CLEE011A2206,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1235,20-151,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1236,2020(55),Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
1237,I-3364822,Interventional,"Active Comparator, Experimental","Other, Other, Procedure, Other",Parallel Assignment,,,,Not Applicable
1238,CASE3118,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1239,m-VCAP1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1240,CS003-BC,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Sequential Assignment,,,,Phase 2
1241,ML39208,Interventional,Experimental,"Device, Drug",Single Group Assignment,,,,Phase 2
1242,19-133,Interventional,"Experimental, Placebo Comparator",Behavioral,Crossover Assignment,,,,Not Applicable
1243,H-43432,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1244,Contralateral Screening,Observational,,,,Cohort,,Non-Probability Sample,
1245,HCRN BRE18-334,Interventional,"Experimental, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug, Other",Parallel Assignment,,,,Phase 2
1246,Geneplus2020BC01,Observational,,,,Case-Only,,Non-Probability Sample,
1247,2007-206-1145,Observational,,,,Cohort,2 Years,Non-Probability Sample,
1248,AC699-001,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
1249,2020-010,Observational,,Other,,Cohort,,Probability Sample,
1250,20140299,Interventional,"Experimental, Experimental","Biological, Biological",Single Group Assignment,,,,Phase 1
1251,ACT16105,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1252,2020-07-064-002,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1253,STUDY-20-01174,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1254,UC-BCG-2204,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 3
1255,MD-127-2019,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1256,ICO-N-2019-04,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1257,2019.629,Observational,,Other,,Cohort,,Probability Sample,
1258,2020-005722-28,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1259,TMZ-TNBC,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1260,RJBC-SHF RNI,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
1261,PYHOPE-BC-104,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1262,UW17107,Interventional,"Experimental, Experimental","Drug, Dietary Supplement",Parallel Assignment,,,,Phase 2
1263,EORTC-1617-QLG-BCG,Observational,,,,Cohort,,Non-Probability Sample,
1264,SAMuhammad,Interventional,"Active Comparator, Active Comparator",Drug,Single Group Assignment,,,,"Phase 2, Phase 3"
1265,HREBA.CC-21-0429,Interventional,"Active Comparator, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
1266,ShantouCH02,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1267,202201100,Interventional,Experimental,"Other, Procedure",Single Group Assignment,,,,Not Applicable
1268,SIM-1907-02-SERD-101,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
1269,KCSG BR19-15,Observational,,,,Case-Only,,Non-Probability Sample,
1270,PekingUPH10B003,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1271,2020-AHL-001,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 1
1272,19-586,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1273,CTMS# 19-0028,Interventional,"Experimental, No Intervention",Dietary Supplement,Parallel Assignment,,,,Not Applicable
1274,2/108/7,Interventional,Experimental,"Other, Other, Other",Single Group Assignment,,,,Not Applicable
1275,LQ006,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1276,Metastatic Breast Cancer,Observational,,,,Cohort,3 Years,Non-Probability Sample,
1277,YOUNGBC-17,Observational,,,,Cohort,,Non-Probability Sample,
1278,ABLE02,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
1279,2017-0071,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1280,NL63209 041 18,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
1281,MCC-21-BRE-54,Interventional,Experimental,"Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
1282,GE-280-401,Observational,,Drug,,Cohort,,Non-Probability Sample,
1283,2019-A02195-52,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1284,IRB00158622,Interventional,"Active Comparator, Sham Comparator, Other","Other, Other, Other",Factorial Assignment,,,,Not Applicable
1285,EOC202A1101,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,Phase 1
1286,HUM00140468,Interventional,"Active Comparator, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1287,CER2021,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
1288,MCC-19-15740,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1289,IIT-0005,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Drug",Parallel Assignment,,,,Phase 2
1290,IB 2017-05,Interventional,"Experimental, Active Comparator",Behavioral,Parallel Assignment,,,,Phase 3
1291,K180603J,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1292,NL58040.091.16,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1293,NEO-01,Interventional,Experimental,Device,Sequential Assignment,,,,Not Applicable
1294,CLEE011A3201C,Interventional,"Active Comparator, Experimental","Combination Product, Combination Product, Combination Product, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1295,Shengjing-LCG004,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1296,SYSU-CSCO-2020,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1297,2014CB543202-02,Interventional,"Experimental, Experimental, No Intervention","Other, Other",Parallel Assignment,,,,Not Applicable
1298,2019-09-023,Interventional,"Placebo Comparator, Experimental",Procedure,Single Group Assignment,,,,Not Applicable
1299,MD 134/2022,Observational,,,,Cohort,,Non-Probability Sample,
1300,18-2562.cc,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1301,LUN_DBT_121,Observational,,Radiation,,Cohort,,Probability Sample,
1302,A5481093,Observational,,,,Case-Control,,Probability Sample,
1303,s63338,Interventional,"Active Comparator, Experimental, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
1304,99mTc- RM26,Interventional,"Experimental, Experimental",Diagnostic Test,Parallel Assignment,,,,Phase 1
1305,On4Rehab Pilot Trial,Interventional,"Active Comparator, Experimental",Other,Parallel Assignment,,,,Not Applicable
1306,GO 22/41,Observational,,,,Other,,Probability Sample,
1307,2019-KY-049,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1308,2019/00283,Observational,,Other,,Case-Control,,Non-Probability Sample,
1309,NCC2129,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1310,PROTECT,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1311,IRB18-0970,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
1312,001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1313,AAAT4412,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1314,07068-02,Observational,,,,Cohort,1 Day,Probability Sample,
1315,SHR-A1811-III-306,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1316,MedOPP168,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1317,ATOS-Z-201,Interventional,"Experimental, Experimental, Active Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1318,CFT / sp123,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1319,SBU-PCWRT-BREAST,Interventional,Experimental,Radiation,Single Group Assignment,,,,Early Phase 1
1320,I239,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1321,PI20/596,Observational,,,,Cohort,,Non-Probability Sample,
1322,REO 028,Interventional,"Active Comparator, Experimental, Experimental","Drug, Biological, Drug",Parallel Assignment,,,,Phase 2
1323,OBU-BC-II-079,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1324,200277,Interventional,"Experimental, Experimental, Experimental","Drug, Device, Other",Parallel Assignment,,,,Phase 1
1325,EC/2017/0200,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1326,99mTc-DARPinG3 breast cancer,Observational,,Drug,,Cohort,,Non-Probability Sample,
1327,CFT/sp123,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1328,ANLO-BC,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1329,20200628GD,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1330,MA-BC-II-026,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1331,LQ007,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1332,RFTMBCPW,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 4
1333,D9268C00001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1334,BCD-178-2,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1335,FDRT-BC012,Interventional,Experimental,Radiation,Single Group Assignment,,,,"Phase 1, Phase 2"
1336,ET17-203 DISCO,Interventional,"Experimental, Experimental, Experimental, No Intervention","Device, Behavioral",Factorial Assignment,,,,Not Applicable
1337,CA209-7A8,Interventional,"Experimental, Experimental, Active Comparator","Biological, Drug, Drug",Parallel Assignment,,,,Phase 2
1338,2103254164,Interventional,"Active Comparator, Active Comparator, No Intervention","Drug, Drug",Parallel Assignment,,,,Phase 2
1339,HNCH-BC008,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1340,KY20192081-F-1,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
1341,2021.240,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1342,YOUNGBC-16,Observational,,,,Cohort,,Non-Probability Sample,
1343,2021-1201,Interventional,"Experimental, No Intervention",Diagnostic Test,Single Group Assignment,,,,Phase 2
1344,KC19EESI0325,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1345,SHR6390-Ib/II-201,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1346,1711-048-898,Interventional,"Experimental, Active Comparator",Diagnostic Test,Parallel Assignment,,,,Not Applicable
1347,HERMIONE-10,Observational,,,,Cohort,,Probability Sample,
1348,Luminal A sirt1,Observational,,,,Cohort,,Non-Probability Sample,
1349,UC-0140/1711 - UCBG3-06,Interventional,"Experimental, Other","Drug, Drug",Parallel Assignment,,,,Phase 2
1350,SCBCG-022,Observational,,Drug,,Cohort,,Probability Sample,
1351,EVER-132-002,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1352,S2010,Interventional,"Experimental, Active Comparator","Other, Procedure, Procedure, Behavioral, Other, Other",Parallel Assignment,,,,Not Applicable
1353,RSRB00066846,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1354,AC682-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1355,YOUNGBC-24,Observational,,Drug,,Cohort,,Non-Probability Sample,
1356,16-007764,Interventional,Other,"Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
1357,N19MIM,Interventional,"Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 2
1358,22-002857,Observational,,"Procedure, Procedure, Procedure, Procedure",,Cohort,,Non-Probability Sample,
1359,SYSU005,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1360,IRB-59141,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1361,18-8214-BO,Interventional,"Experimental, Active Comparator","Procedure, Behavioral",Parallel Assignment,,,,Not Applicable
1362,HR-BLTN-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1363,MC200302,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
1364,UMCC 2018.016,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1365,18-621,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
1366,2021-A03091-40,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1367,PLATO study,Interventional,Experimental,"Drug, Drug, Genetic",Single Group Assignment,,,,Phase 2
1368,2018-05-0155,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1369,YOUNGBC-6,Observational,,,,Cohort,,Non-Probability Sample,
1370,DokuzEU.Com.Garments,Observational,,,,Other,,Non-Probability Sample,
1371,STOP-BC Trial,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1372,Pro00088926,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1373,B00157,Observational,,Procedure,,Cohort,,Probability Sample,
1374,TP.102.17.22.PAR,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1375,SMX 18001,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1376,AABCSR,Observational,,,,Cohort,,Non-Probability Sample,
1377,Fudan University,Interventional,"Experimental, No Intervention","Drug, Drug",Parallel Assignment,,,,Phase 3
1378,ZN-c5-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1379,A5481166,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
1380,CALORIE,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
1381,4-2020-1131,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1382,TEBICA002,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
1383,145358,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1384,NRG-BR008,Interventional,"Active Comparator, Active Comparator","Radiation, Drug",Parallel Assignment,,,,Phase 3
1385,D081CC00012,Observational,,,,Cohort,,Non-Probability Sample,
1386,CWCD118B12201,Interventional,"Experimental, Active Comparator, Active Comparator, Other","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1387,P.T.REC/012/002968,Interventional,"Active Comparator, Active Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
1388,EFC15935,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1389,202202045MIPA,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1390,LCCC 1639,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
1391,IIT-2021-ASSET,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
1392,S-detect 2019,Observational,,,,Cohort,,Probability Sample,
1393,BC-NEO-IIT-SHR6390,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1394,A5481154,Observational,,Drug,,Cohort,,Non-Probability Sample,
1395,GDWCH-001,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1396,21090645,Interventional,"Experimental, Experimental, Experimental, No Intervention","Dietary Supplement, Dietary Supplement, Combination Product",Parallel Assignment,,,,Early Phase 1
1397,22-07025006,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1398,AHQU-2021004,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1399,SMC-2018-10-062,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1400,20-1434.cc,Observational,,,,Cohort,,Non-Probability Sample,
1401,ABY-025-MI301,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1402,Tmab-TK006-102b,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
1403,IFOM-CPO007/2019/PO006,Observational,,Other,,Other,,Non-Probability Sample,
1404,Ahead-BC-20170323,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Phase 2
1405,Pro00107216,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1406,FMSU2017-002B,Observational,,"Device, Device",,Case-Crossover,,Probability Sample,
1407,B2017-11,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
1408,2019-A01592-55,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1409,STUDY00003282,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1410,P20CA217199-9492018,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1411,2022-0651,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
1412,MINERVA,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 4
1413,SCBCG-021,Observational,,Drug,,Cohort,,Probability Sample,
1414,2019/044,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1415,114421,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
1416,AMC2020-17,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
1417,HREBA.CC 19-0363,Interventional,Experimental,"Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
1418,YOUNGBC-10,Observational,,,,Cohort,,Non-Probability Sample,
1419,H20-03123,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
1420,18-004803,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1421,18-0234,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1422,EA1183,Interventional,Experimental,"Procedure, Other, Procedure",Single Group Assignment,,,,Phase 2
1423,SYS-C-201801-5010,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1424,CLIN-52014-452,Observational,,,,Cohort,,Probability Sample,
1425,CLAG525B2101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1426,CABC - Kreftfor project - SEB,Interventional,"Active Comparator, Active Comparator, Placebo Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
1427,CSPC-KAL-AE-01,Observational,,Other,,Other,,Non-Probability Sample,
1428,ZN-c5-003,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
1429,Radiodermatitistalita60,Observational,,Radiation,,Case-Only,,Non-Probability Sample,
1430,CSIIT-C21,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1431,15-017,Interventional,Experimental,"Other, Other",Single Group Assignment,,,,Not Applicable
1432,M14ABC,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1433,20201540,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1434,MEDOPP447,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1435,34615/4/21,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1436,YXH2022ZX02167,Observational,,Drug,,Case-Control,,Non-Probability Sample,
1437,MEDOPP367,Observational,,,,Cohort,,Probability Sample,
1438,GE-226-004,Interventional,"Experimental, Experimental","Drug, Diagnostic Test, Diagnostic Test",Sequential Assignment,,,,Phase 1
1439,HSEARS20210816002,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
1440,LACOG 0419,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
1441,21-06023682,Observational,,Procedure,,Cohort,,Non-Probability Sample,
1442,201708076,Interventional,"Experimental, Active Comparator","Other, Procedure, Behavioral, Procedure, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1443,HRS-8080-I-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1444,TWT-203,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1445,CHB18.04,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
1446,BOOG 2018-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1447,NCCH1607,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1448,WO42312,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1449,RCVDBCIIR005,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1450,201805027RSA,Observational,,Other,,Case-Only,,Probability Sample,
1451,2022-0431,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1452,KY20222062-C-1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1453,IRB-2022-348,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
1454,CO41101,Interventional,"Experimental, Experimental, Active Comparator, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1455,CBYL719C1201,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1456,SYSA1802-CSP-006,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1457,NL69081.041.19,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 3
1458,2021P002871,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1459,STUDY00018504,Interventional,"Experimental, Experimental, Experimental, Experimental","Procedure, Drug, Drug, Biological, Drug, Other, Drug",Parallel Assignment,,,,Phase 2
1460,99mTc-DARPinG3,Observational,,Drug,,Cohort,,Non-Probability Sample,
1461,SCHBCC-N034,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 2
1462,KY2022-097-B,Observational,,Drug,,Cohort,,Non-Probability Sample,
1463,SYSEC-KY-KS-2019-054-001,Observational,,Other,,Cohort,,Non-Probability Sample,
1464,KY2019-023,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1465,D926XC00001,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1466,IRFMN-BRC-7103,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1467,4469,Interventional,Experimental,Genetic,Single Group Assignment,,,,Not Applicable
1468,CCR5316,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1469,NHP,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1470,S2020-300-01,Observational,,,,Other,,Probability Sample,
1471,JU 2020/1732-51,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1472,BL-M02D1-101,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
1473,STU00216520,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Phase 3
1474,20805,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1475,STUDY00000675,Interventional,Experimental,"Procedure, Drug, Drug, Procedure",Single Group Assignment,,,,Phase 1
1476,BC2,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1477,ICO-2020-25,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1478,NICSO-GINSENG,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
1479,YO41137,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Procedure, Radiation, Drug",Parallel Assignment,,,,Phase 3
1480,PUMCH-BC500,Observational,,,,Cohort,3 Months,Non-Probability Sample,
1481,ATADEK-2018 / 9,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
1482,ONA-XR-103,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1483,PELICAN-IPC 2015-016,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1484,2022-0315,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 1
1485,ADIGYN,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1486,201900115B0,Interventional,"Experimental, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
1487,NSABP FB-12,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Diagnostic Test",Single Group Assignment,,,,Phase 2
1488,Soh-Med-22-05-24,Observational,,,,Other,,Probability Sample,
1489,KCSG BR19-13,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1490,CO40016,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1491,CTFSp161,Observational,,,,Other,,Non-Probability Sample,
1492,RJBC1901,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 2
1493,HRS-1358-I-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1494,AAAS2359,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1495,2021-A02664-37,Interventional,Other,Biological,Single Group Assignment,,,,Not Applicable
1496,RTM 2015,Observational,,Device,,Cohort,,Non-Probability Sample,
1497,UW22095,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1498,HREBA.CC-18-0657,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1499,FILBLAU1022,Interventional,"Active Comparator, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 3
1500,BC-IIT-SHR6390-FMTN,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1501,38RC19.362,Observational,,Biological,,Other,,Non-Probability Sample,
1502,Breast-Chi-2022,Observational,,Drug,,Cohort,,Non-Probability Sample,
1503,HMPL-012-SPRING-R101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1504,CBYL719C2303,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Crossover Assignment,,,,Phase 3
1505,YOUNGBC-19,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1506,ADG106-T6002,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1507,D20148,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1508,07-2021/EK OUSA,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
1509,2019000486,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1510,ShandongCHI-08,Observational,,,,Cohort,5 Years,Non-Probability Sample,
1511,US-MAM,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
1512,TRIO036,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
1513,MD.22.07.674,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 3
1514,NCC2167,Interventional,"Experimental, Experimental, Experimental, Experimental, Active Comparator","Drug, Biological, Biological, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1515,VICC BREP 1898,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Phase 1
1516,Breast PTC,Interventional,,Procedure,Single Group Assignment,,,,Not Applicable
1517,P0268,Observational,,Other,,Cohort,,Non-Probability Sample,
1518,2107239-9,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1519,173-18-CA,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
1520,Velocity,Interventional,"Active Comparator, Active Comparator","Behavioral, Drug",Parallel Assignment,,,,Phase 3
1521,CAPRICE-IPC 2020-053,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1522,LV,Interventional,"Experimental, No Intervention",Biological,Factorial Assignment,,,,Phase 2
1523,H-1905-141-1035,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1524,UW 18-526,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
1525,RJBC1801,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1526,CBYL719C2202,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1527,Alpha-Lipoic Acid,Interventional,"Experimental, Experimental","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
1528,EUBREAST-2 INDAX,Interventional,"Experimental, Experimental","Procedure, Radiation",Parallel Assignment,,,,Phase 3
1529,EF 160,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1530,NSABP FB-14,Interventional,Experimental,"Biological, Biological",Single Group Assignment,,,,Phase 2
1531,PUMCH-BC503,Observational,,,,Cohort,,Non-Probability Sample,
1532,TIPN in China,Observational,,"Other, Other",,Case-Control,,Non-Probability Sample,
1533,EG017,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1534,I241,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Other, Drug, Drug",Parallel Assignment,,,,Phase 2
1535,853.4,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
1536,ICON CA209-9FN,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1537,HCRN BRE20-468,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1538,TOL2506A,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 3
1539,2019-A02500-57,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
1540,UTAR- 8068/000,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
1541,201711073,Interventional,"Experimental, Experimental, Experimental","Biological, Drug, Drug, Drug, Procedure, Procedure, Procedure",Sequential Assignment,,,,Phase 1
1542,AI-BMRI-S,Observational,,Diagnostic Test,,Cohort,6 Months,Non-Probability Sample,
1543,1400,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
1544,MOST Pain,Interventional,"No Intervention, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
1545,2021-04,Interventional,"Other, Other",Device,Parallel Assignment,,,,Not Applicable
1546,HRHB-CB001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Biological",Parallel Assignment,,,,"Phase 2, Phase 3"
1547,SH APBI RISE,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
1548,E7389-M065-401,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
1549,1812850942,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1550,UPCC 04119,Interventional,"Active Comparator, Active Comparator, Active Comparator, Other","Radiation, Drug, Procedure",Parallel Assignment,,,,"Phase 1, Phase 2"
1551,Prix Ruban Rose/2020/FF-03,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1552,31052019,Interventional,"Active Comparator, Other","Other, Other",Parallel Assignment,,,,Not Applicable
1553,JCOG1919E,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
1554,852000,Interventional,Experimental,"Device, Drug",Single Group Assignment,,,,Early Phase 1
1555,19-300,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
1556,HR-BLTN-003,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1557,L21-076,Interventional,"No Intervention, Experimental, Experimental","Device, Combination Product",Single Group Assignment,,,,"Phase 1, Phase 2"
1558,2020-A00398-31,Interventional,Other,Biological,Single Group Assignment,,,,Not Applicable
1559,SBU-SBRT-BREAST-NO-SX,Interventional,Experimental,Radiation,Single Group Assignment,,,,Early Phase 1
1560,BCT 2102,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1561,IUSCC-0680,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
1562,GBG105,Interventional,"Experimental, Other","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1563,AQUAFIT-2018,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
1564,Moderate Dose Omega-3,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
1565,A5481168,Observational,,,,Cohort,,Non-Probability Sample,
1566,201900180,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1567,GUMPTION,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1568,MA40,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Other",Parallel Assignment,,,,Phase 3
1569,Pro00104863,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1570,RnaDx-BRV-BC- 01,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1571,18-000718,Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1572,KN026-201,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1573,SGNTUC-016,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1574,OCOG-2019-RHEAL,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Phase 3
1575,27600,Interventional,"Experimental, Other","Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
1576,2021C0102,Observational,,,,Cohort,,Non-Probability Sample,
1577,KN026-208,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1578,CSIIT-C10,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
1579,CAAP CA,Interventional,"Experimental, Sham Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
1580,ZN-c5-001,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1581,MA-BC-II-018,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1582,KY20223267-1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1583,NL74126.091.20,Interventional,"Experimental, Experimental, Other, Other","Behavioral, Other",Parallel Assignment,,,,Not Applicable
1584,20P.020,Interventional,Experimental,"Drug, Biological, Biological, Biological, Other, Other",Single Group Assignment,,,,"Phase 1, Phase 2"
1585,iOM-110393,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1586,JTU-6H-20211230001,Observational,,"Procedure, Procedure",,Cohort,1 Year,Probability Sample,
1587,2020-007,Interventional,"Experimental, Other",Other,Parallel Assignment,,,,Not Applicable
1588,SCHBCC-N041,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1589,LAE205INT3101,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,,,,Phase 1
1590,201911047,Interventional,Experimental,"Device, Drug, Drug, Other, Other, Drug, Device, Procedure, Procedure",Single Group Assignment,,,,Phase 1
1591,RAD1901-308,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1592,HNCH-BC006,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1593,CTO-IUSCCC-0758,Observational,,"Drug, Procedure",,Case-Crossover,,Non-Probability Sample,
1594,IOM-050371,Interventional,"Experimental, Active Comparator","Combination Product, Combination Product",Parallel Assignment,,,,Phase 3
1595,SHEPHERD-2021-2,Observational,,Diagnostic Test,,Case-Only,,Non-Probability Sample,
1596,ICPS002/20,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1597,KCSG-BR18-13/TR-03,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1598,ICO-2020-28,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
1599,FUSCC-T-sunflower,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1600,SPI-GCF-104,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological, Biological, Biological, Drug, Drug",Sequential Assignment,,,,Phase 1
1601,ALTERBC008,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1602,2019-0550,Interventional,Other,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1603,2017-004909-41,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 2
1604,CSIIT-C18,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Not Applicable
1605,IBIO-301,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
1606,BTP-66732,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1607,1401,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
1608,21-698,Interventional,"Experimental, Experimental","Other, Other",Crossover Assignment,,,,Not Applicable
1609,05022020,Observational,,,,Case-Only,,Non-Probability Sample,
1610,CLOVER,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1611,LOXO-PIK-21001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
1612,NOGGO B3,Observational,,Other,,Case-Only,10 Years,Non-Probability Sample,
1613,DPMBC301,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1614,CSPC-KAL-BC-11,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1615,21-225,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,"Phase 1, Phase 2"
1616,IRB-2021-04,Interventional,"Other, No Intervention",Behavioral,Factorial Assignment,,,,Not Applicable
1617,2022JC-55,Interventional,"Experimental, Sham Comparator, No Intervention","Other, Other",Parallel Assignment,,,,Not Applicable
1618,SYHX2011-001,Interventional,"Experimental, Experimental",Drug,Crossover Assignment,,,,Phase 1
1619,HER2BRAIN,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1620,ET17-093 BreastImmune03,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1621,RJBC2001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 2
1622,BELIEVE@BC,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,,,,Not Applicable
1623,GB491-005,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1624,H-2009-079-1157,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1625,012342QM,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1626,IC 2020-20,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1627,GDWCH002(TNBC),Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1628,HNCH-MBC10,Interventional,"Experimental, Other","Drug, Drug",Parallel Assignment,,,,Phase 2
1629,HR-BLTN 015,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1630,197520,Interventional,"Experimental, Experimental","Biological, Drug, Drug",Parallel Assignment,,,,Phase 2
1631,KA22053,Interventional,"Experimental, Active Comparator","Other, Other",Single Group Assignment,,,,Not Applicable
1632,AI-Breast-US,Observational,,Diagnostic Test,,Other,,Probability Sample,
1633,HIFU202207,Interventional,Experimental,"Drug, Drug, Procedure, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1634,Twisted Pink Foundation,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
1635,18-195,Observational,,"Device, Device",,Cohort,,Probability Sample,
1636,SPY LNM 01,Interventional,Experimental,"Combination Product, Combination Product",Single Group Assignment,,,,Phase 3
1637,HNCH-MBC12,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1638,1910208-9,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1639,IKP275 / GBG91,Interventional,"No Intervention, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1640,2021-0974,Interventional,"Experimental, No Intervention, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1641,1808189-7,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
1642,XJTU1AF-CRF-2020-006,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1643,HORMONOVILLE,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1644,ET17-057,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1645,60905722.0.0000.0072,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
1646,2022JC-55-1,Interventional,"Active Comparator, Sham Comparator, No Intervention","Other, Other",Parallel Assignment,,,,Not Applicable
1647,1503144-7,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1648,IRB00022667,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
1649,BOOG-2017-01,Interventional,"Other, Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1650,TOL2506A-EXT,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 3
1651,GCC 1926,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator",Radiation,Sequential Assignment,,,,Not Applicable
1652,Pro00107615,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1653,Version 1.0_16.08.2021,Observational,,Procedure,,Cohort,,Non-Probability Sample,
1654,82071993,Observational,,Device,,Cohort,,Probability Sample,
1655,MUKDEN01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1656,BO40747,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1657,2021-0532,Observational,,,,Cohort,,Probability Sample,
1658,BC-IIT-FMTN-SHR6390-ET,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1659,QUILT-3.067,Interventional,Experimental,"Drug, Biological, Biological, Biological, Biological, Biological, Biological, Biological, Biological, Biological, Biological, Drug, Drug, Drug, Drug, Drug, Drug, Procedure",Single Group Assignment,,,,"Phase 1, Phase 2"
1660,GO39869,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
1661,ShandongCHI-20,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1662,200218,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
1663,P2100-SUR-S11,Interventional,"Experimental, Experimental, Experimental","Biological, Drug, Drug, Radiation",Parallel Assignment,,,,Phase 1
1664,FAVOR,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1665,2018-062,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1666,TSL-CM-TSL1502-â¡,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1667,17041,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
1668,QL1701-002,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1669,R174-A11507-17-S52,Interventional,"Experimental, Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
1670,55516,Interventional,"Experimental, Experimental, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
1671,21-018,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1672,2019-A02397-50,Observational,,Behavioral,,Case-Control,,Non-Probability Sample,
1673,17249,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
1674,4-2018-0765,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1675,Onkologikoa,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1676,48347821.8.0000.5249,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Not Applicable
1677,PRO00037175,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1678,19-004343,Interventional,Experimental,Genetic,Single Group Assignment,,,,Not Applicable
1679,AL-2001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1680,YBCSG-22-08,Observational,,Other,,Cohort,,Probability Sample,
1681,GEICAM/2021-08,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1682,RSINETE,Observational,,Drug,,Cohort,,Non-Probability Sample,
1683,kazuma,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
1684,308-2017,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
1685,AC682-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1686,MA-BC-II-007,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1687,OBU-BC-II-086,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1688,D-FR-01070-003,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1689,MYBC,Interventional,"Placebo Comparator, Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1690,1808189-8,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
1691,2017 0105,Interventional,"Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1692,2022/0035983,Observational,,,,Cohort,,Non-Probability Sample,
1693,SCHBCC-NO27,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1694,NCC-006461,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1695,SCHBCC-N032,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1696,OZM-103,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1697,NCC2225,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1698,UC-0109/1805,Interventional,"Other, Experimental","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1699,Shandong CHI-11,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1700,18-240,Observational,,"Other, Behavioral",,Cohort,,Non-Probability Sample,
1701,BG01-2102,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1702,D8664R00002,Observational,,,,Case-Control,,Probability Sample,
1703,erector-spinae,Interventional,"Active Comparator, Placebo Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
1704,000001,Interventional,"Experimental, Experimental",Other,Crossover Assignment,,,,Not Applicable
1705,IEO 0834/,Observational,,,,Cohort,,Non-Probability Sample,
1706,OE861801,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,,,,Phase 1
1707,ZDWY.XBZL.002,Interventional,Other,Drug,Single Group Assignment,,,,Phase 2
1708,19-886,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
1709,CIBI375Y008,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1710,2020/482,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1711,RP6530-2101,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1712,TUXEDO-1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1713,NL76658.029.21,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Not Applicable
1714,2020/134,Observational,,Procedure,,Cohort,,Probability Sample,
1715,LB,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1716,BO41843,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1717,CSIIT-C34,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1718,38406,Observational,,,,Cohort,3 Months,Probability Sample,
1719,OnkoFit I,Interventional,"Experimental, Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
1720,2017-IIT-HER2-Aspire,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1721,FACILE,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1722,270-2018,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
1723,SYHX2011-002,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1724,Shandong CHI-10,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1725,D967RC00001,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1726,2020-0198,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1727,0379520202023,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1728,KM10B,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1729,HSEARS20180509004,Interventional,"Experimental, Sham Comparator, No Intervention",Device,Parallel Assignment,,,,Not Applicable
1730,SHR-1210-III-318,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1731,CHD049-17,Observational,,Other,,Cohort,,Non-Probability Sample,
1732,H21089,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1733,IMMU-132-09,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1734,103089,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1735,SHR6390-III-301,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1736,QL1209-301,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 3
1737,17575,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
1738,SGNLVA-002,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1739,19-486,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Other",Parallel Assignment,,,,Phase 2
1740,17395,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 4
1741,2019-A01323-54,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1742,UPCC 10119,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 2
1743,TriMix-Breast,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Sequential Assignment,,,,Phase 1
1744,WO41554,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
1745,I 72218,Interventional,"Experimental, Active Comparator","Other, Other, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
1746,CSPC-DMS-BC-11,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1747,UC-GMP-2206,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1748,RJBC2001,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1749,CBYL719G12301,Interventional,"Experimental, Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1750,SYSUCC-003,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1751,S63893,Interventional,"Experimental, Experimental, Experimental, No Intervention","Drug, Drug",Parallel Assignment,,,,Early Phase 1
1752,GS-US-586-6144,Interventional,"Experimental, Experimental, Active Comparator, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
1753,soh-Med-21-10-17,Observational,,Radiation,,Case-Control,,Probability Sample,
1754,MRG002-009,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1755,20150288,Interventional,"Experimental, Active Comparator, Active Comparator, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
1756,PMC_TTAC-0001_05,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
1757,2021-005,Interventional,Experimental,"Other, Other, Other",Single Group Assignment,,,,Not Applicable
1758,TCF20-BRE-01,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
1759,Pro2021000838,Interventional,"Active Comparator, No Intervention",Behavioral,Crossover Assignment,,,,Not Applicable
1760,HR-BLTN-016,Observational,,Other,,Cohort,2 Years,Non-Probability Sample,
1761,EOC103A3101,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1762,FCN-437c-III201,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1763,CO41012,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1764,SHR6390-III-302,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1765,KSVGH20-CT7-26,Observational,,Other,,Cohort,,Probability Sample,
1766,MCC-20899,Interventional,"Experimental, Experimental","Radiation, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1767,CSPC-DMS-BC-K07,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1768,SYM013,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1769,FCN-437c-III202,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1770,EMBRAVE-001,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
1771,WO43919,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1772,IRB#18853,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
1773,2021-TNBC-01,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1774,breast-202204,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1775,FDRT-BC015,Observational,,Radiation,,Cohort,,Non-Probability Sample,
1776,206010,Interventional,"Active Comparator, Experimental","Biological, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1777,POL6326-009,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
1778,2018-001705-91,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1779,PCZCTP-220702-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
1780,D9673R00005,Observational,,Other,,Other,,Non-Probability Sample,
1781,ERC-260,Interventional,"Placebo Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
1782,NK/7784/Study/249,Interventional,"Active Comparator, Experimental",Radiation,Parallel Assignment,,,,Phase 3
1783,HBBL-01,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
1784,P170927J,Interventional,"Active Comparator, Experimental, Experimental","Device, Device, Device",Parallel Assignment,,,,Not Applicable
1785,KA-20007,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1786,EAGER-001,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1787,Arise-FJ-B02,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1788,911,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
1789,17-428,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
1790,UKFC-PU-2019-01-08,Interventional,"Placebo Comparator, Experimental, Experimental","Dietary Supplement, Dietary Supplement, Other",Parallel Assignment,,,,"Phase 1, Phase 2"
1791,STUDY00019489,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1792,CTMX-2009-002,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1793,HNCH-BC011,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1794,SHR-A1811-II-202,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1795,SYSU-2021,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1796,SunYatsenU2H-LQ5,Observational,,Drug,,Cohort,,Non-Probability Sample,
1797,017-396,Interventional,"Experimental, Experimental",Dietary Supplement,Sequential Assignment,,,,Not Applicable
1798,2020-006106-23,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1799,0000012,Observational,,"Genetic, Drug",,Cohort,,Non-Probability Sample,
1800,G1T28-213,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1801,REaCT-Algorithm,Observational,,,,Cohort,,Non-Probability Sample,
1802,ZEN003694-004,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1803,UC-0140/1812,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1804,Shengjing-LCG012,Interventional,"Experimental, Other","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1805,MAMA_MOVE_Gaia After Treatment,Interventional,"Experimental, No Intervention",Other,Crossover Assignment,,,,Not Applicable
1806,IEO 1730,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
1807,2019-A03112-55,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
1808,GS-US-569-6172,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
1809,2018.451,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1810,A5481159,Observational,,"Drug, Drug",,Cohort,,Probability Sample,
1811,s2192648,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
1812,15.03.2023,Observational,,"Drug, Drug, Drug",,Cohort,,Probability Sample,
1813,CL0006,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
1814,SDX-0103,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1815,NCC3397,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Other, Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1816,TED15954,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1817,202103030005,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1818,IC 2020-10,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 2
1819,HR-NeoBC-HN003,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
1820,D8530C00002,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1821,PR351/20,Observational,,Procedure,,Cohort,3 Years,Probability Sample,
1822,2021-SR-592,Observational,,,,Cohort,,Non-Probability Sample,
1823,DOUBLE,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1824,17320,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
1825,202007016,Interventional,"Active Comparator, Experimental","Drug, Drug, Biological, Biological, Procedure, Procedure, Procedure",Parallel Assignment,,,,"Phase 1, Phase 2"
1826,PALBOBIN,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1827,2017-A03413-50,Observational,,Other,,Cohort,,Non-Probability Sample,
1828,GIM23-POSTER,Observational,,Other,,Cohort,,Non-Probability Sample,
1829,AK117-203,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1830,MA-BC-II-033,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1831,CO42177,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
1832,2021-0491,Observational,,"Procedure, Other",,Case-Control,,Non-Probability Sample,
1833,MO39874,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 3
1834,AH150201,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1835,BAC,Observational,,,,Cohort,,Non-Probability Sample,
1836,20200225,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
1837,BOOG-2017-02,Interventional,"No Intervention, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1838,NL81896.078.22,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
1839,B003-101,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
1840,TQB2450-Ib-07,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1841,CO40151,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
1842,REaCT-5G,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
1843,2021/609,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1844,R19-149,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1845,HR-NeoBC-HN002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1846,14/2021,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1847,SI 475/2019,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
1848,99mTc-ADAPT6 in breast cancer,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
1849,2021-A02007-34,Observational,,,,Cohort,2 Years,Probability Sample,
1850,AND019-MN-101,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
1851,SKB264-â¢-03,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 3
1852,ESPB in breast cancer surgery,Interventional,"Placebo Comparator, Experimental, Experimental","Procedure, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1853,JS001-026-III-TNBC,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1854,NCR191600,Observational,,Other,,Cohort,,Non-Probability Sample,
1855,WO43571,Interventional,"Other, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1856,495573096,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
1857,GIM26-TRASTHER,Observational,,Drug,,Other,,Non-Probability Sample,
1858,2020-0232,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
1859,TQB2450-III-06,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1860,CBYL719CIN01,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 4
1861,CASE5119,Interventional,"Active Comparator, Experimental","Dietary Supplement, Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1862,SPORT-DS,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 1
1863,EVER-132-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1864,TBDBreast50,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
1865,STUDY00004350,Interventional,Experimental,"Other, Other, Other, Other",Single Group Assignment,,,,Not Applicable
1866,MOST Pain Pilot,Interventional,"No Intervention, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
1867,275142,Observational,,Other,,Cohort,,Non-Probability Sample,
1868,RG1006427,Interventional,"Active Comparator, Experimental","Behavioral, Other, Behavioral, Other, Other",Parallel Assignment,,,,Phase 2
1869,BC-Fluzoparib,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1870,QUILT-3.058,Interventional,Experimental,"Biological, Biological, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1871,214-2018,Observational,,,,Cohort,5 Years,Probability Sample,
1872,SCCC-03121; STU-2021-0657,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
1873,I237,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
1874,KarolinskaUD,Interventional,"Active Comparator, Experimental",Other,Factorial Assignment,,,,Phase 3
1875,NCC1969,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1876,SYSU-2022-UCAN,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1877,HX008-Ib/II-TNBC-01,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1878,21030,Interventional,Experimental,"Device, Other, Other",Single Group Assignment,,,,Not Applicable
1879,HNCH-MBC07,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1880,BC- T-DM1,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Not Applicable
1881,A5481123,Observational,,,,Cohort,,Non-Probability Sample,
1882,B013-301,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 2, Phase 3"
1883,HR-BLTN-III-NeoBC,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1884,IIT2022-07-YUAN-IB-TNBC,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1885,19-113,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Other,Parallel Assignment,,,,Phase 1
1886,4CAST,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1887,SHR1210-III-322,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
1888,222.20,Interventional,"Experimental, Experimental, Experimental",Radiation,Sequential Assignment,,,,Phase 1
1889,MedOPP190,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1890,CBYL719A0US03T,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1891,HERMIONE-7,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1892,811,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
1893,22-x354,Interventional,"Experimental, Experimental, Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1894,MK 3475-318,Interventional,"Other, Other, Other, Other, Other, Other",Drug,Single Group Assignment,,,,Early Phase 1
1895,2019-0634,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1896,IJB-LOB-2019,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1897,BAT-8001-002-CR,Interventional,"Experimental, Active Comparator","Biological, Drug, Drug",Parallel Assignment,,,,Phase 3
1898,CO41863,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1899,EH20-251,Observational,,Diagnostic Test,,Other,,Non-Probability Sample,
1900,A5481095,Observational,,,,Cohort,,Non-Probability Sample,
1901,Combined CTH and HT in MBC,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1902,KN046-203,Interventional,"Experimental, Experimental","Biological, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1903,DZ2019HE001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1904,SHR6390-SHR1020-I-101-BC,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1905,2022-A01192-41,Observational,,Behavioral,,Other,6 Months,Non-Probability Sample,
1906,U025,Interventional,Experimental,"Drug, Drug, Drug, Procedure",Single Group Assignment,,,,Phase 1
1907,NCC2474,Interventional,"Experimental, Active Comparator","Biological, Drug, Drug, Drug, Device",Parallel Assignment,,,,Phase 2
1908,MA-BC-II-047,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
1909,NCI-2021-08921,Interventional,"Experimental, Active Comparator","Procedure, Drug, Other, Other, Other",Parallel Assignment,,,,Phase 2
1910,FUSCC,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Other","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1911,ShandongCHI-06,Interventional,"No Intervention, Experimental",Drug,Parallel Assignment,,,,Phase 2
1912,NCC201711008,Interventional,,Drug,Single Group Assignment,,,,Phase 2
1913,S62794,Interventional,"Active Comparator, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
1914,Bioscore in breast cancer,Observational,,Other,,Cohort,,Non-Probability Sample,
1915,MORE-T trial,Interventional,"Experimental, Active Comparator","Drug, Diagnostic Test, Procedure",Parallel Assignment,,,,Phase 2
1916,Soh-Med-21_10_18,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
1917,Medical Research Institute,Interventional,"Experimental, Active Comparator, Placebo Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
1918,Cardiotoxicity study,Observational,,Drug,,Case-Control,,Non-Probability Sample,
1919,20-068,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1920,262840,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1921,2021P002943,Observational,,,,Cohort,,Non-Probability Sample,
1922,MS200647_0020,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1923,HNCH-HER2-MBC001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1924,GB491-004,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1925,P170929J,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1926,19-002448,Interventional,Experimental,"Other, Other, Other",Single Group Assignment,,,,Phase 1
1927,MCLA-128-CL02,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1928,2019-185-AGH,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Phase 2
1929,KN026-205,Observational,,Drug,,Cohort,,Non-Probability Sample,
1930,SPH4336-301,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
1931,HCB/2019/0786,Interventional,"Sham Comparator, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
1932,AIs with chemotherapy in MBC,Interventional,,Drug,Single Group Assignment,,,,Phase 2
1933,SIBP-01-3,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1934,REaCT-OGF,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 4
1935,CTRIAL-IE 22-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1936,CO42867,Interventional,"Active Comparator, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Active Comparator, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1937,EC2019/0127,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Device,Parallel Assignment,,,,Not Applicable
1938,UC Laser,Interventional,"Active Comparator, Active Comparator","Drug, Device",Parallel Assignment,,,,Not Applicable
1939,2022-09/2057,Observational,,Drug,,Cohort,,Probability Sample,
1940,TEMPLATE,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1941,M19-992,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
1942,2021-1122,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
1943,IJB-LBC-NEOCHECKRAY-2018,Interventional,"Experimental, Experimental, Experimental","Drug, Radiation, Drug",Parallel Assignment,,,,Phase 2
1944,CBYL719CIN02,Observational,,Other,,Cohort,,Non-Probability Sample,
1945,2022-0500,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1946,Labra-001,Interventional,"Sham Comparator, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
1947,GBG 93,Interventional,"Experimental, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
1948,HR-MBC-HN001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1949,CS2-19004,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1950,20-130,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1951,MCC-19803,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
1952,SYSU-2021-UCAN,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug",Factorial Assignment,,,,Phase 3
1953,ROGABREAST,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1954,18040334,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1955,BG01-2001,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
1956,ZhejiangCH-0709,Observational,,,,Cohort,,Non-Probability Sample,
1957,CBYL719C2404,Observational,,"Other, Other",,Cohort,,Non-Probability Sample,
1958,SYSKY-2022-105-01,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1959,IRB18-1178,Interventional,"Experimental, Other, Other, Other, Other","Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
1960,I2I1,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1961,MO43110,Interventional,"Other, Other, Experimental, Experimental, Other","Drug, Drug, Drug, Drug, Drug, Procedure, Radiation",Parallel Assignment,,,,Phase 3
1962,MC1831,Interventional,Experimental,"Procedure, Procedure, Procedure, Procedure, Biological",Single Group Assignment,,,,Phase 2
1963,UC-BCG-2011,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1964,FOENIX-MBC2 TAS-120-201,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1965,2019-01-064,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1966,ML43171,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1967,SHR-A1811-206,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1968,OSU-20380,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
1969,EOC202A2102,Interventional,"Active Comparator, Active Comparator","Biological, Drug",Parallel Assignment,,,,Phase 2
1970,IEO 675,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1971,7339-009,Interventional,"Experimental, Experimental","Biological, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1972,CSIIT-C41,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1973,MP-05-2021-2605,Interventional,Experimental,"Procedure, Diagnostic Test",Single Group Assignment,,,,Not Applicable
1974,EUBREAST 3,Observational,,,,Cohort,5 Years,Probability Sample,
1975,2020-1190,Interventional,"Experimental, Active Comparator","Behavioral, Other, Device, Behavioral, Other, Other",Single Group Assignment,,,,Not Applicable
1976,D933LC00001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1977,BreCLIM-2018-116-31M,Interventional,"Experimental, Active Comparator","Procedure, Drug",Parallel Assignment,,,,Phase 3
1978,I 73718,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Biological, Drug",Single Group Assignment,,,,Phase 1
1979,SHR-1210-III-327,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
1980,IRB18-00912,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
1981,Shengjing-LJY03,Observational,,Drug,,Cohort,,Non-Probability Sample,
1982,MA-BC-II-042,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1983,HCB/2020/0971,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1984,2019-00673; sp19Kurzeder,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
1985,HKUCTR-2709,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
1986,Prevention of neuropathy,Interventional,"Active Comparator, Active Comparator, Placebo Comparator","Device, Device, Device",Parallel Assignment,,,,Not Applicable
1987,HRS8807-I-101,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Device, Drug",Single Group Assignment,,,,Phase 1
1988,MUKDEN5,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
1989,s17-00995,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1990,18/0059,Observational,,Other,,Other,,Non-Probability Sample,
1991,UW19046,Interventional,Experimental,"Drug, Diagnostic Test",Single Group Assignment,,,,Early Phase 1
1992,2018-1133,Observational,,"Other, Other, Behavioral",,Case-Only,,Non-Probability Sample,
1993,TQ-B3525-I-02,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1994,MC01/05/20; IST-325 (KPT),Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1995,TQB3616-II-01,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1996,2020-1267,Interventional,Experimental,"Procedure, Procedure, Other, Drug",Single Group Assignment,,,,Not Applicable
1997,s61033,Observational,,Drug,,Cohort,,Probability Sample,
1998,SHR9549-I-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1999,IRB00109957,Interventional,"No Intervention, Active Comparator, Active Comparator","Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
2000,21/079,Observational,,Radiation,,Cohort,,Non-Probability Sample,
2001,3-2019-0140,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2002,0392-18-HMO,Interventional,"Active Comparator, Sham Comparator",Device,Sequential Assignment,,,,Not Applicable
2003,22012020,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2004,FJD-LCO2-19-01,Interventional,"Experimental, Active Comparator","Device, Combination Product",Parallel Assignment,,,,Not Applicable
2005,ARIANNA (SOLTI-1502),Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2006,KROG 21-07,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Phase 3
2007,18291,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
2008,HER2BAT,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2009,Regina Elena,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
2010,Geriatric-CDK4/6,Observational,,Drug,,Cohort,6 Months,Non-Probability Sample,
2011,CLEAR,Interventional,Experimental,"Procedure, Radiation, Procedure",Single Group Assignment,,,,Phase 2
2012,PROICM 2019-05 MAC,Interventional,"No Intervention, Experimental, Experimental","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
2013,2.777.676,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,,,,"Phase 2, Phase 3"
2014,BLI-1401-2-01,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2015,R018-SABI-00193,Observational,,,,Cohort,,Non-Probability Sample,
2016,2018-0287,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2017,Pro00087654,Observational,,Genetic,,Cohort,,Non-Probability Sample,
2018,20221120,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 2
2019,PMCT-IMSLNB-MIT,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
2020,IC 2017-06,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2021,2020-2-4023,Observational,,Device,,Cohort,,Non-Probability Sample,
2022,CO40115,Interventional,"Active Comparator, Experimental, Experimental, Active Comparator, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2023,1605576856,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2024,111-009-F,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Phase 1
2025,V2000701,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2026,21129002,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2027,IRMA,Observational,,,,Case-Only,,Non-Probability Sample,
2028,MCC-20915,Interventional,"Experimental, Experimental, Experimental","Biological, Drug, Drug, Drug, Procedure",Sequential Assignment,,,,Phase 2
2029,ZJCH-CK19B,Interventional,"No Intervention, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
2030,69HCL21_0145,Observational,,"Other, Other",,Cohort,,Non-Probability Sample,
2031,2017-0500,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2032,3475-B49,Interventional,"Experimental, Active Comparator","Biological, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2033,UW20037,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2034,University Brunswick,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2035,22-259,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
2036,BLTN-NeoBC1115,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
2037,4-2022-0600,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2038,SABO 21-01,Interventional,"Experimental, No Intervention",Radiation,Parallel Assignment,,,,Not Applicable
2039,IPI-549-03,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2040,20201101,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2041,17384,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2042,NNG17.2,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2043,UW18099,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
2044,22239,Interventional,"Experimental, Placebo Comparator","Procedure, Drug, Drug, Other, Other",Parallel Assignment,,,,Phase 2
2045,I 571719,Observational,,"Other, Other, Other",,Cohort,,Non-Probability Sample,
2046,APG2575XU103,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2047,M21CSM,Interventional,Other,"Procedure, Radiation, Other",Single Group Assignment,,,,Phase 2
2048,20171,Interventional,Experimental,"Other, Drug",Single Group Assignment,,,,Not Applicable
2049,BL-B01D1-104,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2050,202107015,Interventional,"Experimental, Experimental, Experimental","Device, Other",Parallel Assignment,,,,Not Applicable
2051,IRB-52869,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2052,ICRG0201,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2053,2019-40016-06,Interventional,"Active Comparator, Other",Drug,Factorial Assignment,,,,Not Applicable
2054,UPCC 17119,Observational,,Radiation,,Cohort,,Non-Probability Sample,
2055,D9266C00001,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2056,XJTU1AF-CRF-2018-001,Observational,,Other,,Cohort,,Probability Sample,
2057,CHANGEABLE,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2058,U21-02-4401,Interventional,,Drug,Single Group Assignment,,,,Phase 2
2059,HS-10352-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2060,1B-21-6,Observational,,"Procedure, Other, Other, Other",,Case-Only,,Non-Probability Sample,
2061,Pro00100408,Observational,,,,Cohort,,Non-Probability Sample,
2062,2017/78,Interventional,Experimental,Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
2063,NNG17.1,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
2064,Polarhis,Observational,,Device,,Other,,Probability Sample,
2065,SHR-A1811-III-301,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2066,IRB-63041,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2067,GS-US-592-6173,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2068,SCO-120-19-22,Interventional,Experimental,"Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2069,AssiutU AAHelmy,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
2070,GS-US-592-6238,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2071,CBYL719C2201,Interventional,"Experimental, Placebo Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2072,NCI-2022-00004,Interventional,Experimental,"Drug, Dietary Supplement",Single Group Assignment,,,,"Phase 1, Phase 2"
2073,19/218,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2074,AIPAC-003,Interventional,"Experimental, Experimental, Experimental, Placebo Comparator","Biological, Drug, Other",Parallel Assignment,,,,"Phase 2, Phase 3"
2075,STUDY00004618,Interventional,"Experimental, Active Comparator","Other, Behavioral, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2076,2019-00174 Neoadj Breast Pilot,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
2077,INT/2020/VOICE,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2078,SCT200IITNBC,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 2
2079,SuleymanDU-SALMAN-F-001,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2080,TQB3616-III-01,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2081,19-3032.cc,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2082,H3B-6545-J081-103,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
2083,UPNA-CUMACA-B2022,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2084,MO40628,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Crossover Assignment,,,,Phase 2
2085,IIBSP-SIL-2017-70,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,,,,Not Applicable
2086,18-1068,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2087,19959,Interventional,"Active Comparator, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
2088,651,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
2089,2021SQGH00743,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2090,213831,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2091,Shoulder exercise cancer,Interventional,"Experimental, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
2092,LCCC 2104,Interventional,"Active Comparator, Experimental","Radiation, Drug",Parallel Assignment,,,,Phase 2
2093,N assisted,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2094,32158620.0.0000.0072,Observational,,Other,,Cohort,1 Year,Probability Sample,
2095,GC-627-05,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2096,PI2018_843_0061,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2097,LightCT-PKUPH,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
2098,SYSKY-2022-024-01,Interventional,Experimental,Procedure,Sequential Assignment,,,,Not Applicable
2099,rosuva2020,Interventional,"No Intervention, Active Comparator",Drug,Parallel Assignment,,,,Phase 3
2100,GCO 17-2320,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2101,NL62441.068.17,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
2102,2110244-11,Interventional,"Experimental, Sham Comparator, Sham Comparator",Device,Parallel Assignment,,,,Phase 4
2103,N21CPB-IRBd22-103,Interventional,"Experimental, Experimental, Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
2104,Pro00109917,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2105,SUGBG-2021001,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2106,EP0062-101,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
2107,MA-BC-II-025,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2108,"S-20200021, 19-16321",Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2109,CPO-NBP-2002,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2110,MCC-19220,Interventional,Experimental,"Diagnostic Test, Biological, Diagnostic Test",Single Group Assignment,,,,Early Phase 1
2111,PROSOM-K,Interventional,"Other, Other, Other","Other, Drug",Parallel Assignment,,,,Not Applicable
2112,HSM/VGH-2019-12-009CC,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2113,BR-003,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2114,2021/156064(REK),Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Phase 2
2115,StrataXRT,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2116,KY2022-044-B,Interventional,"Active Comparator, Other",Device,Parallel Assignment,,,,Not Applicable
2117,2018-09-20 Version 1.2,Observational,,Drug,,Cohort,,Probability Sample,
2118,events in breast cancer,Observational,,Drug,,Cohort,24 Months,Non-Probability Sample,
2119,2021-A01550-41,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
2120,20220430GD,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2121,MC220902,Observational,,"Other, Other, Other",,Cohort,,Non-Probability Sample,
2122,ShengjingH 3,Observational,,Other,,Cohort,10 Years,Probability Sample,
2123,2449PT,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
2124,MedOPP199,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2125,Exo-LCR-1807,Interventional,Experimental,"Procedure, Procedure, Procedure",Single Group Assignment,,,,Not Applicable
2126,ILLUMINE,Observational,,"Drug, Drug, Drug",,Cohort,,Non-Probability Sample,
2127,C4891016,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2128,TQB3909-Ib/II-01,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2129,UCI 19-145 [HS# 1459],Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2130,AGO/2019/003,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
2131,2020-A01916-33,Interventional,"Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
2132,NBK 171/1/2021,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2133,18496,Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Other, Other",Parallel Assignment,,,,"Phase 1, Phase 2"
2134,18459,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2135,NCC1787,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
2136,DBCG RT SDM,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2137,20923,Observational,,"Procedure, Other",,Cohort,,Non-Probability Sample,
2138,PRO00030295,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2139,SUN-2252,Observational,,Diagnostic Test,,Cohort,3 Years,Probability Sample,
2140,RECHMPL21_0680,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2141,RIBBS 2019/37,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
2142,INT214/22,Interventional,"Placebo Comparator, Experimental",Dietary Supplement,Parallel Assignment,,,,Phase 2
2143,Folio No.03-2022,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2144,22-250,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2145,201906,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2146,HCI130492,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2147,A171601,Interventional,Experimental,"Drug, Drug, Drug, Other, Other",Single Group Assignment,,,,Phase 2
2148,2021-0669,Observational,,"Procedure, Procedure, Radiation",,Cohort,,Non-Probability Sample,
2149,BL-M07D1-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2150,S63330,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
2151,CA209-8H3,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2152,CARDIEJERCAN,Interventional,"No Intervention, Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
2153,E7090-J081-102,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
2154,2574,Interventional,"Experimental, Sham Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2155,A5481122,Observational,,"Drug, Drug, Drug",,Cohort,,Non-Probability Sample,
2156,21-091,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2157,VHIO20002,Interventional,Experimental,"Drug, Drug, Drug, Biological, Drug",Single Group Assignment,,,,Phase 1
2158,439-21,Interventional,"Experimental, Active Comparator, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2159,OP-1250-001,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
2160,MC1835-ACCRU-BR-1701,Interventional,"Experimental, Placebo Comparator, Experimental","Biological, Biological, Other, Biological, Biological, Biological",Parallel Assignment,,,,Phase 2
2161,FDRT-BC010,Interventional,Experimental,Other,Single Group Assignment,,,,"Phase 1, Phase 2"
2162,H-45698,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2163,CCR5234,Interventional,"Experimental, No Intervention, Experimental, No Intervention","Other, Other",Sequential Assignment,,,,Not Applicable
2164,1890-1-2019,Observational,,Drug,,Other,,Probability Sample,
2165,IFG-06-2019,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
2166,11066,Interventional,"Active Comparator, Active Comparator, Active Comparator","Behavioral, Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
2167,PHDW-006,Observational,,,,Cohort,1 Day,Non-Probability Sample,
2168,OTT 17-02,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
2169,21094,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
2170,IEO 0837/,Observational,,Other,,Cohort,,Non-Probability Sample,
2171,CCR4772,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
2172,PECP,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
2173,UC-BCG-2205,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2174,UPCC 11121,Observational,,Other,,Cohort,,Non-Probability Sample,
2175,22-655,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Phase 2
2176,D8666C00004,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2177,AnhuiPH,Observational,,,,Case-Only,,Non-Probability Sample,
2178,NL67422.041.18,Interventional,Experimental,"Drug, Procedure, Drug",Single Group Assignment,,,,Phase 1
2179,S-64813,Observational,,,,Case-Only,2 Years,Non-Probability Sample,
2180,17-0310,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2181,VICC BRE 20104,Observational,,"Other, Other, Other",,Cohort,,Non-Probability Sample,
2182,2020-0831,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
2183,SDO-006-20-01,Interventional,"Active Comparator, Active Comparator",Drug,Crossover Assignment,,,,Phase 1
2184,CBYL719A03201,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2185,ASSOCIHER,Observational,,Drug,,Cohort,,Non-Probability Sample,
2186,2021-40-2343,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
2187,CL0007,Interventional,"Experimental, No Intervention",Combination Product,Parallel Assignment,,,,Phase 3
2188,HSR210410,Interventional,"Other, Other, Other, Other","Drug, Drug, Radiation, Radiation",Parallel Assignment,,,,"Phase 2, Phase 3"
2189,MO39193,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2190,"CD133, Breast Cancer",Observational,,,,Other,,Non-Probability Sample,
2191,NCI-2018-01581,Interventional,"Experimental, Active Comparator","Procedure, Procedure, Drug, Procedure, Biological, Drug, Procedure, Drug, Biological, Drug, Biological",Parallel Assignment,,,,Phase 2
2192,EPTTCSM (239BRC18.0129),Observational,,,,Cohort,,Non-Probability Sample,
2193,ALTER-BC-003,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2194,2021-0261,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Drug, Device, Other",Parallel Assignment,,,,Phase 3
2195,H3B-6545-G000-102,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,Phase 1
2196,SIB16134,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
2197,QUILT-3.057,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Biological, Biological, Biological, Biological, Biological, Biological, Drug, Biological, Biological, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2198,AL-TNBC-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2199,CAR202,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2200,69HCL19_0593,Observational,,Other,,Cohort,,Non-Probability Sample,
2201,41494,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2202,300007016,Interventional,"Experimental, Active Comparator",Behavioral,Parallel Assignment,,,,Not Applicable
2203,HSaleem,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2204,20D.876,Interventional,"Active Comparator, Experimental","Other, Radiation, Procedure, Other, Other, Procedure, Other",Parallel Assignment,,,,Phase 2
2205,19D.799,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
2206,112626,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
2207,220493,Interventional,Other,Drug,Single Group Assignment,,,,Not Applicable
2208,2020-q12,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
2209,2020-11/15,Interventional,"Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
2210,22-225,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2211,GM1-CIPN-202,Interventional,"Experimental, Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,"Phase 2, Phase 3"
2212,21-110,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
2213,21050,Interventional,Experimental,"Other, Procedure, Device, Biological, Biological",Single Group Assignment,,,,Phase 4
2214,1280-0022,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2215,MC1733,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
2216,RLY-2608-101,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
2217,BL2014084,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2218,ShandongCHI-04,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
2219,0124-18-TLV,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2220,20160504,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
2221,55054,Interventional,"Experimental, Sham Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2222,PILOT 171548,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2223,CLEE011A2207,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2224,IFG-NIB-01,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2225,VICC BRE 17107,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2226,1710018694,Interventional,Other,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2227,29747,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2228,YWBC-001,Observational,,,,Case-Only,5 Years,Probability Sample,
2229,294-2018,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2230,2022/005-OST,Observational,,Diagnostic Test,,Cohort,1 Year,Non-Probability Sample,
2231,WSG-AM08,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 3
2232,PRESSODOU-1809,Interventional,"Experimental, Sham Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2233,IRB-53650,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2234,NCI-2018-01519,Interventional,"Experimental, Active Comparator","Drug, Radiation",Parallel Assignment,,,,Phase 2
2235,NCI-2022-07265,Interventional,"Experimental, Active Comparator, Experimental","Drug, Procedure, Procedure, Procedure, Drug, Procedure",Parallel Assignment,,,,Phase 2
2236,HLX10-013-TNBCneo,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Sequential Assignment,,,,Phase 3
2237,Pro00103625,Interventional,"Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2238,MRG002-005,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2239,INT 192/19,Interventional,"Experimental, Experimental","Dietary Supplement, Drug, Drug",Parallel Assignment,,,,Phase 2
2240,AURORA US,Observational,,"Procedure, Other",,Case-Only,,Non-Probability Sample,
2241,G1T28-208,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2242,2017/01,Interventional,"Active Comparator, Placebo Comparator",Other,Parallel Assignment,,,,Phase 3
2243,2017-004938-28,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2244,2020-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2245,G0F9119N,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,,,,Not Applicable
2246,I-3010822,Interventional,"Experimental, Experimental","Procedure, Procedure, Drug, Procedure, Biological, Procedure, Biological, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2247,OP_1413,Interventional,"No Intervention, Experimental",Diagnostic Test,Parallel Assignment,,,,Not Applicable
2248,18HH4880,Observational,,Other,,Cohort,,Non-Probability Sample,
2249,ZZBGCART-016,Interventional,Experimental,Biological,Single Group Assignment,,,,Early Phase 1
2250,STUDY00004257,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Early Phase 1
2251,HYPART,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
2252,PALBO01/2021,Observational,,Drug,,Other,,Probability Sample,
2253,21-038,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2254,IUSCC-0647,Observational,,,,Cohort,,Non-Probability Sample,
2255,09.2019.865,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2256,2022-A00171-42,Observational,,,,Cohort,,Non-Probability Sample,
2257,AZV2022,Interventional,"Experimental, Experimental, Experimental, No Intervention","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2258,UMCC 2021.056,Interventional,"Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
2259,UC-0140/1814,Interventional,Other,"Drug, Other",Single Group Assignment,,,,Not Applicable
2260,SL-2020076,Observational,,Other,,Cohort,,Non-Probability Sample,
2261,IC 2020-15,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
2262,BOOG 2019-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2263,NBG-19-01; SWEBCG 19-01,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2264,RF-2016-02362383,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2265,2018/14-01,Interventional,"Experimental, Active Comparator",Behavioral,Crossover Assignment,,,,Not Applicable
2266,UTD-1-BM-II,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
2267,3-2020-0448,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2268,9764,Interventional,Experimental,"Drug, Drug, Other, Drug, Other, Other, Drug, Drug",Single Group Assignment,,,,Phase 4
2269,CLEE011AUS65,Observational,,"Drug, Drug, Drug",,Cohort,,Non-Probability Sample,
2270,LCCC1934,Observational,,,,Cohort,,Non-Probability Sample,
2271,Lymphedema Rehabilitation,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2272,bakircaymzeren07,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
2273,EA1211,Interventional,Experimental,"Drug, Procedure, Other, Procedure, Procedure",Single Group Assignment,,,,Phase 2
2274,Pro2020001306,Interventional,Experimental,"Other, Other, Radiation, Procedure, Radiation, Other",Single Group Assignment,,,,Not Applicable
2275,IRB-30000320,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2276,11B1920N_BCS-PAIN,Interventional,"Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
2277,17502,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
2278,ShandongCHI-13,Interventional,"Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2279,2021SCR,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
2280,Pro00109777,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2281,MIMIR-mTNBC,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
2282,2861/20,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Other",Factorial Assignment,,,,Phase 2
2283,STUDY00146320,Interventional,"Experimental, Other",Drug,Parallel Assignment,,,,Phase 2
2284,2-114-18,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
2285,VMA-253-18,Interventional,"Experimental, No Intervention",Dietary Supplement,Parallel Assignment,,,,Not Applicable
2286,2018-01-054,Observational,,Diagnostic Test,,Case-Only,5 Years,Non-Probability Sample,
2287,2.073.549,Interventional,"Experimental, Experimental, No Intervention","Other, Other",Factorial Assignment,,,,Not Applicable
2288,2020-12518,Observational,,,,Cohort,5 Years,Non-Probability Sample,
2289,NCI-2020-02319,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Procedure, Drug, Drug, Procedure",Sequential Assignment,,,,"Phase 1, Phase 2"
2290,2022-A00437-36,Interventional,"Experimental, Active Comparator, Active Comparator",Diagnostic Test,Parallel Assignment,,,,Not Applicable
2291,BMTN,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2292,30388,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
2293,WO40181,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2294,SM-88-001,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2295,GY202201,Interventional,"Experimental, Sham Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
2296,NL76792.091.21,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
2297,UKT HT03_1,Observational,,,,Cohort,5 Years,Non-Probability Sample,
2298,P170407J,Interventional,Other,Drug,Single Group Assignment,,,,Phase 2
2299,BRAVE,Observational,,Other,,Other,,Non-Probability Sample,
2300,20190304-01H,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2301,QF-SC10914-203,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2302,A011801,Interventional,"Active Comparator, Experimental","Biological, Drug, Drug, Other, Other",Parallel Assignment,,,,Phase 3
2303,H19-02480,Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2304,190025,Observational,,,,Cohort,,Non-Probability Sample,
2305,ICS Maugeri - CE 2202,Interventional,"Active Comparator, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
2306,CBCSG041,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
2307,IRB202000746,Interventional,"Experimental, Experimental, Other","Drug, Combination Product, Combination Product",Parallel Assignment,,,,"Phase 1, Phase 2"
2308,D926PC00001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2309,IRB00376235,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2310,PILHLE-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2311,HCRN BRE18-360,Interventional,Experimental,"Drug, Radiation, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
2312,19-1974.cc,Interventional,"Other, Other","Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
2313,21-579,Interventional,"Active Comparator, Experimental",Device,Parallel Assignment,,,,Not Applicable
2314,A5481151,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
2315,HS-10342-201,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2316,WEBAPPAC,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2317,108818,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
2318,2020-01-mp-BUS,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2319,NCI-2019-00048,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
2320,Maple Tree Exercise,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2321,22145,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 2
2322,ERC/2019/10/05,Interventional,"Experimental, Experimental","Procedure, Other",Parallel Assignment,,,,Not Applicable
2323,19-001881,Interventional,Experimental,"Drug, Other",Single Group Assignment,,,,Phase 2
2324,OSU-21185,Interventional,Experimental,"Behavioral, Other, Other",Single Group Assignment,,,,Not Applicable
2325,I 60517,Interventional,"Active Comparator, Experimental","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2326,MC220303,Observational,,"Procedure, Procedure, Other",,Cohort,,Non-Probability Sample,
2327,STU-2020-1043,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2328,TCHP,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
2329,IndonesiaU2022,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2330,STUDY00003100,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
2331,041-2018,Interventional,"No Intervention, Experimental",Combination Product,Parallel Assignment,,,,"Phase 2, Phase 3"
2332,RESCREEN,Interventional,"Experimental, Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
2333,20-009279,Observational,,"Procedure, Other",,Case-Only,,Non-Probability Sample,
2334,IRB-57111,Interventional,"Active Comparator, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2335,A221803,Interventional,"Active Comparator, Experimental","Other, Device, Other, Other",Parallel Assignment,,,,Phase 3
2336,PUMCH-2020-EBC,Observational,,,,Cohort,5 Years,Non-Probability Sample,
2337,Organoids Breast,Observational,,Other,,Cohort,,Non-Probability Sample,
2338,KKKR-Neulasta OS-01,Observational,,,,Cohort,,Non-Probability Sample,
2339,H19094,Interventional,"Other, Experimental","Other, Behavioral",Parallel Assignment,,,,Not Applicable
2340,BYEC20211201,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2341,D0819C00005,Observational,,,,Cohort,,Non-Probability Sample,
2342,18-140,Interventional,Experimental,"Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
2343,2022-0959,Interventional,"Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Single Group Assignment,,,,"Phase 2, Phase 3"
2344,20-133,Interventional,Experimental,Procedure,Single Group Assignment,,,,Early Phase 1
2345,16-185671,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2346,FM-17-B01,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 3
2347,SunYatsenU2H-LQ3,Interventional,"Experimental, Active Comparator, Experimental, No Intervention","Drug, Drug",Parallel Assignment,,,,Phase 2
2348,STUDY00001007,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2349,HCC 20-243,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2350,Alaa_Negm_MSc_2023,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
2351,21656,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2352,STUDY00007842,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2353,20-221,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2354,E-HHC-2016-0245,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2355,I 1680021,Interventional,Experimental,"Biological, Procedure, Procedure, Procedure, Biological, Other",Single Group Assignment,,,,Phase 2
2356,ACCRU-BR-1801,Interventional,"Active Comparator, Experimental","Drug, Biological",Parallel Assignment,,,,Phase 2
2357,HE072-CSP-002,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,,,,Phase 1
2358,M18BEL,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
2359,"UPCC# 15122, IRB # 852205",Interventional,"Experimental, Experimental","Drug, Device",Sequential Assignment,,,,Phase 1
2360,2020-01,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2361,LCCC1745,Observational,,Device,,Cohort,,Non-Probability Sample,
2362,BPI-1178-2019-001,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2363,UC-0140/1901,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2364,HMCC-BR22-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2365,2022-0378,Interventional,"Other, Other","Other, Other",Parallel Assignment,,,,Not Applicable
2366,IRB-58571,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2367,TransRosaLEE-IPC 2021-075,Interventional,Experimental,"Genetic, Genetic, Genetic, Genetic",Single Group Assignment,,,,Not Applicable
2368,2000024495,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
2369,NCC1692,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2370,NCI-2019-06461,Interventional,"Experimental, Active Comparator","Drug, Biological, Biological",Parallel Assignment,,,,"Phase 1, Phase 2"
2371,CIH-TZS-20190912,Observational,,"Drug, Drug",,Case-Control,,Non-Probability Sample,
2372,TROIKA,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2373,19/002,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2374,17-00890,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2375,UMCC 2021.109,Interventional,"Active Comparator, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 4
2376,249571,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2377,HNCH-BC001,Interventional,"Placebo Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2378,17782,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 4
2379,0201-21,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2380,0201263,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
2381,HCI103657,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2382,KutahyaMSUcancer,Observational,,,,Cohort,,Non-Probability Sample,
2383,AAAS9859,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2384,ExtremeHypofractionationBreast,Observational,,,,Cohort,,Non-Probability Sample,
2385,S-169,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Other,Parallel Assignment,,,,Phase 1
2386,NCI-2022-10810,Interventional,Experimental,"Procedure, Procedure, Procedure, Drug, Procedure, Drug, Biological",Single Group Assignment,,,,Phase 1
2387,LQ004,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2388,HS627-III,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2389,RG1004302,Interventional,Experimental,"Drug, Biological",Single Group Assignment,,,,Phase 1
2390,CORE,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2391,001,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2392,ENZENO-C-101,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2393,UMCC 2020.122,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2394,2022/050,Interventional,"Experimental, Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2395,BR01/01/22,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2396,2021-A03166-35,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2397,ATENTO19,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2398,Pro00100093,Interventional,"Active Comparator, Active Comparator, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 2
2399,19206,Interventional,Experimental,"Drug, Other",Single Group Assignment,,,,Phase 2
2400,POLAR-01,Observational,,Drug,,Cohort,,Non-Probability Sample,
2401,STUDY00002373,Interventional,"Experimental, Active Comparator","Device, Procedure, Other",Parallel Assignment,,,,Phase 2
2402,09.2018.,Observational,,Other,,Other,,Probability Sample,
2403,SCHBCC-N048,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2404,S2020-09,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2405,CA048-001,Interventional,"Experimental, Experimental, Experimental","Biological, Biological, Drug",Single Group Assignment,,,,Phase 1
2406,S00748-NIM,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2407,NEO-R-IPC 2019-041,Observational,,Other,,Cohort,,Probability Sample,
2408,22-074,Interventional,"Experimental, Experimental, Placebo Comparator","Drug, Drug, Other",Sequential Assignment,,,,Phase 2
2409,UW 19-045,Interventional,"Active Comparator, Placebo Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2410,3-2020-0343,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2411,18549,Interventional,Experimental,"Other, Behavioral, Behavioral, Other, Other",Single Group Assignment,,,,Not Applicable
2412,2017-073,Interventional,Experimental,"Other, Drug",Single Group Assignment,,,,Phase 2
2413,201710109,Interventional,"Experimental, Experimental","Drug, Biological, Device, Procedure",Parallel Assignment,,,,Phase 1
2414,lithium and breast cancer,Interventional,"No Intervention, Experimental",Drug,Parallel Assignment,,,,Phase 3
2415,KSF2-1707,Interventional,Experimental,"Procedure, Biological, Procedure",Single Group Assignment,,,,Not Applicable
2416,RG1718047,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,Phase 2
2417,19-0448,Observational,,Radiation,,Cohort,5 Years,Non-Probability Sample,
2418,Multimodal Project,Interventional,"Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2419,22-490,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2420,C-MOT,Observational,,Other,,Cohort,,Non-Probability Sample,
2421,EGC002,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2422,2016-003518-28,Interventional,"Experimental, Active Comparator","Other, Drug, Drug",Parallel Assignment,,,,Phase 3
2423,ZLiu,Observational,,Other,,Cohort,,Probability Sample,
2424,XJLL-KY20212136,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2425,SYSKY-2022-445-01,Observational,,"Drug, Procedure, Drug, Drug",,Cohort,,Non-Probability Sample,
2426,CGAprediting,Observational,,,,Cohort,,Non-Probability Sample,
2427,CMUH107-REC3-102,Interventional,"Active Comparator, Placebo Comparator",Other,Crossover Assignment,,,,Not Applicable
2428,J17118,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2429,19P.117,Interventional,Experimental,"Drug, Procedure, Other, Other",Single Group Assignment,,,,Phase 1
2430,TX05-03,Interventional,"Experimental, Active Comparator","Biological, Biological, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2431,BR01/02/19,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2432,HCRN BRE19-433,Interventional,Experimental,"Drug, Drug, Radiation",Single Group Assignment,,,,Phase 2
2433,BC-P32,Observational,,,,Cohort,,Non-Probability Sample,
2434,THALIA-01,Observational,,Drug,,Cohort,,Non-Probability Sample,
2435,HBO001,Interventional,"Experimental, Active Comparator","Procedure, Drug, Dietary Supplement",Parallel Assignment,,,,Phase 2
2436,2023-3181,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2437,CH-BC-086,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
2438,2016/65,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2439,UW21062,Interventional,"Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
2440,2020-006,Interventional,"Other, Other","Other, Other",Parallel Assignment,,,,Not Applicable
2441,2018/8361/I,Interventional,Other,"Diagnostic Test, Diagnostic Test, Procedure, Procedure",Single Group Assignment,,,,Not Applicable
2442,20210901-jiangchunling,Interventional,"Experimental, Active Comparator",Combination Product,Parallel Assignment,,,,Phase 2
2443,01,Interventional,"Experimental, Sham Comparator, Other","Other, Other, Other",Parallel Assignment,,,,Not Applicable
2444,2020KT151,Observational,,Drug,,Cohort,,Non-Probability Sample,
2445,NCC3222,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
2446,427 BC SDM,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
2447,STUDY00018239,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,Phase 1
2448,IJB-EBC-Decrescendo-2020,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 2
2449,170115,Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2450,EQ132-201,Interventional,Other,Drug,Single Group Assignment,,,,Phase 2
2451,NCO-21001,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
2452,ACT16106,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2453,FASCINATE-N,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2454,IRB00154162,Observational,,Drug,,Case-Only,,Non-Probability Sample,
2455,CHUV-DO-0009-CyberImmunoBreast,Interventional,"Experimental, Experimental","Radiation, Drug",Parallel Assignment,,,,Phase 2
2456,ANG1005-CLN-07,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2457,17471,Interventional,Experimental,"Drug, Other, Other, Other, Drug",Single Group Assignment,,,,Phase 2
2458,BAIBU-FTR-ED-001,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2459,Shengjing-LJY02,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2460,PEMBRACA,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2461,KaratayUHaticeTEZ,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2462,22-10590-BO,Observational,,,,Cohort,,Non-Probability Sample,
2463,Manual Therapy BCS,Interventional,"Experimental, Sham Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
2464,KUH5101090,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2465,16-015,Interventional,"Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Early Phase 1
2466,IIT-2017-MM-BRST-Her2noRT,Interventional,"Experimental, No Intervention, No Intervention",Radiation,Parallel Assignment,,,,Not Applicable
2467,YBCSG-21-01,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2468,GBG 97,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2469,DOT-1871-KIE-0120-I,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2470,PROICM 2018-02 SKY,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2471,2016-6346,Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2472,UniUrb_21/10.07.2019,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2473,NCI-2016-01293,Interventional,Experimental,"Procedure, Drug, Procedure",Single Group Assignment,,,,Phase 1
2474,BOOG 2021-01 SEQUEL-Breast,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2475,GRASPA-TNBC-2018-02,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
2476,4-2017-1108,Observational,,Procedure,,Cohort,,Non-Probability Sample,
2477,SIMR_onc19_IIS_DAndre_Ashwaga,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Crossover Assignment,,,,Phase 2
2478,RI-002,Observational,,,,Cohort,,Non-Probability Sample,
2479,N19TON,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2480,20170770,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2481,1070741-1,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
2482,GATTUM -1,Observational,,,,Cohort,,Probability Sample,
2483,Soh-Med-23-02-16,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 1
2484,MCC-19337,Interventional,"Active Comparator, Active Comparator, Experimental","Biological, Drug, Procedure",Parallel Assignment,,,,Early Phase 1
2485,YX2021-070(F1),Interventional,"Placebo Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
2486,2020-1138,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2487,1B-16-11,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2488,7119-001,Interventional,Experimental,"Drug, Biological, Drug",Single Group Assignment,,,,Phase 2
2489,LCI-BRE-MTN-NIR-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2490,CDX-ONC-101,Interventional,"Experimental, Experimental, Experimental, Experimental",Biological,Sequential Assignment,,,,Phase 1
2491,18175,Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2492,432-17,Interventional,Other,Behavioral,Single Group Assignment,,,,Not Applicable
2493,2021332GD,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
2494,2021-1031,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2495,PRO2,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
2496,KTI-21-01,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
2497,MO42319,Interventional,"Active Comparator, Experimental","Drug, Drug, Other",Parallel Assignment,,,,Phase 3
2498,I 62218,Interventional,Experimental,"Procedure, Procedure, Drug, Biological, Drug, Biological",Single Group Assignment,,,,Early Phase 1
2499,ICL-2022-1,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2500,21152,Interventional,"Experimental, Experimental","Drug, Other, Other, Other",Parallel Assignment,,,,Phase 1
2501,22-364,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Phase 2
2502,18238,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2503,NCI-2019-02752,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2504,4090,Interventional,"Experimental, Experimental",Device,Parallel Assignment,,,,Not Applicable
2505,E2019316,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Phase 4
2506,BLTN-Ig,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2507,Pro00080769,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2508,ISK-N103,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
2509,BCIG,Observational,,Procedure,,Cohort,5 Years,Probability Sample,
2510,RECHMPL20_0130,Observational,,,,Cohort,,Non-Probability Sample,
2511,OSU-17122,Interventional,Experimental,"Other, Other, Other, Other, Other, Other",Single Group Assignment,,,,Not Applicable
2512,STao-003,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2513,2018-0473,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Procedure",Parallel Assignment,,,,Not Applicable
2514,MCC-21-18633,Interventional,"Experimental, Active Comparator, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2515,SKB264-â¡-07,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2516,PTC-breastNAT,Interventional,"Experimental, No Intervention",Diagnostic Test,Parallel Assignment,,,,Phase 2
2517,LonghuaH,Interventional,"Active Comparator, Sham Comparator",Other,Parallel Assignment,,,,Not Applicable
2518,ZL-1302-002,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2519,2019-0638,Interventional,Experimental,"Procedure, Other, Other, Other, Other, Other, Other, Other",Single Group Assignment,,,,Not Applicable
2520,Fudan-P1-201701,Interventional,"Experimental, Experimental, Experimental, Experimental","Combination Product, Combination Product, Combination Product, Combination Product",Parallel Assignment,,,,Phase 1
2521,OTT 18-01,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
2522,NU 19B07,Interventional,Experimental,"Drug, Biological, Genetic",Single Group Assignment,,,,Phase 1
2523,MEDOPP445,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2524,OSU-21035,Interventional,"Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
2525,NCC1786,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
2526,CBYL719C2005,Observational,,Other,,Other,,Non-Probability Sample,
2527,69HCL21_0552,Observational,,Other,,Cohort,,Probability Sample,
2528,ICR-CTSU/2017/10065,Interventional,"No Intervention, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2529,Neo-RT,Observational,,"Radiation, Drug, Procedure",,Cohort,,Non-Probability Sample,
2530,ZG-2021-002,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2531,LUT-RD-02-01,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2532,OSU-18174,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2533,20-166,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2534,OSU-20101,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2535,DR210090_SILENCE,Interventional,"Experimental, Sham Comparator","Device, Drug, Device",Parallel Assignment,,,,Not Applicable
2536,VICC BRE 18108,Interventional,"Experimental, Active Comparator","Dietary Supplement, Drug",Single Group Assignment,,,,Early Phase 1
2537,RIGAIN,Interventional,"Experimental, Active Comparator","Radiation, Radiation, Radiation",Parallel Assignment,,,,Not Applicable
2538,Survey_App,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
2539,ML42876,Observational,,,,Cohort,,Non-Probability Sample,
2540,N201912134,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2541,INCMNSZ REF 1239,Interventional,Experimental,"Drug, Drug, Drug, Procedure, Drug",Single Group Assignment,,,,Phase 2
2542,19-031,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
2543,OSU-18201,Interventional,"Experimental, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
2544,UW18063,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2545,IRST174.21,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2546,PEAR-TNBC_ Protocol_v2.0,Observational,,Procedure,,Cohort,,Non-Probability Sample,
2547,SAHZhejiangU---Breast,Observational,,Combination Product,,Cohort,5 Years,Non-Probability Sample,
2548,I 2612022,Interventional,Experimental,"Procedure, Procedure, Procedure, Biological, Drug, Other",Single Group Assignment,,,,Phase 2
2549,IRB00049171,Observational,,"Biological, Procedure, Drug, Procedure",,Case-Only,,Non-Probability Sample,
2550,MA-BC-II-002,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2551,UPCC 21118,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2552,RG1122380,Interventional,Experimental,"Biological, Biological",Single Group Assignment,,,,Phase 2
2553,M21CAR,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
2554,MHICC-2018-003,Observational,,"Diagnostic Test, Other",,Cohort,,Non-Probability Sample,
2555,H-1912-010-086,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
2556,DAN-22220205,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2557,RG1003977,Interventional,"Experimental, Active Comparator","Behavioral, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2558,IFOM-CPT008/2022/PO007,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2559,BabesBolyaiOncovox,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2560,R21052,Observational,,Procedure,,Cohort,3 Years,Non-Probability Sample,
2561,V2011801,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2562,20190812,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
2563,2022-0239,Observational,,Drug,,Cohort,,Non-Probability Sample,
2564,4070,Interventional,"Active Comparator, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
2565,MCC-19-14621,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2566,I-19-04120,Interventional,Experimental,"Biological, Biological",Single Group Assignment,,,,Phase 2
2567,042001,Interventional,Experimental,"Biological, Other, Other, Biological",Single Group Assignment,,,,Phase 2
2568,R.18.02.33,Interventional,"Experimental, Active Comparator","Procedure, Drug, Procedure, Procedure",Parallel Assignment,,,,Phase 3
2569,i 67518,Interventional,"Experimental, Active Comparator","Other, Behavioral, Other, Other",Parallel Assignment,,,,Not Applicable
2570,268-2017,Interventional,"Other, Other",Device,Parallel Assignment,,,,Not Applicable
2571,CADPT01A12101C,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological, Drug, Drug, Biological, Biological",Single Group Assignment,,,,Phase 1
2572,Exactis-05,Observational,,Other,,Cohort,,Non-Probability Sample,
2573,GIM25-CAPT,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
2574,STUDY00002985,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2575,767/29-09-2017,Interventional,"Experimental, Placebo Comparator",Device,Parallel Assignment,,,,Not Applicable
2576,HCI153239,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Phase 2
2577,2022-191,Interventional,"Experimental, Sham Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2578,WSG-AM12,Interventional,"Experimental, Experimental, Other, Other","Drug, Drug",Crossover Assignment,,,,Phase 2
2579,CSIIT-C37,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2580,16-304,Interventional,"Experimental, Active Comparator",Radiation,Parallel Assignment,,,,Not Applicable
2581,ELA-0121,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2582,NCI-2017-02320,Interventional,"Active Comparator, Experimental","Drug, Drug, Other, Drug",Parallel Assignment,,,,Phase 2
2583,S2020-300,Observational,,,,Other,1 Month,Probability Sample,
2584,844978,Observational,,Diagnostic Test,,Other,,Non-Probability Sample,
2585,ERC/2018/06/01,Observational,,"Behavioral, Device",,Case-Control,,Non-Probability Sample,
2586,187519,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug, Drug, Biological, Drug, Drug",Parallel Assignment,,,,Phase 2
2587,2019-A02374-53,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2588,APPI2-PT-2020-AIMSS,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2589,OnerCengiz,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2590,EDP1503-101,Interventional,"Experimental, Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 1
2591,PH-CP026,Interventional,"Placebo Comparator, Experimental","Drug, Drug, Procedure",Parallel Assignment,,,,Phase 2
2592,B1432020000025,Interventional,"Experimental, Experimental, Active Comparator","Other, Other",Crossover Assignment,,,,Not Applicable
2593,50619,Observational,,"Diagnostic Test, Diagnostic Test, Diagnostic Test",,Cohort,,Probability Sample,
2594,CTP-BRST-01,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2595,2016-0538,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2596,TN.32.1.17.SATF,Interventional,"Experimental, Experimental, Experimental",Device,Parallel Assignment,,,,Not Applicable
2597,A221801,Interventional,"Experimental, Sham Comparator","Device, Device, Other, Other",Parallel Assignment,,,,Phase 3
2598,ANI251_BCS-PI,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2599,IFG-05-2019,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2600,PHRI.SCHOLAR-2,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2601,MC1931,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2602,MC2031,Interventional,Experimental,"Drug, Procedure, Drug",Single Group Assignment,,,,Early Phase 1
2603,CBTMMUH,Interventional,"Active Comparator, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2604,2018/455,Interventional,"Experimental, Placebo Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
2605,2019-1237,Observational,,"Behavioral, Other",,Cohort,,Non-Probability Sample,
2606,9988,Interventional,"Active Comparator, Experimental","Behavioral, Other, Other, Device, Other, Other",Parallel Assignment,,,,Not Applicable
2607,OSU-18317,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Other, Other",Parallel Assignment,,,,Phase 1
2608,e-OTCAT20,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
2609,19447,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
2610,KN026-US-I-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2611,ACT-MBC,Observational,,Diagnostic Test,,Case-Only,,Probability Sample,
2612,2017-0502,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2613,20180259-01H,Interventional,"Active Comparator, Experimental, Sham Comparator","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2614,NCI-2019-05187,Interventional,Experimental,"Drug, Procedure, Other, Other, Radiation",Single Group Assignment,,,,Phase 1
2615,23-050,Interventional,"Experimental, Active Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
2616,20G.093,Interventional,Experimental,"Other, Device, Other, Other, Other",Single Group Assignment,,,,Not Applicable
2617,OUMK59829,Interventional,Experimental,"Drug, Drug, Drug, Drug, Procedure",Single Group Assignment,,,,Phase 2
2618,STUDY00000057,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2619,55457122.3.0000.5330,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
2620,239531,Interventional,"Experimental, Active Comparator","Drug, Combination Product",Parallel Assignment,,,,Phase 2
2621,Castle06(BC),Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
2622,IFG-01-2022,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
2623,LACOG 0122,Observational,,,,Cohort,,Non-Probability Sample,
2624,STUDY02000934_1,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2625,RG1718049,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2626,PI-0171-2020,Interventional,"Experimental, Active Comparator, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
2627,OSU-19152,Interventional,"Experimental, Active Comparator","Device, Other",Crossover Assignment,,,,Not Applicable
2628,STU-2019-0529,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,,,,Phase 4
2629,NBC Sur001,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
2630,OSU-20340,Interventional,"Active Comparator, Experimental","Drug, Drug, Other, Other",Parallel Assignment,,,,Early Phase 1
2631,NCI-2022-04956,Interventional,"Experimental, Experimental","Drug, Procedure, Procedure, Procedure, Procedure, Drug, Biological",Sequential Assignment,,,,Phase 1
2632,PAXMAN,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
2633,S1703,Interventional,"Active Comparator, Experimental","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2634,2020-A02045-34,Observational,,Other,,Cohort,,Non-Probability Sample,
2635,ESPvsPECS/AOP,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2636,MP-12-2021-2565,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
2637,NL80749.058.22 DIRECT 2,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Phase 3
2638,2020-01097,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2639,IRB-2022-329,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2640,MC210303,Interventional,Experimental,"Other, Procedure, Procedure, Device",Single Group Assignment,,,,Not Applicable
2641,UZBRU_VHH1_3,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2642,2018-11-128,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Not Applicable
2643,17753,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Biological, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
2644,2019-5382,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2645,N20ESP,Interventional,"Active Comparator, Experimental","Drug, Other",Parallel Assignment,,,,Not Applicable
2646,SMC2018-09-029-003,Observational,,Other,,Case-Only,,Non-Probability Sample,
2647,IRB00105944,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Radiation, Drug",Single Group Assignment,,,,Phase 2
2648,35945/10/22,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
2649,2022-376,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2650,20-002712,Interventional,Experimental,"Other, Other, Biological",Single Group Assignment,,,,Phase 1
2651,MC18C3,Interventional,"Experimental, Active Comparator","Other, Other, Drug",Parallel Assignment,,,,Phase 2
2652,IRB202201483,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2653,2019-1042,Observational,,"Procedure, Other, Other",,Cohort,,Non-Probability Sample,
2654,167514,Interventional,Experimental,"Drug, Biological, Drug, Drug",Single Group Assignment,,,,Phase 2
2655,ReMig,Observational,,,,Cohort,,Probability Sample,
2656,Gabapentin RCT,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,"Phase 2, Phase 3"
2657,G1T48-01,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
2658,2018-0550,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2659,EVE-CWM-01,Observational,,Other,,Case-Only,,Non-Probability Sample,
2660,2018-0062,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2661,PH-CP032,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2662,SAFE-FORWARD,Observational,,Radiation,,Cohort,,Non-Probability Sample,
2663,EstroTEP COMPARE,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
2664,FS-CY1502-Ph1-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2665,URomLS-2019a,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
2666,CF22200A,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2667,2020-0715,Interventional,Experimental,"Drug, Drug, Drug, Drug, Biological, Biological",Single Group Assignment,,,,Phase 2
2668,3543,Interventional,"Active Comparator, Active Comparator","Procedure, Other",Parallel Assignment,,,,Not Applicable
2669,20-001275,Interventional,"Active Comparator, Experimental","Drug, Procedure, Biological",Parallel Assignment,,,,Phase 2
2670,230/HÄÄÄ-ÄHYD,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
2671,20-222,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
2672,NCI-2019-06088,Interventional,"Experimental, Active Comparator","Procedure, Procedure, Procedure, Drug, Radiation",Parallel Assignment,,,,Phase 2
2673,OSU-22083,Interventional,Experimental,"Procedure, Other, Procedure, Other",Single Group Assignment,,,,Not Applicable
2674,ODO-TE-B201,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2675,LCZ696ABM001.001,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 4
2676,2018-8984,Observational,,Device,,Case-Only,,Probability Sample,
2677,MAMMoutreach,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
2678,MC1635,Interventional,"Experimental, Experimental","Radiation, Other, Radiation",Parallel Assignment,,,,Phase 2
2679,115300-20-52703,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2680,A5481152,Observational,,Drug,,Cohort,,Non-Probability Sample,
2681,MA-BC-II-037,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2682,2018-0127,Interventional,"Experimental, No Intervention","Drug, Procedure, Procedure",Parallel Assignment,,,,Early Phase 1
2683,ANG-002,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
2684,S2007,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 2
2685,IIT2019-21-Basho-TOPAZ,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
2686,19-004024,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2687,BTCRC BRE15-024,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
2688,18-000427,Interventional,Experimental,"Biological, Biological, Biological",Single Group Assignment,,,,Phase 1
2689,REaCT-CHRONO,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Phase 4
2690,81603703,Interventional,"Experimental, Sham Comparator, No Intervention","Device, Device",Parallel Assignment,,,,Not Applicable
2691,19.07,Interventional,Experimental,Other,Single Group Assignment,,,,"Phase 1, Phase 2"
2692,3474028/2019,Interventional,"Experimental, Experimental, Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
2693,2020-0245,Interventional,Experimental,"Drug, Biological, Radiation",Single Group Assignment,,,,Phase 1
2694,CASE11119,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2695,38RC20.120,Observational,,,,Case-Only,1 Day,Non-Probability Sample,
2696,2021-375,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2697,202104085,Interventional,"Experimental, Experimental",Radiation,Parallel Assignment,,,,Not Applicable
2698,D19160,Observational,,Other,,Cohort,,Non-Probability Sample,
2699,ZLYNXM202014,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
2700,MedOPP150,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2701,ZL-MG-BC-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2702,PRO00035701,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2703,REaCT-Low Risk HER-2,Interventional,"Active Comparator, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 3
2704,I 60217,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2705,P170104J,Interventional,Other,Drug,Single Group Assignment,,,,Phase 2
2706,Acu-CIPN,Interventional,"Active Comparator, Experimental","Procedure, Drug",Parallel Assignment,,,,Not Applicable
2707,IO Panel,Observational,,Other,,Case-Control,,Probability Sample,
2708,Pro00104214,Interventional,"Experimental, Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2709,CLEE011AIT01,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 3
2710,17-546,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2711,RIPH2_BREYSSE_ETAPH,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2712,ODO-TE-B202,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2713,21-001819,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Biological, Other, Drug, Biological, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2714,PA18-1077,Observational,,Other,,Cohort,,Non-Probability Sample,
2715,ARC-2 (AB928CSP0002),Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2716,Study00146761,Interventional,"Experimental, Other",Drug,Parallel Assignment,,,,Early Phase 1
2717,DRACARYS,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2718,OSU-20408,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Other, Other",Parallel Assignment,,,,Not Applicable
2719,IRB00076577,Observational,,"Biological, Biological",,Cohort,,Probability Sample,
2720,RJ-101-RCT-001,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Early Phase 1
2721,2021-1151-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
2722,SCHBCC-N046,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2723,21D.625,Interventional,Experimental,"Other, Other",Single Group Assignment,,,,Not Applicable
2724,KEK 2021-D0051,Observational,,,,Case-Control,,Non-Probability Sample,
2725,RD19/125787,Observational,,Other,,Cohort,,Probability Sample,
2726,TNBC-NEO,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
2727,Aqua POLO-IPC 2019-028,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2728,NCI-2017-01960,Interventional,Experimental,"Drug, Other",Sequential Assignment,,,,Phase 1
2729,CSIIT-C25,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
2730,13/21,Interventional,"Active Comparator, Sham Comparator","Procedure, Other",Parallel Assignment,,,,Not Applicable
2731,CE 193/17,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
2732,USB_22 Trial,Interventional,"Experimental, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2733,SAKK 95/17,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2734,Fisioterapia en Linfedema,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2735,2020-01,Interventional,"Experimental, Other","Radiation, Other",Parallel Assignment,,,,Not Applicable
2736,2019-0752,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2737,YOUNGBC-12,Observational,,,,Cohort,,Non-Probability Sample,
2738,STUDY00003705,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2739,X9001194,Observational,,Drug,,Cohort,,Non-Probability Sample,
2740,2018-A01019-46,Interventional,"Active Comparator, Sham Comparator","Drug, Other",Parallel Assignment,,,,Not Applicable
2741,D5336C00001,Interventional,"Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2742,CL 2775,Interventional,"Active Comparator, Active Comparator, Placebo Comparator","Drug, Drug, Other",Parallel Assignment,,,,Phase 4
2743,MUST-02-001,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2744,UEM QuirÃ³n,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
2745,STUDY00003782,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2746,IB2022-04,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2747,LCCC 1716,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
2748,IRAS 314460,Interventional,Other,Procedure,Single Group Assignment,,,,Phase 2
2749,UPCC12118,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 1
2750,227/KEPK/IX/2022,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
2751,EXERT-BC,Observational,,Other,,Other,3 Months,Non-Probability Sample,
2752,D3614C00001,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2753,AH150202-1,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 2
2754,YL202-INT-101-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2755,STUDY00021243,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2756,OFA,Interventional,"Experimental, Sham Comparator","Procedure, Drug, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2757,Prevention of radiodermatitis,Interventional,"Placebo Comparator, Experimental",Device,Parallel Assignment,,,,Not Applicable
2758,HNCH-2022KY59,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2759,yifeng,Observational,,Other,,Cohort,,Non-Probability Sample,
2760,MEC-2021-0829,Observational,,Other,,Cohort,,Non-Probability Sample,
2761,D8530C00007,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2762,21-194,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
2763,SYSU003-2020,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2764,Exactis-03,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2765,NEODOC-2021668610-165,Observational,,Device,,Case-Only,,Non-Probability Sample,
2766,MedOPP100,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2767,YOUNGBC-23,Observational,,Drug,,Cohort,,Non-Probability Sample,
2768,MS201922_0010,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2769,202207200MIPB,Interventional,"Experimental, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2770,MC1892,Interventional,Experimental,"Device, Other",Single Group Assignment,,,,Phase 2
2771,C4391002,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2772,ZWI-ZW25-202,Interventional,Experimental,"Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
2773,HR-BLTN-III-MBC-C,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2774,DokuzEUBanuNihan,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
2775,UW20058,Interventional,Experimental,"Device, Drug",Single Group Assignment,,,,Not Applicable
2776,MC1734,Interventional,"Experimental, Experimental","Drug, Procedure",Parallel Assignment,,,,Phase 2
2777,TADANAC,Observational,,Procedure,,Other,,Non-Probability Sample,
2778,20-153,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2779,MC1935,Interventional,"Experimental, Experimental","Radiation, Other, Radiation",Parallel Assignment,,,,Phase 2
2780,00055029,Observational,,,,Cohort,,Non-Probability Sample,
2781,HCRN BRE17-141,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2782,C4891018,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2783,2021-5644,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2784,CPH-2022-10-MHS-2,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2785,19F.265,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2786,2019COIMBRA001,Interventional,"Other, Other","Procedure, Procedure",Parallel Assignment,,,,Phase 2
2787,SHR-1210-APTN-IIT-TNBC,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2788,FMUUH-BC-2201,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 2
2789,2066383,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2790,YOUNGBC-11,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2791,P-2020-246,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2792,YOUNGBC-18,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2793,201901698B0,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2794,OBU-BC-II-024,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2795,328717,Interventional,"Placebo Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2796,PF008,Observational,,Drug,,Case-Only,,Non-Probability Sample,
2797,2,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2798,BZ01/17,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2799,2018-0477,Observational,,"Behavioral, Other",,Cohort,,Non-Probability Sample,
2800,712,Observational,,"Other, Other, Other",,Cohort,10 Days,Probability Sample,
2801,KGYY-001,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
2802,MedOPP253,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2803,RC48-C006,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Crossover Assignment,,,,"Phase 2, Phase 3"
2804,S-20180117,Interventional,"Experimental, Placebo Comparator","Procedure, Procedure, Procedure, Biological, Procedure",Parallel Assignment,,,,Phase 2
2805,UHaiArtBC,Interventional,"Experimental, Sham Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2806,1808852902,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
2807,NL67059.068.18,Interventional,"No Intervention, Experimental",Procedure,Parallel Assignment,,,,Not Applicable
2808,16381,Interventional,"Active Comparator, Active Comparator, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2809,IRB00223131,Interventional,"Experimental, Active Comparator","Drug, Behavioral",Sequential Assignment,,,,Phase 2
2810,202301160RINA,Observational,,Procedure,,Cohort,,Non-Probability Sample,
2811,VSN-18-199,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, No Intervention","Device, Device",Parallel Assignment,,,,Not Applicable
2812,ALRN-6924-1-05,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2813,WHUH-BC-001,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2814,22-544,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2815,202111198,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2816,Shengjing-LCG003,Interventional,"Other, Other","Drug, Drug",Parallel Assignment,,,,Phase 4
2817,STU00201961B,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2818,2-107-05-079,Interventional,"Experimental, No Intervention",Combination Product,Parallel Assignment,,,,Not Applicable
2819,AHQU-2022002,Interventional,"Experimental, Placebo Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2820,2001272738,Observational,,Procedure,,Cohort,,Non-Probability Sample,
2821,IC 2019-04,Interventional,"Placebo Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2822,IRB00054587,Interventional,"Experimental, Active Comparator","Other, Drug",Parallel Assignment,,,,Early Phase 1
2823,2012-090-1182,Interventional,"Experimental, Other","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
2824,2018/781,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2825,GCO 15-1783,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
2826,2022YF035-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2827,METIS,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2828,2019-06-027,Observational,,,,Cohort,3 Years,Non-Probability Sample,
2829,NCI-2017-01119,Interventional,"Experimental, Active Comparator","Drug, Procedure, Procedure, Procedure, Drug, Procedure, Drug, Biological, Other, Other, Biological",Parallel Assignment,,,,Phase 3
2830,MRI in response assesment,Observational,,Device,,Other,,Non-Probability Sample,
2831,1191/2018,Interventional,"Active Comparator, Placebo Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2832,021-013772,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
2833,UAB 1794,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2834,CRM-BRE-002,Interventional,"Experimental, Active Comparator, No Intervention","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
2835,H1901940,Observational,,"Procedure, Radiation",,Cohort,10 Years,Non-Probability Sample,
2836,IUSCC-0616 (1709077419),Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2837,19-5080,Observational,,,,Cohort,,Probability Sample,
2838,HSM/VGH-2017-01-011AC,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2839,APA-PG1,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2840,26778919.3.0000.0072,Interventional,"Experimental, Sham Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2841,ICO-N-2018-03,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2842,RG1121659,Interventional,Experimental,"Procedure, Drug, Other",Single Group Assignment,,,,Phase 4
2843,CETC 002,Observational,,"Radiation, Drug",,Cohort,,Non-Probability Sample,
2844,H2207-207-1346,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2845,BC-TATOO-2020,Interventional,Other,Drug,Single Group Assignment,,,,Not Applicable
2846,20190511,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Phase 3
2847,BGB-A317-ZW25-101,Interventional,"Experimental, Experimental","Biological, Drug, Biological, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2848,17-AKD-186,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2849,Immuno2020-01,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2850,ATOX-2018,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2851,TQB3616-â¢-02,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2852,STUDY00011444,Interventional,"Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
2853,SHAW001,Interventional,"Experimental, Placebo Comparator, Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2854,A5481150,Observational,,,,Cohort,,Non-Probability Sample,
2855,71306642-5/24,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2856,2021-0077,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
2857,CTPR-0015,Interventional,Other,Radiation,Single Group Assignment,,,,Not Applicable
2858,QoLMa,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
2859,TDM of TAM,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2860,SYSA1501-CSP-005,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2861,1028595,Interventional,"Active Comparator, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2862,ECP 250 - 15/16,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Early Phase 1
2863,STUDY20110029,Interventional,Experimental,"Device, Drug",Single Group Assignment,,,,Phase 4
2864,00031569,Observational,,Diagnostic Test,,Case-Only,,Non-Probability Sample,
2865,FZPL-Ib-105,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2866,OSU-16288,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
2867,CTR20220630,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2868,20.478.486,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2869,2022-001,Observational,,Other,,Cohort,,Probability Sample,
2870,REC 22/WA/0164,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2871,829400,Observational,,,,Other,,Non-Probability Sample,
2872,2019DEPO-TRIGGER001,Interventional,"Experimental, Active Comparator","Drug, Procedure, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2873,STUDY00001721,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2874,J16146,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
2875,46.20 PAR ComEt CBM,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
2876,2022-A02337-36,Interventional,"No Intervention, Experimental",Other,Crossover Assignment,,,,Not Applicable
2877,1100903,Interventional,"Experimental, Experimental, Experimental","Device, Drug",Parallel Assignment,,,,Not Applicable
2878,H19017,Interventional,"Experimental, Sham Comparator, Other","Other, Other, Other",Parallel Assignment,,,,Not Applicable
2879,BXu-1839,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2880,NABP201801,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2881,LAAVA2,Interventional,"Active Comparator, Placebo Comparator","Device, Device",Crossover Assignment,,,,Not Applicable
2882,RG1121642,Interventional,Experimental,"Biological, Biological, Drug",Single Group Assignment,,,,Phase 1
2883,16-0040-02,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2884,2021-0031,Interventional,Experimental,"Procedure, Procedure, Other, Other",Single Group Assignment,,,,Not Applicable
2885,C-plus-Pairs,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2886,URomLS_4,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2887,012418QM,Interventional,"Other, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2888,R_ReLoCC,Observational,,,,Cohort,5 Years,Non-Probability Sample,
2889,2022-008,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2890,2020466,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2891,736-19,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
2892,2017-0479,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2893,SYM011,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2894,X4P-001-201,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2895,2018/827,Observational,,,,Cohort,,Non-Probability Sample,
2896,HelouEl,Observational,,Procedure,,Cohort,1 Day,Non-Probability Sample,
2897,SYSU-2022-01,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Not Applicable
2898,SAKK 21/18,Interventional,"Experimental, Active Comparator","Drug, Other, Other",Parallel Assignment,,,,Phase 3
2899,AP1907-50101,Interventional,"Experimental, Experimental, Active Comparator","Procedure, Procedure, Drug",Parallel Assignment,,,,Not Applicable
2900,RWS-PEGCSF,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
2901,198411013011,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2902,A5481170,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
2903,YOUNGBC-13,Observational,,Drug,,Cohort,,Non-Probability Sample,
2904,2021-19,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2905,BRI-ROL-001,Interventional,"Experimental, Experimental","Biological, Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
2906,RLY-5836-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
2907,RP-PG-1214-20016,Interventional,"Experimental, Active Comparator","Other, Other",Sequential Assignment,,,,Not Applicable
2908,BCP-25,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Phase 3
2909,PI17/01687,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2910,220287,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2911,EUBREAST-4,Observational,,,,Cohort,,Probability Sample,
2912,2018-1518,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
2913,URCC16070,Interventional,"Experimental, Experimental, Experimental","Drug, Other, Drug, Drug, Other, Drug, Other",Parallel Assignment,,,,Phase 3
2914,20210312/2,Interventional,"Experimental, Active Comparator","Device, Drug",Parallel Assignment,,,,Not Applicable
2915,UCI 18-79 [HS# 2020-5660],Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2916,Shengjing-LJY06,Interventional,"Experimental, Experimental, Experimental","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2917,ePOST,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2918,202210064DIPD,Interventional,"Experimental, Placebo Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
2919,69HCL17_0480,Observational,,Other,,Other,,Non-Probability Sample,
2920,Pro00105104,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
2921,MedOPP068,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2922,HCI140278,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
2923,PERT.21.001,Interventional,"Experimental, Active Comparator","Biological, Biological",Parallel Assignment,,,,Phase 3
2924,SILMET_0107665,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
2925,2021/270,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2926,KCT003,Interventional,"Experimental, Active Comparator",Device,Crossover Assignment,,,,Not Applicable
2927,202109031MIPD,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2928,241379,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2929,S-20180134,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
2930,A5481158,Observational,,Drug,,Cohort,,Non-Probability Sample,
2931,SCHBCC-N023,Observational,,"Procedure, Procedure",,Cohort,24 Months,Non-Probability Sample,
2932,00048814,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2933,2018-A03054-51,Observational,,Other,,Cohort,,Non-Probability Sample,
2934,2017/12-SBO-GHMG,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2935,LYT-100-2020-01,Interventional,"Experimental, Placebo Comparator, Experimental, Placebo Comparator, Experimental, Placebo Comparator, Experimental, Placebo Comparator","Drug, Other, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2936,Pro00117242,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2937,MC1937,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
2938,JD-LK-2022-136-01,Interventional,Experimental,"Drug, Radiation, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2939,2179 CE,Interventional,"Experimental, Experimental, Other","Other, Radiation",Parallel Assignment,,,,Not Applicable
2940,2017-0328,Interventional,"Experimental, Experimental",Device,Parallel Assignment,,,,Not Applicable
2941,WSG-NIS04 / PROOFS,Observational,,,,Cohort,10 Years,Non-Probability Sample,
2942,2018-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2943,CAPRICE,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2944,7119-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2945,mavis20023,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2946,US-003,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2947,12345,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
2948,21-169,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator","Device, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2949,A221702,Interventional,"Active Comparator, Experimental","Drug, Procedure, Procedure, Other, Other",Parallel Assignment,,,,Phase 3
2950,CT/2019/CANFLAX,Interventional,"Experimental, Experimental","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
2951,22-006606,Interventional,Experimental,Device,Single Group Assignment,,,,Early Phase 1
2952,GN19ON381,Observational,,,,Case-Control,,Probability Sample,
2953,IJB-BC-TDM1BM-2016,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2954,Self-compassion FCR,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2955,GLSI-21-01,Interventional,"Placebo Comparator, Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 3
2956,1024489,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
2957,20-754,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2958,1B-15-6,Interventional,"Experimental, Experimental, Active Comparator","Other, Behavioral, Behavioral, Other, Device, Other, Other",Parallel Assignment,,,,Not Applicable
2959,HiFi-APBI,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
2960,CBYL719H12301,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2961,20-010751,Interventional,Experimental,"Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
2962,2021-01-075,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2963,URomLS-2019,Interventional,"Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
2964,WSG-AM11,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 3
2965,2020-10/850,Observational,,Diagnostic Test,,Other,8 Months,Probability Sample,
2966,P018,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2967,IEO 0758/,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
2968,2018-0528,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
2969,2021/03,Observational,,Other,,Cohort,,Non-Probability Sample,
2970,CCR 5006,Observational,,,,Case-Control,,Probability Sample,
2971,QUILT 2021-1,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2972,MC18C1,Interventional,Experimental,"Drug, Drug, Other",Single Group Assignment,,,,Phase 1
2973,20180349,Observational,,,,Cohort,,Non-Probability Sample,
2974,OBI-822-011,Interventional,"Experimental, Active Comparator","Biological, Device, Other",Parallel Assignment,,,,Phase 3
2975,ICO-N-2018-12,Observational,,Other,,Cohort,,Non-Probability Sample,
2976,H-18016600,Observational,,,,Cohort,,Non-Probability Sample,
2977,MSCW2019,Interventional,"Active Comparator, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2978,NIS07075,Observational,,Drug,,Cohort,,Non-Probability Sample,
2979,IJB-PRINTEMPS-2022,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
2980,2020-12-044-012,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,,,,Not Applicable
2981,c5ZTCN100,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
2982,Ref. 070/2018,Interventional,"Active Comparator, Active Comparator, Active Comparator","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2983,HNCH-BC009,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2984,ICO_UCC_202001,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2985,CRO-2019-26,Interventional,"Experimental, Active Comparator","Drug, Procedure, Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2986,19-578,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 2
2987,A211601,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
2988,LCCC1921,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2989,182113,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2990,AP2205-5015,Interventional,"Experimental, Experimental, Active Comparator","Procedure, Procedure, Drug",Parallel Assignment,,,,Not Applicable
2991,YM111146EF,Interventional,"Experimental, Other",Other,Parallel Assignment,,,,Not Applicable
2992,2018-172,Observational,,Dietary Supplement,,Case-Only,,Non-Probability Sample,
2993,EC /2018/0996,Interventional,"Experimental, Active Comparator",Radiation,Parallel Assignment,,,,Not Applicable
2994,19-008929,Interventional,Experimental,"Device, Other",Single Group Assignment,,,,Not Applicable
2995,22-4004,Observational,,"Other, Other",,Cohort,1 Year,Non-Probability Sample,
2996,CD07_TNBC,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2997,2021-04031,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
2998,STU-2019-0769,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
2999,F16J16000620002,Interventional,"Active Comparator, Experimental","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
3000,PSCI 21-045,Interventional,"Experimental, Other","Behavioral, Other",Parallel Assignment,,,,Not Applicable
3001,R-2021-3203-005,Interventional,"Experimental, Active Comparator",Radiation,Parallel Assignment,,,,Not Applicable
3002,32551/09/2018,Interventional,"Placebo Comparator, Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
3003,AC-TMSQ-2018,Interventional,"Experimental, Sham Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3004,HUM00208684,Observational,,Drug,,Cohort,,Non-Probability Sample,
3005,CADEX-0001,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
3006,AAAS3402,Observational,,Device,,Cohort,,Probability Sample,
3007,2017-1535,Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
3008,NUR20-0124CRYO,Interventional,"Active Comparator, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3009,Mepitel RCT,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Phase 3
3010,12341234,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3011,ShandongCHI-07,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
3012,IRB00074154,Interventional,"Experimental, Active Comparator","Drug, Dietary Supplement, Other",Parallel Assignment,,,,Phase 2
3013,ELIPSE (SOLTI-1905),Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
3014,D8532C00005,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3015,R.20.11.1099,Interventional,Experimental,"Diagnostic Test, Procedure, Diagnostic Test, Procedure",Single Group Assignment,,,,Not Applicable
3016,ShandongCHI-18,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
3017,FEMAL,Interventional,"Experimental, Placebo Comparator",Other,Single Group Assignment,,,,Not Applicable
3018,5652-18-SMC,Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
3019,VI-ISRP-026,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3020,Ä°boelif22,Observational,,,,Case-Control,,Non-Probability Sample,
3021,20-30638,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Crossover Assignment,,,,Phase 1
3022,JWCI OBCS WITH IORT,Interventional,Other,"Radiation, Procedure",Single Group Assignment,,,,Not Applicable
3023,SMC 2021-05-045,Observational,,Radiation,,Cohort,2 Years,Non-Probability Sample,
3024,SamsunU,Observational,,Other,,Cohort,1 Year,Probability Sample,
3025,20-513,Interventional,Experimental,Radiation,Single Group Assignment,,,,Early Phase 1
3026,110.01-2016-GES-0001,Observational,,"Device, Device",,Cohort,30 Months,Non-Probability Sample,
3027,HE-202012,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 4
3028,REaCT-Hot Flashes Pilot,Interventional,Other,Other,Single Group Assignment,,,,Phase 4
3029,IRB00313835,Interventional,"Active Comparator, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3030,AAAT8915,Interventional,"Experimental, Other","Other, Device",Parallel Assignment,,,,Not Applicable
3031,NCC201804007,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
3032,GCO 18-1832,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
3033,PREVENT,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3034,VIL-HEQ-17-014,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
3035,QL-KPTB-150,Interventional,"Active Comparator, Experimental","Drug, Drug",Crossover Assignment,,,,Phase 1
3036,IRB00081356,Observational,,Drug,,Cohort,,Probability Sample,
3037,GS18/107321,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3038,COMPLEMENT,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3039,EA1181,Interventional,"Experimental, Experimental","Drug, Procedure, Procedure, Drug, Drug, Biological, Radiation, Biological, Biological",Parallel Assignment,,,,Phase 2
3040,DHLI-BC/OC-BE-001,Interventional,"Active Comparator, Experimental",Drug,Crossover Assignment,,,,Phase 1
3041,PAL-ZJCC-02,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
3042,80252,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
3043,DS_v01,Observational,,Drug,,Cohort,,Probability Sample,
3044,2019-003825-56,Interventional,Other,"Drug, Drug",Single Group Assignment,,,,Phase 4
3045,MCC-19117,Interventional,"Active Comparator, Active Comparator","Biological, Biological",Parallel Assignment,,,,Phase 2
3046,Exo-LCR,Interventional,Experimental,"Procedure, Procedure, Biological",Single Group Assignment,,,,Not Applicable
3047,Study00145121,Interventional,"Experimental, Other",Drug,Parallel Assignment,,,,Early Phase 1
3048,T06/024/21,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3049,A012103,Interventional,"Active Comparator, Experimental","Biological, Other, Procedure, Procedure, Other, Other",Parallel Assignment,,,,Phase 3
3050,STU 042018-083,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3051,ES,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
3052,AcuBreast 2020,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3053,4-2020-1093,Observational,,Procedure,,Cohort,,Probability Sample,
3054,A191901,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Other, Other, Behavioral, Other, Other, Other",Parallel Assignment,,,,Phase 3
3055,VICCBRE2257,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Procedure, Procedure, Biological",Parallel Assignment,,,,Phase 2
3056,2019/639,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3057,TX05-03E,Interventional,"Experimental, Active Comparator, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 3
3058,HCI69515,Interventional,Experimental,"Drug, Drug, Diagnostic Test",Single Group Assignment,,,,Phase 2
3059,HREBA.CC-22-0128,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3060,GBG 107,Observational,,,,Cohort,10 Years,Probability Sample,
3061,CE-MRI&CESM in breast lesions,Observational,,Device,,Case-Only,,Non-Probability Sample,
3062,PBCST,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
3063,NEODOC- 2021668610-221,Interventional,"Active Comparator, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
3064,IRB202202679,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3065,2021-03165,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
3066,202110124,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3067,MCC-21262,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
3068,9785-CL-0018,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
3069,RenJiH-2018-038,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3070,Arise-FJ-B102,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
3071,CKRC2021-CCV,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
3072,453190,Interventional,"Experimental, Other","Drug, Behavioral",Parallel Assignment,,,,Phase 4
3073,18-003544,Interventional,Other,"Diagnostic Test, Drug",Single Group Assignment,,,,Early Phase 1
3074,BEXMET,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
3075,IRB00046759,Interventional,"Experimental, Active Comparator","Other, Other, Device",Parallel Assignment,,,,Not Applicable
3076,2021-A03027-34,Interventional,"No Intervention, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
3077,18947,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3078,IRB00049061,Interventional,"Experimental, Active Comparator","Procedure, Other, Other, Other",Parallel Assignment,,,,Not Applicable
3079,PICC One Day 01 (ET15-123),Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Phase 3
3080,CP-13-001,Observational,,Device,,Case-Only,,Probability Sample,
3081,IJB-SYNERGY-012017,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3082,IRB-44367,Interventional,Experimental,"Device, Other",Single Group Assignment,,,,Not Applicable
3083,SOLTI-1710,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Early Phase 1
3084,SHR6390-III-303,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3085,NEPA-17-05,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
3086,I3Y-MC-B009,Observational,,Other,,Other,104 Weeks,Non-Probability Sample,
3087,2022-761,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
3088,17/222,Observational,,"Other, Other",,Other,,Non-Probability Sample,
3089,JCL2020,Interventional,Other,"Drug, Radiation",Single Group Assignment,,,,"Phase 1, Phase 2"
3090,19-302,Interventional,Experimental,"Other, Device, Diagnostic Test",Single Group Assignment,,,,Not Applicable
3091,RT 1901,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
3092,BFH-BC,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3093,MC1732,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
3094,2021/271,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3095,University in Zielona Gora,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3096,A5481160,Observational,,Drug,,Cohort,,Non-Probability Sample,
3097,CASE10116,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Other",Parallel Assignment,,,,Not Applicable
3098,ICO-2019-16,Observational,,,,Cohort,,Non-Probability Sample,
3099,ET19-084 - CICA-RT,Interventional,"Experimental, Active Comparator","Drug, Other",Parallel Assignment,,,,Phase 3
3100,M21REO,Observational,,"Procedure, Procedure, Procedure",,Cohort,,Non-Probability Sample,
3101,CASE5Y21,Interventional,"Active Comparator, Active Comparator","Device, Other, Other",Parallel Assignment,,,,Not Applicable
3102,21623,Interventional,"Experimental, Experimental","Other, Procedure, Procedure, Other",Parallel Assignment,,,,Not Applicable
3103,T148/2020,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3104,ISI dV SP - NSM-01,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,,,,Not Applicable
3105,ATOPE18,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3106,EC/2017/1261,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
3107,ET19-283,Observational,,,,Cohort,,Non-Probability Sample,
3108,ChungnamNU.J1,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3109,22-001501,Observational,,"Procedure, Other",,Cohort,,Non-Probability Sample,
3110,EORTC-2129-BCG,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
3111,THERMOEDEME,Interventional,"Active Comparator, Sham Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3112,202101421A0,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3113,NCI-2021-11793,Interventional,Experimental,"Drug, Drug, Procedure, Procedure, Procedure, Procedure",Single Group Assignment,,,,Phase 1
3114,2019-4433,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3115,LSB-12345,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3116,C3621001,Interventional,"Experimental, Experimental",Biological,Sequential Assignment,,,,Phase 1
3117,PROICM 2018-09 BSA,Observational,,Radiation,,Other,,Non-Probability Sample,
3118,108511,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3119,22-508,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 1
3120,960-CSP-USA_DenseBreasts_USS1,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3121,211521,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3122,2017-0672,Interventional,"Experimental, Experimental","Biological, Biological, Biological, Drug, Drug, Biological, Biological, Other, Other",Parallel Assignment,,,,Phase 2
3123,BC-P30(FZQ),Interventional,"Experimental, Other","Device, Drug",Parallel Assignment,,,,Not Applicable
3124,2019-4432,Observational,,,,Cohort,,Non-Probability Sample,
3125,Pectoral nerve block in breast,Interventional,"Active Comparator, Sham Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3126,NCC2021-0335,Observational,,,,Cohort,,Probability Sample,
3127,LET,Observational,,Drug,,Cohort,2 Years,Non-Probability Sample,
3128,NU 18B05,Interventional,Experimental,"Drug, Procedure, Other",Single Group Assignment,,,,Phase 2
3129,TNBC,Observational,,,,Case-Control,,Non-Probability Sample,
3130,ICRCTSU/2019/10068,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
3131,2020-06245,Observational,,"Procedure, Procedure, Procedure",,Cohort,,Non-Probability Sample,
3132,18D.003,Interventional,"Active Comparator, Experimental, Experimental","Other, Other, Other, Other, Other, Behavioral, Other",Parallel Assignment,,,,Phase 2
3133,20476,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3134,EU001,Interventional,"Other, Other",Device,Parallel Assignment,,,,Not Applicable
3135,18-168,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3136,2021-A01407-34,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Not Applicable
3137,2018-63,Interventional,Other,Biological,Single Group Assignment,,,,Not Applicable
3138,20-002505,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3139,XianganHXiamenU,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3140,soh-Med-21-02-05,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
3141,CIMPAX BREAST,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
3142,MEDOPP459,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
3143,YOUNGBC-20,Observational,,,,Cohort,,Non-Probability Sample,
3144,09.2019.866,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3145,Shengjing-LCG011,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3146,YOUNGBC-21,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
3147,201900572,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3148,MedOPP485,Interventional,"No Intervention, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
3149,2020-KY-051,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
3150,A5481128,Observational,,,,Cohort,,Non-Probability Sample,
3151,GCO 19-0477,Interventional,Experimental,"Drug, Drug, Radiation, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
3152,S1904,Interventional,"Active Comparator, Experimental","Behavioral, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
3153,2021-02902,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3154,YOUNGBC-3,Observational,,,,Cohort,,Non-Probability Sample,
3155,LQiao,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 2
3156,020-008,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
3157,2021157,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3158,YOUNGBC-14,Observational,,,,Cohort,,Non-Probability Sample,
3159,19-458,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
3160,YOUNGBC-25,Observational,,,,Cohort,,Non-Probability Sample,
3161,E2018210,Observational,,"Procedure, Procedure, Radiation",,Cohort,2 Years,Non-Probability Sample,
3162,BC-09374,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
3163,202100318,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
3164,CL(3204),Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3165,Seno_Ex_MAC 003,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3166,211-2018,Interventional,"Experimental, No Intervention",Diagnostic Test,Parallel Assignment,,,,Not Applicable
3167,AAAO1760,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3168,J17120,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3169,1712078374,Interventional,Experimental,"Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
3170,D17168,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3171,2020-KY-007,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3172,ShandongCHI-14,Observational,,Drug,,Cohort,,Non-Probability Sample,
3173,ERAS-ABR,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3174,BreastIls-1605,Observational,,,,Cohort,,Non-Probability Sample,
3175,3125001,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
3176,2005P002282,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
3177,ProFertil,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3178,ShandongCHI-16,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
3179,STUDY00020501,Interventional,"Experimental, Active Comparator","Other, Other, Behavioral",Parallel Assignment,,,,Not Applicable
3180,PRISMA,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3181,DELFINO trial,Interventional,"No Intervention, No Intervention, Active Comparator",Drug,Parallel Assignment,,,,Phase 3
3182,2023-9333,Interventional,"Other, Other, Other","Other, Other, Other",Parallel Assignment,,,,Not Applicable
3183,7964,Observational,,,,Case-Only,,Non-Probability Sample,
3184,MEDOPP240,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
3185,MCP Study,Interventional,"Other, Other, Other","Diagnostic Test, Diagnostic Test, Diagnostic Test",Factorial Assignment,,,,Not Applicable
3186,TQB3616-I-0001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3187,IIT2018-04-MCARTHUR-NEOHP,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3188,18-00309,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
3189,[2016]124,Interventional,"Placebo Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3190,STUDY00000194,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Other, Drug",Parallel Assignment,,,,Phase 1
3191,mastectomy coverage formula 20,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
3192,KC19EEDT0031,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3193,OSU-20429,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Other, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
3194,2020/295,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
3195,22-008,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3196,SunYatsenU2H-LQ4,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
3197,SUGBG-2021002,Interventional,"Other, Other","Drug, Combination Product",Parallel Assignment,,,,Not Applicable
3198,SIB2232,Interventional,"Other, Other","Other, Other",Single Group Assignment,,,,Not Applicable
3199,1807188-16,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3200,S2018-2450-0001,Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
3201,00130272,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3202,jcl2020-2 breast cancer,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3203,Phaon1,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Procedure, Procedure, Procedure",Parallel Assignment,,,,Phase 2
3204,URCC-18007,Interventional,"Experimental, Placebo Comparator","Drug, Other, Other, Other",Parallel Assignment,,,,Phase 3
3205,IIT-0016,Interventional,"Active Comparator, Experimental, Experimental","Device, Device, Device, Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
3206,OP-1250-003,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
3207,ICOnnectat-BC,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3208,N.sativavsRID BreastCancerpt.,Interventional,"No Intervention, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
3209,21-3117.cc,Interventional,Experimental,"Drug, Drug, Radiation, Drug",Single Group Assignment,,,,Phase 2
3210,20-028,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
3211,TMP-0315-2018,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3212,38285020.8.0000.0072,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
3213,STU-2022-0091,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3214,C3441038,Observational,,Drug,,Case-Only,,Non-Probability Sample,
3215,17-001546,Observational,,Other,,Cohort,,Probability Sample,
3216,ICO-2021-36,Observational,,Procedure,,Cohort,,Non-Probability Sample,
3217,IRB00103558,Interventional,"Experimental, Active Comparator","Other, Behavioral",Parallel Assignment,,,,Not Applicable
3218,2,Interventional,"Experimental, Other","Device, Other",Parallel Assignment,,,,Not Applicable
3219,L424,Observational,,Other,,Other,,Non-Probability Sample,
3220,2021-0048-B,Interventional,"Placebo Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3221,BHP0111,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3222,18-001926,Interventional,"Experimental, Experimental","Dietary Supplement, Behavioral, Other",Parallel Assignment,,,,Not Applicable
3223,Breastblock,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
3224,REDHEMOPACH,Interventional,"Other, Active Comparator","Device, Procedure",Parallel Assignment,,,,Not Applicable
3225,INSPIRE-001,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3226,OMS-I141 (KEYNOTE-890),Interventional,"Experimental, Experimental","Biological, Biological, Device, Drug",Parallel Assignment,,,,Phase 2
3227,Patient reported outcome,Observational,,Procedure,,Cohort,,Non-Probability Sample,
3228,20CX6399,Observational,,Device,,Other,,Non-Probability Sample,
3229,IIT2021-10-Giuliano-OmitRT,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3230,STUDY00149312,Interventional,"Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3231,PMC_TTAC-0001_06 / KEYNOTE-C14,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3232,EAZ171,Interventional,"Experimental, Experimental","Drug, Drug, Other, Other",Parallel Assignment,,,,Phase 2
3233,VICCBRE2256,Interventional,"Active Comparator, Experimental","Drug, Other, Other",Parallel Assignment,,,,Phase 2
3234,2017/62,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3235,2000020335,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3236,17-001864,Interventional,Experimental,"Device, Procedure",Single Group Assignment,,,,Early Phase 1
3237,20429001,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3238,SCHBCC-N031,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3239,21-374,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3240,KN026-CHN-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3241,Pro00103527,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3242,22-5074,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
3243,MC02/04/19,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
3244,STUDY00018789,Interventional,"Experimental, Active Comparator","Drug, Other, Other, Drug, Drug",Parallel Assignment,,,,Not Applicable
3245,CBCRP 23AB-1400,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3246,EJERDIETLINF,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3247,ATADEK-2022/08/20,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3248,SCHBCC-SOAPET,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3249,3212,Observational,,Other,,Cohort,,Non-Probability Sample,
3250,RD19/123502,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement",Crossover Assignment,,,,Not Applicable
3251,OBU-BC-â¡-077,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3252,2018-06,Observational,,Other,,Cohort,,Non-Probability Sample,
3253,RG1005296,Interventional,Experimental,"Biological, Drug, Biological, Biological",Single Group Assignment,,,,Phase 2
3254,ONCO-FIRE,Observational,,Other,,Cohort,,Non-Probability Sample,
3255,B7391012,Observational,,Drug,,Case-Only,,Probability Sample,
3256,091-19,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3257,2021-01534,Observational,,Diagnostic Test,,Cohort,2 Years,Non-Probability Sample,
3258,17-361,Interventional,"Other, Experimental, Other","Behavioral, Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
3259,2021.341,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3260,PPMP_INO,Observational,,,,Cohort,,Probability Sample,
3261,PR139/21,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3262,DS8201-A-A103,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3263,Overcome project,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3264,OBU-BJ-BB-BC-II-007,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3265,Xiangan Hospital of XMU,Observational,,Drug,,Other,,Non-Probability Sample,
3266,NU 21B01,Interventional,Experimental,"Procedure, Device",Single Group Assignment,,,,Phase 2
3267,110.01-2018-GES-0001,Observational,,Device,,Cohort,,Non-Probability Sample,
3268,UUBreast01,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Phase 3
3269,COOL-CLIN-2022-01,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3270,NURS-IIR-IUSCCC-0748,Observational,,Behavioral,,Case-Only,,Non-Probability Sample,
3271,IMPACTT,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3272,OSU-19085,Interventional,Experimental,"Drug, Drug, Other",Single Group Assignment,,,,Phase 1
3273,SYSUCC-012,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3274,2020-1243,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
3275,1/2020,Observational,,"Genetic, Other",,Cohort,5 Years,Non-Probability Sample,
3276,CBBCT2018CIH,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3277,060021-HMO-CTIL,Observational,,,,Cohort,,Non-Probability Sample,
3278,2018/13,Interventional,"Experimental, Other, Experimental, Other","Drug, Procedure",Parallel Assignment,,,,"Phase 1, Phase 2"
3279,ITSligo SG,Interventional,"Experimental, Active Comparator","Other, Procedure, Device",Parallel Assignment,,,,Not Applicable
3280,PROICM 2019-02 PRA,Interventional,"Experimental, Other","Other, Drug",Parallel Assignment,,,,Phase 2
3281,30-225 ex 17/18,Interventional,"Active Comparator, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
3282,202302077,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3283,MC210301,Observational,,"Procedure, Other",,Cohort,,Non-Probability Sample,
3284,STUDY00003067,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3285,Yunwei Wei 2019-09-12,Observational,,Drug,,Case-Control,,Probability Sample,
3286,A095053,Interventional,"No Intervention, Active Comparator, Active Comparator, Active Comparator","Diagnostic Test, Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
3287,850366,Interventional,"Experimental, Experimental, Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
3288,2.510.081,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3289,K170702J,Observational,,Other,,Cohort,,Probability Sample,
3290,IC 2018-09,Interventional,"Other, Other, Other, Other, Other, Other","Behavioral, Behavioral, Other, Other",Sequential Assignment,,,,Not Applicable
3291,GX-I7-CA-006,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3292,NeoCAT,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
3293,2021-395,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3294,AAAR9515,Interventional,"Active Comparator, Active Comparator, Placebo Comparator","Device, Device, Device",Sequential Assignment,,,,Not Applicable
3295,1613494-3,Observational,,Behavioral,,Ecologic or Community,,Non-Probability Sample,
3296,RG1007463,Interventional,Experimental,"Drug, Drug, Drug, Biological, Biological",Single Group Assignment,,,,"Phase 1, Phase 2"
3297,R17137,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
3298,18070604,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,"Phase 2, Phase 3"
3299,201801105,Interventional,Experimental,"Procedure, Drug, Procedure, Drug, Drug",Single Group Assignment,,,,Early Phase 1
3300,2019-01395CE3508,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3301,PROTOCOL-M7-037,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3302,STUDY00001356,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3303,PA191001001,Interventional,"Experimental, Active Comparator","Procedure, Procedure, Other",Parallel Assignment,,,,Not Applicable
3304,2021198-1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
3305,CHIR-05-IMTAD,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
3306,EAQ201,Observational,,Other,,Cohort,,Non-Probability Sample,
3307,202004120MINB,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
3308,PANTHERA,Observational,,,,Case-Only,3 Years,Non-Probability Sample,
3309,Remimazolam_recovery,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
3310,BIOC-046,Observational,,Device,,Cohort,,Non-Probability Sample,
3311,IC 2020-04,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
3312,RECHMPL21_0525,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
3313,S64410,Interventional,Other,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
3314,MC1689,Interventional,Experimental,"Drug, Drug, Drug, Biological, Drug, Drug, Other, Biological, Biological, Biological, Procedure, Biological, Drug, Other, Biological",Single Group Assignment,,,,Phase 1
3315,2017-0301,Interventional,"Experimental, Active Comparator","Radiation, Other",Parallel Assignment,,,,Phase 2
3316,S59396,Interventional,"Experimental, Active Comparator, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3317,2022037,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3318,Q122-2001,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
3319,2017C0165,Observational,,,,Case-Only,,Non-Probability Sample,
3320,1105/18,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
3321,RFID,Observational,,"Device, Device",,Case-Control,,Probability Sample,
3322,H-37314,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
3323,5505,Observational,,Diagnostic Test,,Other,,Non-Probability Sample,
3324,EKNZ 2015-026,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
3325,852666,Interventional,"No Intervention, Experimental, Experimental, Experimental","Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
3326,SP11631,Interventional,"Experimental, Active Comparator",Biological,Parallel Assignment,,,,Phase 3
3327,XZP-3287-1001,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
3328,Three birds with one stone,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3329,I 56617,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3330,TAK-676-1003,Interventional,Experimental,"Drug, Drug, Radiation",Sequential Assignment,,,,Phase 1
3331,STUDY00022229,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
3332,UPCC 25920,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,"Phase 1, Phase 2"
3333,CR108557,Interventional,"Experimental, Experimental","Drug, Drug",Crossover Assignment,,,,Phase 1
3334,22-269,Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
3335,MEDOPP243,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3336,2016-051-000001- 1731,Observational,,,,Case-Control,,Non-Probability Sample,
3337,4901,Interventional,,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3338,Yvonne Wengstrom,Interventional,"Experimental, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
3339,None yet,Observational,,Device,,Cohort,,Non-Probability Sample,
3340,Abbreviated Breast MRI,Observational,,Radiation,,Case-Crossover,,Probability Sample,
3341,REaCT-Hold BMA,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
3342,202005217,Interventional,"Experimental, Active Comparator, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
3343,4-2019-0795,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3344,20180569-01H,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
3345,DS8201-A-U106,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
3346,2020-0761,Interventional,"Active Comparator, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
3347,SBI-CIP 20-002,Interventional,"Placebo Comparator, Experimental","Drug, Device, Drug",Sequential Assignment,,,,Phase 3
3348,A2018-002,Interventional,Other,Drug,Single Group Assignment,,,,Phase 4
3349,2669,Observational,,,,Cohort,,Probability Sample,
3350,STUDY00016221,Interventional,"Experimental, Other",Behavioral,Parallel Assignment,,,,Not Applicable
3351,SHF-WBI,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
3352,X-PACT 101,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 1
3353,PR275/20,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
3354,MCC-20257,Observational,,"Behavioral, Behavioral",,Case-Only,,Non-Probability Sample,
3355,DS8201-A-U105,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
3356,BrUOG 387,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
3357,19-07020531,Interventional,Other,Radiation,Single Group Assignment,,,,Phase 2
3358,NAUTILUS study,Interventional,"Experimental, Other","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3359,Instituto Nacional do CÃ¢ncer,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3360,HP-LY-CL-2063,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
3361,9785,Observational,,"Device, Device",,Cohort,,Non-Probability Sample,
3362,BCP24,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3363,IRB00083573,Interventional,Experimental,"Drug, Diagnostic Test, Diagnostic Test, Other, Behavioral",Single Group Assignment,,,,Early Phase 1
3364,CCR5199,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
3365,2008222-12,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Phase 3
3366,1708018471,Observational,,,,Other,,Non-Probability Sample,
3367,2019-0837-002,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
3368,HVST-HEMO-20,Interventional,"Experimental, Other","Device, Other",Parallel Assignment,,,,Phase 4
3369,STUDY00019979,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3370,APBI Registry,Observational,,Radiation,,Cohort,,Non-Probability Sample,
3371,SGNTUC-019,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
3372,109489,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3373,IIT2019-14-SHIRAZIP-SWEAT,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Early Phase 1
3374,EORTC-1984-BCG,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
3375,H-43277,Interventional,"Experimental, Experimental","Device, Device, Other",Crossover Assignment,,,,Not Applicable
3376,OE20/2020,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
3377,Oncolact2020,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
3378,GNC-035-101ï¼V1.1ï¼,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3379,PSIBBR,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3380,2022-0880,Interventional,"Experimental, Experimental","Radiation, Other",Single Group Assignment,,,,Phase 3
3381,ACT16432,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
3382,ABCB1 in Paclitaxel Neuropathy,Observational,,Genetic,,Cohort,,Non-Probability Sample,
3383,THRIVORSBH-01,Interventional,"Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
3384,RECHMPL20_0614,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3385,19-07020533,Interventional,"Experimental, Experimental","Radiation, Radiation",Parallel Assignment,,,,Phase 3
3386,AAAT8817,Interventional,"Experimental, Other","Behavioral, Other",Single Group Assignment,,,,Not Applicable
3387,RD19/121361,Interventional,Experimental,"Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
3388,20190516,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
3389,R/19.08.578,Interventional,Experimental,Procedure,Single Group Assignment,,,,Phase 1
3390,201902048MINC,Interventional,"Active Comparator, Experimental","Drug, Radiation",Parallel Assignment,,,,Phase 3
3391,DHP107_Bioimaging,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
3392,BRAVEHeartV1,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
3393,18-5029,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3394,050811,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
3395,0594,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator",Diagnostic Test,Parallel Assignment,,,,Not Applicable
3396,APHP201173,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3397,2019-001,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3398,19-315,Observational,,,,Cohort,,Non-Probability Sample,
3399,UMCC 2019.125,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Phase 2
3400,2022P000354,Interventional,"Experimental, Experimental, No Intervention, No Intervention","Other, Other",Crossover Assignment,,,,Not Applicable
3401,SB-2101,Observational,,,,Cohort,,Probability Sample,
3402,00001137,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3403,21-012300,Interventional,Experimental,"Other, Behavioral",Single Group Assignment,,,,Not Applicable
3404,C3661001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
3405,Breast MRI,Observational,,Device,,Case-Only,,Non-Probability Sample,
3406,4-2020-0430,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
3407,2017/2805,Observational,,"Other, Other, Other",,Other,,Non-Probability Sample,
3408,N16PRB,Interventional,Other,Radiation,Single Group Assignment,,,,Not Applicable
3409,CASE10119,Interventional,Experimental,"Other, Behavioral",Single Group Assignment,,,,Not Applicable
3410,KY-Q-2021-182,Interventional,"Experimental, No Intervention",Behavioral,Single Group Assignment,,,,Not Applicable
3411,17/0774,Observational,,,,Cohort,,Non-Probability Sample,
3412,DOLPHIN,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
3413,21-3100.cc,Observational,,,,Cohort,,Probability Sample,
3414,OSU-18094,Interventional,Experimental,"Procedure, Procedure, Other",Single Group Assignment,,,,Not Applicable
3415,NUV-422-03,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3416,METC20-099,Interventional,"Active Comparator, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3417,10840098-604.01.01-E.184,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
3418,D8534C00001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
3419,FIS-APBI-2019-02,Observational,,,,Case-Only,,Non-Probability Sample,
3420,CLEE011ARU01,Observational,,"Other, Other, Other, Other",,Cohort,,Non-Probability Sample,
3421,2020/6422,Interventional,"Experimental, Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Phase 4
3422,Breast Cancer Chemotherapy,Interventional,Experimental,"Procedure, Procedure, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Drug",Single Group Assignment,,,,Not Applicable
3423,STUDY02001039,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3424,CSCS,Interventional,"Experimental, Active Comparator","Other, Other",Sequential Assignment,,,,Not Applicable
3425,PRESIONA20,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3426,2-028-22,Observational,,Other,,Case-Only,,Non-Probability Sample,
3427,2022-0150,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Single Group Assignment,,,,Phase 2
3428,GEN-602-CT-101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
3429,2007-0003,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3430,IPAC,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3431,CASE2119,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3432,STUDY00000228,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
3433,CTMS# 18-0135,Interventional,Experimental,"Other, Other",Single Group Assignment,,,,Not Applicable
3434,STX-478-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3435,18-486,Interventional,"Active Comparator, Experimental","Radiation, Drug",Parallel Assignment,,,,Phase 2
3436,2022LS100,Observational,,,,Cohort,,Non-Probability Sample,
3437,3734,Observational,,,,Cohort,,Non-Probability Sample,
3438,GS3,Observational,,Other,,Cohort,,Non-Probability Sample,
3439,6077,Observational,,,,Other,,Non-Probability Sample,
3440,110181,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
3441,20-124,Interventional,"Experimental, Placebo Comparator, Experimental","Procedure, Procedure, Other, Other",Parallel Assignment,,,,Phase 2
3442,20953,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
3443,2019-02661,Interventional,"Experimental, No Intervention",Diagnostic Test,Parallel Assignment,,,,Not Applicable
3444,GCC1950,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
3445,IRB-55153,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3446,2020-0501,Observational,,"Procedure, Other, Procedure, Other",,Cohort,,Non-Probability Sample,
3447,QT MG PRE Phase 1,Observational,,Diagnostic Test,,Case-Only,,Non-Probability Sample,
3448,EXPLLN21-01,Interventional,Experimental,Diagnostic Test,Parallel Assignment,,,,Not Applicable
3449,22-457,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Early Phase 1
3450,2021-0025,Interventional,Experimental,"Procedure, Procedure, Drug, Other",Single Group Assignment,,,,Not Applicable
3451,2018-A011828-47,Observational,,,,Cohort,,Non-Probability Sample,
3452,MC1932,Interventional,"Experimental, Experimental, Active Comparator",Drug,Parallel Assignment,,,,Phase 2
3453,GW10029,Interventional,"Experimental, Experimental",Device,Parallel Assignment,,,,Not Applicable
3454,21/59848,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3455,Erector block after mastectomy,Interventional,"Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
3456,INT31/19,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
3457,HCI148669,Interventional,Experimental,Device,Single Group Assignment,,,,Early Phase 1
3458,RECHMPL20_0005-UF7919,Observational,,,,Cohort,,Non-Probability Sample,
3459,CBYL719CKR01,Observational,,Other,,Cohort,,Non-Probability Sample,
3460,Telerehab CH Usability,Observational,,Other,,Other,,Non-Probability Sample,
3461,221-005,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 1
3462,228012,Interventional,Experimental,"Drug, Other",Single Group Assignment,,,,Phase 4
3463,69HCL20_1018,Interventional,"Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
3464,ICO-N-2018-15,Observational,,Procedure,,Cohort,,Non-Probability Sample,
3465,300.08-2018-Samsungmedison-S,Interventional,"Active Comparator, Experimental, Experimental","Device, Device, Device, Procedure",Crossover Assignment,,,,Not Applicable
3466,P.T.REC/012/002615,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3467,INT157/17,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3468,BO40933,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
3469,B00394,Interventional,Other,Radiation,Single Group Assignment,,,,Not Applicable
3470,CKMW-1801,Interventional,"Experimental, No Intervention",Behavioral,Crossover Assignment,,,,Not Applicable
3471,EGC101,Interventional,"Experimental, Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
3472,ICO-A-2020-10,Interventional,"Other, Other","Device, Device",Crossover Assignment,,,,Not Applicable
3473,2018-0345-1105,Observational,,,,Other,,Non-Probability Sample,
3474,13155,Interventional,"Experimental, Active Comparator","Procedure, Device, Other",Parallel Assignment,,,,Not Applicable
3475,UW17032,Interventional,Experimental,Device,Single Group Assignment,,,,Phase 2
3476,IRB20-0528,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3477,NL67696.068.18,Interventional,"Active Comparator, Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
3478,RECHMPL21_0379,Observational,,,,Cohort,,Non-Probability Sample,
3479,YH32367-101,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
3480,MedOPP321,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3481,IRB-53132,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3482,AP2204-50104,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Procedure, Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3483,5160378,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
3484,2017-8737,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3485,CYP003,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3486,RS1307/20,Observational,,Other,,Cohort,24 Months,Non-Probability Sample,
3487,H-18041465,Observational,,,,Cohort,,Non-Probability Sample,
3488,315581,Interventional,"Active Comparator, Experimental",Procedure,Parallel Assignment,,,,Not Applicable
3489,R.21.11.1523,Interventional,"Active Comparator, Active Comparator",Other,Parallel Assignment,,,,Phase 2
3490,CTB in Breast surgery,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3491,2022000438,Observational,,Device,,Case-Only,,Non-Probability Sample,
3492,2021.127,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3493,2020-0974,Observational,,Other,,Case-Control,,Non-Probability Sample,
3494,HP-00088085,Observational,,Radiation,,Cohort,1 Year,Probability Sample,
3495,RIS42756,Interventional,"Experimental, Experimental, Experimental, Experimental, No Intervention","Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3496,18-294,Observational,,"Behavioral, Behavioral",,Case-Control,,Non-Probability Sample,
3497,ShantouCH,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
3498,HYACOM,Interventional,"No Intervention, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Sequential Assignment,,,,Not Applicable
3499,00101494,Interventional,"Other, Other, Other",Behavioral,Sequential Assignment,,,,Not Applicable
3500,MCC-20335,Observational,,"Device, Device",,Case-Only,,Non-Probability Sample,
3501,36264PR116/2/23,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Not Applicable
3502,PRO00030436,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Other, Other",Single Group Assignment,,,,Not Applicable
3503,NL82061.096.22,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3504,JS2021-6-1,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
3505,ETK00-2020-0103,Interventional,"Experimental, Experimental, Other","Other, Other, Other",Parallel Assignment,,,,Not Applicable
3506,DIVA-001,Interventional,"Experimental, Placebo Comparator",Device,Parallel Assignment,,,,Not Applicable
3507,UC-0107/1803,Interventional,"Active Comparator, Experimental","Radiation, Other",Parallel Assignment,,,,Not Applicable
3508,20180335,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3509,A221505,Interventional,"Active Comparator, Experimental","Radiation, Other, Other, Other, Radiation",Parallel Assignment,,,,Phase 3
3510,DRBX201901/PRO,Interventional,"Experimental, Active Comparator",Drug,Crossover Assignment,,,,Not Applicable
3511,21-04,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
3512,R01CA249419,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3513,SHS-An-1-2022,Interventional,"Active Comparator, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
3514,STU 072016-058,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Early Phase 1
3515,DS1103-074,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
3516,NEUROTOX,Observational,,Drug,,Case-Only,,Probability Sample,
3517,IRB-21-28,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3518,BREAST-Pyrotinib,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3519,L19-065,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3520,Biofeedback_based_music,Interventional,"Active Comparator, Experimental","Device, Other",Parallel Assignment,,,,Not Applicable
3521,A5481065,Observational,,,,Ecologic or Community,,Probability Sample,
3522,HP-00068503,Observational,,Other,,Case-Control,,Probability Sample,
3523,ELEGANT - ET18-262,Observational,,"Device, Device",,Cohort,,Non-Probability Sample,
3524,AP2110-30111,Interventional,"No Intervention, Experimental, Experimental","Procedure, Procedure",Sequential Assignment,,,,Not Applicable
3525,IIT2021-01-Shiao-CSF1Ri,Interventional,Experimental,"Drug, Radiation, Drug",Single Group Assignment,,,,Phase 2
3526,NL72808.068.20,Observational,,Procedure,,Cohort,,Non-Probability Sample,
3527,A222101,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Other, Other, Drug",Parallel Assignment,,,,Phase 2
3528,TQB211-III-01,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
3529,IRB202101449,Interventional,"Sham Comparator, Experimental",Device,Parallel Assignment,,,,Not Applicable
3530,2017/15,Interventional,Experimental,"Other, Drug",Single Group Assignment,,,,Not Applicable
3531,DMT-2015.002,Observational,,Device,,Case-Control,,Probability Sample,
3532,WHITE TEA,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3533,R17096,Observational,,Other,,Case-Only,,Non-Probability Sample,
3534,AP2014-50103,Interventional,"Experimental, Experimental, No Intervention","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3535,21-318,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
3536,KY2019,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
3537,IRAS 283017,Observational,,Procedure,,Cohort,,Probability Sample,
3538,S61864,Observational,,Device,,Cohort,,Non-Probability Sample,
3539,62/19-06-18,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3540,ZUH-MICB-UMPR,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
3541,BXU572940,Interventional,"Active Comparator, Experimental",Drug,Crossover Assignment,,,,Phase 1
3542,RG1007834,Interventional,Experimental,"Drug, Procedure, Procedure, Drug, Procedure, Procedure, Other",Single Group Assignment,,,,Phase 2
3543,S-20200094,Interventional,"Other, Other","Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
3544,20/WS/0110,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3545,KCT001,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3546,ATADEK 2021-14/18,Interventional,"No Intervention, Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
3547,19-665,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Radiation,Parallel Assignment,,,,Not Applicable
3548,HE641269,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
3549,TBio-4101-001,Interventional,"Experimental, Experimental, Experimental","Biological, Drug",Parallel Assignment,,,,Phase 1
3550,AIUR trial,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3551,RECHMPL18_0244,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3552,LBS-CA-PTL-033,Observational,,Diagnostic Test,,Other,6 Weeks,Non-Probability Sample,
3553,UCCS19102,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3554,CTC-SMMiL-E-1901,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3555,UCCS20127,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3556,U21-08-4519,Observational,,,,Case-Only,,Probability Sample,
3557,PB-2020-01,Observational,,"Drug, Drug, Procedure, Procedure",,Cohort,,Non-Probability Sample,
3558,RCB: 2022-A01349-34,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3559,IRB00180383,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3560,211820931,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
3561,LCI-BRE-VITD-001,Interventional,"Experimental, Active Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
3562,OX2022-203-01,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3563,ID-RCB: 2018-A03356-49,Interventional,"Experimental, Experimental, Experimental, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
3564,CLEE011A2412B,Interventional,Other,"Drug, Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 4
3565,2018-0561,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
3566,2011684,Interventional,"Other, Experimental, Active Comparator","Device, Device, Device",Parallel Assignment,,,,Not Applicable
3567,SAPB for MRM 2.0,Interventional,"Experimental, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3568,2021/058,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
3569,CDK-002-101,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
3570,2020-013-00US3,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3571,D8530C00004,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Radiation, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
3572,TJ107001STM202,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 2
3573,2020_16,Observational,,,,Cohort,,Non-Probability Sample,
3574,19-5250.0,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3575,2015C0090,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3576,Study-21-00112,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3577,NeuroMod-PCCI,Interventional,"Experimental, Sham Comparator","Device, Device, Behavioral",Parallel Assignment,,,,Not Applicable
3578,STU 2019-1099,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Early Phase 1
3579,RCT Pristina 2/TR,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3580,2020.253 NL72539.029.20,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3581,A5481173,Interventional,"Other, Experimental, Other, Other","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3582,2021-0568-001,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Phase 3
3583,STUDY00143316,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
3584,2019P001434-1,Observational,,,,Other,,Non-Probability Sample,
3585,2004-219-1119,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3586,19-238,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
3587,DS1062-A-J101,Interventional,"Experimental, Experimental","Drug, Drug, Other",Sequential Assignment,,,,Phase 1
3588,2000031319,Observational,,"Other, Other, Device, Other, Other",,Cohort,,Probability Sample,
3589,FDRT-BC007,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
3590,CMUH110-REC1-122,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3591,IIT-ePRO,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Phase 3
3592,PMPS 1,Observational,,,,Case-Control,,Probability Sample,
3593,IRMA,Observational,,Other,,Cohort,,Non-Probability Sample,
3594,UTK-IRB-22-07195,Interventional,"Experimental, Other","Other, Device",Parallel Assignment,,,,Not Applicable
3595,22-091,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3596,ERC#2020-3379-10190,Observational,,Other,,Case-Only,,Non-Probability Sample,
3597,ICO-2020-22,Observational,,,,Cohort,,Non-Probability Sample,
3598,PROICM 2018-07 BPR,Interventional,"Other, Other, Other, Other",Other,Factorial Assignment,,,,Not Applicable
3599,5271,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
3600,21-055,Observational,,"Diagnostic Test, Behavioral",,Cohort,,Non-Probability Sample,
3601,ZG01012019,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
3602,IRB-2022- 1451,Interventional,"Placebo Comparator, Experimental",Procedure,Parallel Assignment,,,,Not Applicable
3603,PROICM 2020-06 BIO,Interventional,"Experimental, Experimental, No Intervention","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
3604,1955K,Observational,,"Procedure, Procedure",,Case-Control,,Non-Probability Sample,
3605,2019_NOV_CP_001,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3606,22-197,Interventional,"Active Comparator, Placebo Comparator","Procedure, Other",Parallel Assignment,,,,Phase 2
3607,UPCC 21220,Observational,,Other,,Cohort,1 Year,Non-Probability Sample,
3608,DEGENCA,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
3609,20-5111,Interventional,"Experimental, Other",Other,Parallel Assignment,,,,Not Applicable
3610,ASO.RianGen.22.02,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3611,IRB-46373,Interventional,"Active Comparator, Experimental","Procedure, Radiation",Parallel Assignment,,,,Not Applicable
3612,C4431001,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Diagnostic Test",Sequential Assignment,,,,Phase 1
3613,PO18091,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3614,B-1206-158-005,Interventional,"Experimental, Active Comparator","Biological, Biological",Parallel Assignment,,,,Not Applicable
3615,19-00222,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3616,PECS in Breast Cancer Surgery,Interventional,"Placebo Comparator, Active Comparator, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
3617,MAGREES,Observational,,,,Cohort,,Non-Probability Sample,
3618,M336,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3619,KIA 2018/155,Interventional,"No Intervention, Experimental",Procedure,Crossover Assignment,,,,Not Applicable
3620,190311,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,,,,Not Applicable
3621,202200395A3,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3622,HREBA.CC-19-0354,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
3623,20-021,Interventional,"Experimental, Active Comparator","Procedure, Procedure, Other, Other",Parallel Assignment,,,,Phase 3
3624,Analgesia in breast surgey,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3625,MCC-19650,Interventional,"Active Comparator, Active Comparator, Experimental, Experimental",Biological,Single Group Assignment,,,,Phase 2
3626,159-2019,Interventional,"No Intervention, Experimental",Device,Sequential Assignment,,,,Not Applicable
3627,2018-05-0009,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3628,9778,Observational,,"Diagnostic Test, Other",,Cohort,,Non-Probability Sample,
3629,LCCC1920,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3630,DCIS Cryo,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
3631,STU00214745,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
3632,ENTheR,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3633,Michal Nissim 2,Interventional,"Experimental, Experimental, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
3634,IUSCC-0533,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
3635,Version 1.1.6,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3636,GALENO 1,Interventional,"Experimental, Experimental, Experimental","Dietary Supplement, Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
3637,MMSTD1Pecs2,Interventional,"Other, Other","Procedure, Procedure, Other",Parallel Assignment,,,,Not Applicable
3638,ST-067-001,Interventional,"Experimental, Experimental",Biological,Sequential Assignment,,,,"Phase 1, Phase 2"
3639,875329,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3640,TRV-002,Observational,,,,Cohort,,Non-Probability Sample,
3641,SYSKY-2023-122-02,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3642,H-40045,Interventional,"No Intervention, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3643,TREM-1,Interventional,"Other, Other, No Intervention, No Intervention, No Intervention",Biological,Parallel Assignment,,,,Not Applicable
3644,KOU KAEK 2018/487,Interventional,"Experimental, Experimental","Other, Other",Crossover Assignment,,,,Not Applicable
3645,201912245RINB,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
3646,KND-QX-CXXT,Observational,,Device,,Cohort,,Non-Probability Sample,
3647,RC31/17/0335,Interventional,"Other, Other","Device, Device",Crossover Assignment,,,,Not Applicable
3648,PKUPH10B001,Interventional,"Active Comparator, Experimental",Combination Product,Parallel Assignment,,,,Early Phase 1
3649,CO-338-098,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3650,CUT_DN_02,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3651,Pro00052823,Observational,,Device,,Case-Only,,Non-Probability Sample,
3652,ALTERTASTE,Observational,,Drug,,Cohort,,Non-Probability Sample,
3653,CCS1477-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3654,19.58/ONCO19.08,Interventional,"Active Comparator, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3655,CIRCADIAN,Observational,,,,Cohort,,Non-Probability Sample,
3656,UBP-A103-HER2,Interventional,"Experimental, Experimental, Experimental, Experimental, Active Comparator","Biological, Biological",Sequential Assignment,,,,Phase 1
3657,Pro00040035,Interventional,"Experimental, Active Comparator",Behavioral,Parallel Assignment,,,,Not Applicable
3658,UMCC 2021.071,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3659,18-6047,Interventional,"Experimental, Experimental",Radiation,Single Group Assignment,,,,Not Applicable
3660,PI2018068,Interventional,"Experimental, Experimental",Behavioral,Crossover Assignment,,,,Not Applicable
3661,Real-HER2,Observational,,,,Cohort,,Non-Probability Sample,
3662,Metimedi-202,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3663,NUV-422-02,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
3664,CBCSG-040,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3665,2020-A01534-35,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3666,181367,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3667,UBT 2022-01,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3668,PRO00041443,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3669,19SM5221,Observational,,Device,,Other,,Non-Probability Sample,
3670,METCZ20190024,Interventional,"No Intervention, Experimental",Device,Single Group Assignment,,,,Not Applicable
3671,PUMA-NER-9501,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3672,2022/73,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3673,SY-5609-101,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
3674,22-01024342,Interventional,"Active Comparator, Active Comparator",Radiation,Parallel Assignment,,,,Phase 3
3675,MCC-20487,Interventional,"Experimental, Experimental, Experimental, Experimental","Radiation, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3676,DWI breast cancer,Observational,,Device,,Cohort,,Non-Probability Sample,
3677,BT5528-100,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3678,SYSKY-2022-117-01,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3679,0141-19-RMB,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3680,TBMZ-Radio-boron gel,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3681,2021P000209,Observational,,,,Cohort,,Non-Probability Sample,
3682,IRB 22-211,Observational,,Other,,Cohort,18 Months,Non-Probability Sample,
3683,PROT-P2-024,Interventional,"Other, Other",Device,Parallel Assignment,,,,Not Applicable
3684,REaCT-TEMPO,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 4
3685,ZL-2306-006,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3686,OTT-15-02,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3687,2022-0454,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3688,3121_MATFIH22,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3689,Pro00101109,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3690,22-071,Interventional,"Experimental, Experimental","Procedure, Procedure",Parallel Assignment,,,,Phase 3
3691,K 2020-9716,Interventional,Experimental,"Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Phase 2
3692,Modi-1-001,Interventional,"Experimental, Experimental, Experimental","Biological, Biological, Device",Parallel Assignment,,,,"Phase 1, Phase 2"
3693,CONFIDENCE-01,Observational,,Device,,Other,2 Years,Probability Sample,
3694,20-437,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3695,NCC20180327,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
3696,21-559,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3697,NK-101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
3698,16-01,Interventional,Experimental,"Radiation, Drug",Single Group Assignment,,,,"Phase 2, Phase 3"
3699,IEO 1002/,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3700,3271,Interventional,Experimental,"Radiation, Radiation",Single Group Assignment,,,,Not Applicable
3701,LCCC2139,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
3702,Medipol Hospital 18,Interventional,"Active Comparator, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
3703,1903399639,Interventional,Experimental,"Diagnostic Test, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
3704,18-00684,Observational,,"Diagnostic Test, Diagnostic Test",,Cohort,,Non-Probability Sample,
3705,MCC-19-15167,Interventional,"No Intervention, Active Comparator",Behavioral,Parallel Assignment,,,,Not Applicable
3706,SPI-POZ-203,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 2
3707,INX-315-01,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
3708,21-288,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3709,18-431,Interventional,"Experimental, Active Comparator","Radiation, Drug",Parallel Assignment,,,,Phase 2
3710,2140-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3711,CASE5117,Interventional,"Active Comparator, Experimental, Active Comparator","Device, Device, Other",Parallel Assignment,,,,Not Applicable
3712,CASE10117,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3713,E2018124,Interventional,"No Intervention, Experimental, Experimental",Drug,Parallel Assignment,,,,Not Applicable
3714,OSU-21198,Observational,,Other,,Cohort,,Non-Probability Sample,
3715,JSKN003-101,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
3716,STUDY21070030,Interventional,Experimental,"Device, Drug",Single Group Assignment,,,,Phase 4
3717,20-275,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 1
3718,2019(S073),Observational,,Device,,Case-Only,,Non-Probability Sample,
3719,RadOnc,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3720,Laser LabCorp #001,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3721,NCC2962,Observational,,Device,,Other,,Probability Sample,
3722,21051,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
3723,E20210210,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3724,018-781,Observational,,,,Cohort,,Non-Probability Sample,
3725,B076201420067,Interventional,"Active Comparator, Experimental",Drug,Parallel Assignment,,,,Not Applicable
3726,IGAR-TO-007,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3727,LYL797-101,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
3728,2020-04936,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
3729,IRB-50877,Interventional,Experimental,"Drug, Device",Single Group Assignment,,,,Early Phase 1
3730,CIRB Ref. No: 2019/2090,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3731,PER-19-04,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,,,,Not Applicable
3732,GOG-8023,Observational,,"Other, Other, Other, Genetic, Other, Genetic",,Cohort,,Non-Probability Sample,
3733,APHP220816,Observational,,Other,,Cohort,,Non-Probability Sample,
3734,KL166-I-01-CTP,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
3735,PROTOCOL-P2-054,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3736,254-18,Interventional,"Active Comparator, Active Comparator, Active Comparator","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3737,MIP-2019-001,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3738,TO-TAS0728-101,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
3739,DE-17-17,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3740,CLINP-001013,Observational,,Device,,Other,,Non-Probability Sample,
3741,201701045,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Other",Parallel Assignment,,,,Phase 1
3742,ICO-2021-05,Observational,,Procedure,,Cohort,,Non-Probability Sample,
3743,IB 2019-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3744,735CLD Rev.04,Observational,,Device,,Cohort,,Non-Probability Sample,
3745,CLP-0004,Observational,,"Other, Other, Other, Other, Other",,Cohort,,Non-Probability Sample,
3746,EMC-0124-18,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3747,2022-010,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3748,2834,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Not Applicable
3749,IC 2021 07,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 3
3750,GEN1B-01,Interventional,"Active Comparator, Active Comparator","Device, Device",Sequential Assignment,,,,Not Applicable
3751,IIT2018-25-MITA-NEOBREADS,Interventional,Experimental,"Other, Drug",Single Group Assignment,,,,Phase 1
3752,2020-00493,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
3753,20210817-01H,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3754,20295,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3755,2019-1176,Interventional,"Experimental, Active Comparator","Other, Other, Procedure, Other, Other",Parallel Assignment,,,,Not Applicable
3756,2021-0290,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Phase 2
3757,124.03-2017-GES-0005,Interventional,Other,"Device, Device",Single Group Assignment,,,,Not Applicable
3758,IIT2018-21-AMERSI-BREADS,Interventional,"Experimental, Active Comparator","Other, Drug",Parallel Assignment,,,,Phase 2
3759,ETNA-CRCI,Observational,,Device,,Cohort,,Probability Sample,
3760,PER-19-03,Observational,,Device,,Cohort,,Probability Sample,
3761,INTRUSION,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3762,PSG SOMAVAC,Observational,,Device,,Case-Only,,Non-Probability Sample,
3763,FMSU2017-003,Observational,,"Device, Device",,Case-Crossover,,Non-Probability Sample,
3764,3-2021-0468,Interventional,"Experimental, Placebo Comparator","Procedure, Other",Parallel Assignment,,,,Not Applicable
3765,Reader-02 Study,Interventional,"Active Comparator, Experimental","Device, Device, Device",Sequential Assignment,,,,Not Applicable
3766,20-03,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3767,YWBC-002,Interventional,"Experimental, Experimental, Experimental, No Intervention","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
3768,PROICM 2019-07 PRE,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3769,2018-4107,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Not Applicable
3770,STUDY00025461,Interventional,"Experimental, Active Comparator","Other, Behavioral, Other",Parallel Assignment,,,,Not Applicable
3771,2020-0980,Observational,,Other,,Case-Only,,Non-Probability Sample,
3772,0180910/16,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,,,,Not Applicable
3773,19D.203,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3774,SN132D CSP final version 6.0,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3775,LAE203CN2101,Interventional,"Active Comparator, Active Comparator, Active Comparator, Placebo Comparator","Combination Product, Combination Product, Combination Product, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3776,2019-A00121-56,Observational,,Other,,Cohort,26 Months,Non-Probability Sample,
3777,2018-9409,Observational,,,,Cohort,5 Years,Non-Probability Sample,
3778,R.22.09.1830,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,"Phase 2, Phase 3"
3779,SCOUT2021,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3780,2020-3,Observational,,,,Case-Crossover,,Non-Probability Sample,
3781,2022-A01940-43,Interventional,"Placebo Comparator, Experimental","Drug, Other",Parallel Assignment,,,,Phase 2
3782,Reader-01,Interventional,"Active Comparator, Experimental","Device, Device, Device",Sequential Assignment,,,,Not Applicable
3783,CIRB Ref. No: 2017/3139,Observational,,,,Cohort,,Non-Probability Sample,
3784,BCD-178-1,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 1
3785,2019P003607-11,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
3786,SHR6390-I-114,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
3787,19-005445,Observational,,,,Cohort,,Non-Probability Sample,
3788,2204MDJ,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3789,mastectomy regional anesthesia,Interventional,Experimental,Other,Single Group Assignment,,,,Phase 3
3790,PECS 2019,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Phase 4
3791,R-2017/UEM11,Interventional,"Experimental, Experimental, Experimental, Experimental","Other, Other",Crossover Assignment,,,,Not Applicable
3792,IBIO-302,Interventional,"Experimental, Experimental",Drug,Crossover Assignment,,,,Phase 1
3793,LCCC1754,Observational,,,,Cohort,32 Years,Non-Probability Sample,
3794,2022-1151,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3795,20-378,Interventional,"Experimental, Experimental",Other,Sequential Assignment,,,,Not Applicable
3796,21-BI-1607-01,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3797,NINTAU,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3798,BCA-AI,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
3799,21-002713,Interventional,Experimental,"Other, Procedure",Single Group Assignment,,,,Early Phase 1
3800,Tomosymthesis,Observational,,,,Case-Only,,Probability Sample,
3801,CAAA504A12101,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Early Phase 1
3802,LIVFOU-930411,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure, Procedure, Drug, Device",Parallel Assignment,,,,Not Applicable
3803,2019-A0872-55,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3804,D6900C00001,Interventional,Experimental,Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
3805,20200491,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3806,CMUH106-REC2-117,Observational,,Procedure,,Case-Control,,Probability Sample,
3807,20190701041GH,Observational,,,,Cohort,1 Year,Non-Probability Sample,
3808,HNCH-BC004,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
3809,PRO2021-1428,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
3810,NBE-002-01,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
3811,1B-22-2,Interventional,"Experimental, Experimental","Biological, Drug, Radiation, Biological",Sequential Assignment,,,,Phase 1
3812,ZN-A-1041-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
3813,2019-06214,Observational,,,,Case-Control,,Non-Probability Sample,
3814,PROT001,Interventional,"Active Comparator, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
3815,2020-0498,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Other, Other",Parallel Assignment,,,,Not Applicable
3816,HCC 21-265,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3817,HNCH-BC007,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
3818,UZBRU_VHH2_1,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
3819,PROT002 - Test Plan 01 Rev A,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3820,19-007547,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3821,Gen 2 - 01,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3822,v24-9-2017,Observational,,Behavioral,,Case-Control,5 Years,Non-Probability Sample,
3823,Ageing-NIO,Observational,,"Procedure, Procedure, Procedure, Procedure, Procedure, Procedure",,Cohort,,Probability Sample,
3824,BYON5667.002,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3825,M16-573,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
3826,MW05-2020-CP301,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
3827,Pro00092817,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3828,Pro00112215,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3829,DPCVC,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3830,ACROPOLI (SOLTI-1904),Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3831,SRNSM,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
3832,NL52329.075.15,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3833,AAAT2490,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Other, Other, Other, Other",Factorial Assignment,,,,Not Applicable
3834,5R44CA203608,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,,,,Not Applicable
3835,0S-20-6,Observational,,Other,,Case-Only,,Non-Probability Sample,
3836,CMP-001-009,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
3837,5890-001,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Biological, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
3838,SS-SP01-201904,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3839,H19-03343,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3840,EK 1623/2020,Interventional,"Other, Other","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3841,BPI-2358-106 phase 3,Interventional,"Active Comparator, Experimental","Drug, Drug, Other, Drug",Parallel Assignment,,,,Phase 3
3842,TRX518-004,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3843,KL264-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
3844,20200110,Interventional,"Sham Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
3845,PI-3958,Observational,,Drug,,Case-Control,,Non-Probability Sample,
3846,NeoVAB,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3847,BrUOG 351,Interventional,Experimental,"Radiation, Procedure",Single Group Assignment,,,,Not Applicable
3848,2018-01,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3849,TYKM1602101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3850,Medipol Hospital 26,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Not Applicable
3851,16-136,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
3852,ASPB vs ESBP for mastectomy,Interventional,"Active Comparator, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
3853,SGN228-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3854,1612017795,Interventional,"No Intervention, Experimental, Experimental",Other,Single Group Assignment,,,,Not Applicable
3855,7902-005,Interventional,"Experimental, Experimental","Biological, Drug",Parallel Assignment,,,,Phase 2
3856,UUBreast02,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Phase 3
3857,2021-0842,Interventional,Experimental,Device,Single Group Assignment,,,,Early Phase 1
3858,06-2020/1,Observational,,"Other, Other, Other",,Case-Only,,Non-Probability Sample,
3859,MCC-21622,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Biological",Sequential Assignment,,,,Phase 1
3860,SIBP-03-01,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
3861,GN19HS442,Interventional,"Experimental, Active Comparator","Other, Other",Crossover Assignment,,,,Not Applicable
3862,217510,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
3863,4-2019-0834,Observational,,Procedure,,Case-Control,,Non-Probability Sample,
3864,IRB00047335,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Early Phase 1
3865,RIN20230039,Interventional,"Experimental, Experimental",Behavioral,Sequential Assignment,,,,Not Applicable
3866,UI/EC/20/0275,Interventional,"Active Comparator, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 4
3867,AB-201-01,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3868,IOM-040369,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
3869,18-264,Interventional,"Experimental, No Intervention",Behavioral,Crossover Assignment,,,,Not Applicable
3870,REC/RCR&AHS/22/0511,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
3871,MAR-BAS-18-005,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3872,107709,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3873,20-1456,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
3874,233,Interventional,"Active Comparator, Sham Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
3875,TQB3616-I-02,Interventional,"Experimental, Experimental",Drug,Crossover Assignment,,,,Phase 1
3876,P050001 TiLOOPÂ® Bra Pocket,Observational,,Device,,Cohort,,Non-Probability Sample,
3877,2021-0262,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3878,UTN: U1111-1278-1680,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3879,H18-02014,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3880,STUDY00002789,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3881,IRB19-2074,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
3882,ISPY-P1.01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3883,MASCT-I-1003,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,Phase 1
3884,KY20202093-F-1,Interventional,,Drug,Single Group Assignment,,,,Early Phase 1
3885,19-104,Interventional,"Active Comparator, Active Comparator, Placebo Comparator",Other,Parallel Assignment,,,,Not Applicable
3886,STUDY00018917,Interventional,"No Intervention, Experimental",Combination Product,Parallel Assignment,,,,Not Applicable
3887,TG1819ONC,Interventional,Experimental,"Biological, Biological, Biological, Biological, Biological, Biological, Biological",Sequential Assignment,,,,"Phase 1, Phase 2"
3888,262180,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
3889,S66520,Interventional,"Active Comparator, Active Comparator, Sham Comparator",Device,Parallel Assignment,,,,Not Applicable
3890,NCI-2017-01921,Interventional,"Experimental, Placebo Comparator","Drug, Other, Other",Parallel Assignment,,,,Phase 1
3891,P.T.REC/012/002677,Interventional,"Active Comparator, Sham Comparator","Device, Other",Crossover Assignment,,,,Not Applicable
3892,"2016-051-000001, 1835",Interventional,"Other, Other",Behavioral,Parallel Assignment,,,,Not Applicable
3893,CF21163B,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3894,1413727,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3895,D-FR-01072-002,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
3896,Breast-Nektaria,Interventional,"Active Comparator, Sham Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3897,1049/2018,Observational,,"Device, Other",,Cohort,,Non-Probability Sample,
3898,VALO-001,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
3899,20200426,Interventional,"Experimental, Experimental","Drug, Drug",Crossover Assignment,,,,Phase 1
3900,IMU R204/2017,Interventional,"Active Comparator, Active Comparator, Active Comparator","Dietary Supplement, Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
3901,LCCC1915,Interventional,"Experimental, Experimental, Experimental","Drug, Device",Single Group Assignment,,,,Phase 2
3902,RiphahIU Shafaq,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3903,18-571,Interventional,"Other, Other","Other, Other",Sequential Assignment,,,,Not Applicable
3904,OCOG-2022-RAPID2,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Phase 3
3905,CRX100-001,Interventional,Experimental,Biological,Sequential Assignment,,,,Phase 1
3906,HREBA.CC-20-0077,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3907,TST-9-H,Interventional,"Experimental, Active Comparator","Biological, Drug",Parallel Assignment,,,,Phase 1
3908,R19-159,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
3909,20181004,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3910,2018B0521,Interventional,"Experimental, Placebo Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
3911,2012285106,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3912,287482,Interventional,"Placebo Comparator, Active Comparator","Drug, Other",Parallel Assignment,,,,Phase 4
3913,201612723,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3914,AWS,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
3915,HR-BLTN-DDI-07,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
3916,2022-0328,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
3917,20/007-E_TFM,Interventional,"Experimental, Active Comparator",Behavioral,Parallel Assignment,,,,Not Applicable
3918,180097,Interventional,Experimental,"Drug, Device",Single Group Assignment,,,,Phase 2
3919,190134,Interventional,"Experimental, Active Comparator, Active Comparator","Biological, Biological, Biological",Sequential Assignment,,,,Phase 1
3920,HCI128055,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3921,1380800-R,Interventional,"Active Comparator, Experimental, Other","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3922,18112,Interventional,Experimental,"Procedure, Drug, Other, Procedure",Single Group Assignment,,,,Early Phase 1
3923,TH1902-CTR-0001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3924,0352-2189,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
3925,BREAST HEMATOMA,Observational,,Device,,Other,,Non-Probability Sample,
3926,KY20172047-1,Interventional,Experimental,Procedure,Single Group Assignment,,,,Phase 1
3927,mRNA-2752-P101,Interventional,"Experimental, Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 1
3928,7621,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3929,ART4215C001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3930,D161100000816006,Observational,,,,Cohort,,Probability Sample,
3931,TomBakerCC,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3932,SVIFT Nodal Trial,Interventional,"Active Comparator, Other",Radiation,Factorial Assignment,,,,Not Applicable
3933,CASE1Z21,Interventional,"No Intervention, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
3934,IRB00075787,Interventional,Experimental,"Other, Other",Single Group Assignment,,,,Not Applicable
3935,HB-AT-001,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3936,201907039,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Procedure, Procedure",Parallel Assignment,,,,Phase 2
3937,Duke-NUS,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3938,226947,Observational,,Other,,Other,,Non-Probability Sample,
3939,IIT2018-05-ASHER-IMPROV2,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3940,OU-SCC Virtual Reality,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
3941,SKNA pilot,Interventional,"Active Comparator, No Intervention",Drug,Parallel Assignment,,,,Not Applicable
3942,2020-A03205-34,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3943,OPERA2,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
3944,UMCC 2021.004,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3945,UPMREB 2021-140-01,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Phase 2
3946,TaiHao BR-USCAD VT 20-249,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",Crossover Assignment,,,,Not Applicable
3947,Gyn F-Chem,Interventional,"Experimental, Experimental, Placebo Comparator",Other,Parallel Assignment,,,,Not Applicable
3948,NCCH1905,Observational,,Genetic,,Cohort,,Probability Sample,
3949,15/LO/1038 BRACELET,Observational,,,,Cohort,,Non-Probability Sample,
3950,KS01,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
3951,MS-268-2019,Interventional,"Experimental, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3952,BoCCE,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3953,875329B,Interventional,"Experimental, Experimental","Device, Device",Single Group Assignment,,,,Not Applicable
3954,MS-536-2021,Interventional,"Experimental, Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
3955,PROICM 2019-06 COH,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3956,1449,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3957,CLINP-001001,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3958,D3614C00004,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
3959,RocuMAST,Observational,,Drug,,Cohort,,Probability Sample,
3960,IZKSZ3_188408 / 1,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3961,CHD22_0002,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3962,ORIN1001-C1,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
3963,1920306,Observational,,Other,,Cohort,,Non-Probability Sample,
3964,17-VIN-0855,Interventional,"Experimental, Active Comparator","Drug, Drug",Crossover Assignment,,,,Phase 1
3965,2022-01423-01,Observational,,"Procedure, Procedure, Procedure, Procedure",,Case-Control,,Non-Probability Sample,
3966,H-42207 GAIL-N,Interventional,"Experimental, Experimental",Genetic,Single Group Assignment,,,,Phase 1
3967,TED16925,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
3968,Breast 2019,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
3969,2019-0557,Interventional,Experimental,Diagnostic Test,Sequential Assignment,,,,Early Phase 1
3970,D0817C00098,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 3
3971,2017-377,Interventional,"Active Comparator, Sham Comparator","Other, Device",Crossover Assignment,,,,Not Applicable
3972,RPC006,Interventional,"Other, Placebo Comparator, Active Comparator, Other, Placebo Comparator, Active Comparator, Other, Placebo Comparator, Active Comparator","Dietary Supplement, Drug, Drug",Parallel Assignment,,,,Phase 2
3973,2018-94,Interventional,"Active Comparator, Active Comparator, Other","Device, Other, Other",Crossover Assignment,,,,Not Applicable
3974,Esogu Anesthesia,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3975,Telerehab CH Feasibility,Interventional,"Experimental, Sham Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
3976,UF-STO-ETG-003,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3977,UMCC 2020.041,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3978,UMCC 2020.157,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
3979,R7075-ONC-2009,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3980,OnkoFit II,Interventional,"Experimental, Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3981,CART-TnMUC1-01,Interventional,"Experimental, Experimental","Biological, Drug, Drug",Sequential Assignment,,,,Phase 1
3982,BEX15859,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
3983,waitingroom,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
3984,CP-10-001,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3985,REB16-1463,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,"Phase 2, Phase 3"
3986,2019/2944,Interventional,,Procedure,Single Group Assignment,,,,Not Applicable
3987,PT06-01,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
3988,LCB-1801-001,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
3989,2021-082,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
3990,SPI-POZ-501,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3991,PECS vs SAP,Interventional,"Active Comparator, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
3992,2020-000495-37,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Early Phase 1
3993,2018-0175,Interventional,"Experimental, Active Comparator, Placebo Comparator","Drug, Drug, Other",Parallel Assignment,,,,Phase 2
3994,012018CONTROL,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3995,18232,Observational,,,,Cohort,,Non-Probability Sample,
3996,R19258,Interventional,"Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
3997,2020/03FEV/065,Interventional,"Active Comparator, Experimental, Experimental, Experimental, Other","Device, Other",Parallel Assignment,,,,Not Applicable
3998,2012-001-108,Interventional,"No Intervention, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 4
3999,HREC/74777/Alfred-2021,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
4000,7905,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
4001,ARX788-1711,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4002,BB-1701-101,Interventional,"Other, Experimental, Experimental, Experimental, Experimental",Drug,Single Group Assignment,,,,Phase 1
4003,D9720C00001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4004,69HCL18_0492,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4005,FPX-01-01,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Biological, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4006,XuanWuH-NK,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4007,assuitu faculty of medicine,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
4008,RAPA-201-STP-01,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
4009,HC-404-FCP-2011,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4010,STUDY00015358,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4011,ONCX-NAV-G201,Interventional,"Experimental, Experimental, Experimental","Biological, Biological, Biological",Parallel Assignment,,,,Phase 2
4012,CRUKD/22/002,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
4013,849679,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4014,NM1F-T1-01,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
4015,DCC-2036-01-004,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4016,042201,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4017,OMO-103-01,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4018,213409,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4019,ICO-2020-06,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4020,UC-0101/1709,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
4021,4-2020-0165,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
4022,IRB#56402,Observational,,Other,,Cohort,,Non-Probability Sample,
4023,UW21084,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4024,ZN-A-1041-101-US,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4025,TAEK-VAC-HerBy-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Biological,Sequential Assignment,,,,Phase 1
4026,C4161001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4027,18-27025,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
4028,MORAb-202-G000-201,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4029,19-652,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4030,APHP210583,Observational,,Other,,Cohort,,Probability Sample,
4031,BESTa,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
4032,M19-037,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4033,OSU-21313,Interventional,Experimental,"Behavioral, Other",Single Group Assignment,,,,Not Applicable
4034,SOLTI-1804,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
4035,2020-00256; ch18Weber4,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4036,AN0025S0103,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4037,202202104,Observational,,Other,,Other,,Non-Probability Sample,
4038,Medipol Hospital 9,Interventional,"Active Comparator, Active Comparator, No Intervention","Other, Other",Parallel Assignment,,,,Not Applicable
4039,69HCL18_0369,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
4040,RB-vs-RG-BCS,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
4041,200023,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4042,2019/629,Observational,,Device,,Cohort,,Non-Probability Sample,
4043,CHANCES-IPC 2021-008,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4044,17-694,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4045,AP2207-30110,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Procedure, Procedure, Procedure, Drug",Parallel Assignment,,,,Not Applicable
4046,SLS17-201/MK3475-770,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4047,2015-KAEK-64-22-09,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4048,2022-0329,Interventional,"Other, Other","Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
4049,KE-0254/92/2018,Interventional,"Placebo Comparator, Experimental, Sham Comparator","Procedure, Procedure, Procedure, Procedure, Drug, Drug",Parallel Assignment,,,,Phase 4
4050,FZPL-â¢-301-OC,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4051,G423 Multi TP,Interventional,,Other,Single Group Assignment,,,,Not Applicable
4052,2019-001982-34,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Drug, Other",Parallel Assignment,,,,Phase 3
4053,192004,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,Phase 1
4054,CLODIS,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,,,,Phase 3
4055,Bio2738,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4056,201803061RIND,Interventional,"Active Comparator, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
4057,2021-PrMa-RWiberg,Observational,,,,Cohort,,Non-Probability Sample,
4058,22339,Interventional,"Experimental, Experimental, Placebo Comparator","Drug, Drug, Drug, Other",Parallel Assignment,,,,Early Phase 1
4059,RIPH3-RNI18/NEUROTAX,Observational,,Other,,Cohort,,Probability Sample,
4060,TAS2940-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4061,69HCL20_0346,Observational,,Other,,Case-Control,,Non-Probability Sample,
4062,STM-IRB-22B-001,Interventional,"Experimental, No Intervention","Device, Device",Parallel Assignment,,,,Not Applicable
4063,20252,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4064,21-5539,Interventional,"No Intervention, Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4065,2018-1361,Interventional,"Experimental, Experimental, Experimental","Other, Other, Other",Sequential Assignment,,,,Not Applicable
4066,MC1713,Interventional,Experimental,"Biological, Biological, Procedure",Single Group Assignment,,,,Phase 1
4067,HREBA.CC-18-0028,Interventional,"Experimental, Other",Behavioral,Parallel Assignment,,,,Not Applicable
4068,E-SN@P PROJECT-IPC 2017-029,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4069,PASCA,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4070,H-49731,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4071,CIMS-2019-01,Interventional,"No Intervention, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4072,BrUOG 390,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4073,EC/2018/0315,Interventional,"Other, Other, Other, Other, Other, Other, Other, Other, Other, Other",Procedure,Parallel Assignment,,,,Not Applicable
4074,2021-001624-17,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4075,TJ-IRB20211129,Observational,,,,Other,2 Years,Non-Probability Sample,
4076,XL102-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4077,2018-0004,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4078,Dnr 2019-04151,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4079,GCO 21-0012,Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4080,NIT-110 (KEYNOTE PNA60),Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4081,823981A,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
4082,G-5097-2019,Observational,,,,Case-Only,,Non-Probability Sample,
4083,EAQ161CD,Observational,,Other,,Ecologic or Community,,Non-Probability Sample,
4084,BT-001.01,Interventional,"Experimental, Experimental, Experimental","Biological, Biological",Sequential Assignment,,,,"Phase 1, Phase 2"
4085,Pro00106186,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
4086,Laser treatment,Interventional,"Active Comparator, Sham Comparator, Active Comparator, Sham Comparator, Active Comparator, Sham Comparator, Active Comparator, Sham Comparator","Procedure, Device, Device",Parallel Assignment,,,,Not Applicable
4087,69HCL19_0731,Observational,,Other,,Cohort,,Non-Probability Sample,
4088,GOP,Interventional,"No Intervention, Experimental",Drug,Parallel Assignment,,,,Phase 2
4089,PROICM 2017-05 BAL,Interventional,"Other, Other",Biological,Parallel Assignment,,,,Not Applicable
4090,CE3220.,Interventional,"Active Comparator, Experimental","Device, Other",Parallel Assignment,,,,"Phase 1, Phase 2"
4091,NIMAO/2016/PC-01,Observational,,Other,,Case-Only,,Non-Probability Sample,
4092,IIT-2021-CANINE,Observational,,Biological,,Case-Only,,Probability Sample,
4093,CDKY709A12101C,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4094,19829,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4095,Breast Biopsy,Interventional,"Experimental, Experimental, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
4096,ebeddows,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
4097,2018P000084,Observational,,"Procedure, Device",,Cohort,,Non-Probability Sample,
4098,IRB00167074,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
4099,NIP IT!,Observational,,,,Cohort,,Non-Probability Sample,
4100,IFCT-1703,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4101,Pro00102260,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
4102,19-179,Interventional,"Experimental, Sham Comparator, Other","Other, Other, Other",Parallel Assignment,,,,Phase 2
4103,IRB#21-001169,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4104,PRO 1676,Observational,,Other,,Other,,Probability Sample,
4105,CS001-SA,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4106,RECHMPL22_0024,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4107,00011271,Interventional,Experimental,"Behavioral, Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
4108,METCZ20220056,Interventional,"Experimental, No Intervention",Device,Single Group Assignment,,,,Not Applicable
4109,RC31/17/0350,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
4110,JAB-2485-1001,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4111,69HCL17_0642,Observational,,Other,,Case-Only,,Non-Probability Sample,
4112,213353,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4113,180276,Interventional,"Active Comparator, Experimental, Experimental","Behavioral, Behavioral, Other",Parallel Assignment,,,,Not Applicable
4114,PRT2527-01,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4115,BA3021-001,Interventional,"Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,"Phase 1, Phase 2"
4116,21-369,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4117,2020-05-001B,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
4118,PVMEDCT202201,Observational,,Device,,Cohort,,Probability Sample,
4119,MSK8/22,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
4120,21-192,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4121,13104,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4122,AP2001-50504,Interventional,"Active Comparator, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
4123,SOGUG-2016-A-IEC(PRO)-12,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4124,FMASUMD45/2021,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,"Phase 2, Phase 3"
4125,120134,Interventional,"Experimental, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
4126,SBT6290-101,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4127,CCR5653,Observational,,,,Cohort,,Non-Probability Sample,
4128,Pro00078230,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
4129,18-000948,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
4130,20-08,Interventional,"Other, Other",Device,Single Group Assignment,,,,Not Applicable
4131,HSL 2016-83,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4132,CCR5063,Interventional,Experimental,"Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
4133,FMBSURECS/30042019/Ali,Interventional,"Active Comparator, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
4134,CRYO for Mastectomy (DoD),Interventional,"Active Comparator, Sham Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
4135,Lishui Peoples Hospital,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4136,SHEBA-19-6136-RS-CTIL,Interventional,"Active Comparator, Active Comparator",Combination Product,Sequential Assignment,,,,Phase 1
4137,SAHZhejiangU 123,Observational,,,,Cohort,,Non-Probability Sample,
4138,PT3465,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4139,2021/01159,Interventional,Experimental,"Device, Device, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4140,HAN2014005-CT02,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4141,GS-US-417-5937,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Crossover Assignment,,,,Phase 1
4142,1190532,Observational,,Other,,Cohort,,Probability Sample,
4143,PROACTIVE,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 4
4144,PPP005-Ph2/3-01,Interventional,"Experimental, Placebo Comparator","Radiation, Radiation",Parallel Assignment,,,,Phase 2
4145,IMM2902-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4146,NOX66-005,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Radiation",Sequential Assignment,,,,"Phase 1, Phase 2"
4147,2020/14MAI/273,Interventional,"Active Comparator, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4148,AAAS9968,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4149,METCZ2019016,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4150,BGB-3111-108,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4151,B4T2-PRC-IIT-001,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4152,875351,Interventional,Experimental,Other,Single Group Assignment,,,,Phase 2
4153,CX-839-011,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4154,2017-02028,Observational,,Device,,Cohort,,Probability Sample,
4155,ESG401-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4156,201810102MINC,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 4
4157,JS001-PMS-CO1,Observational,,Drug,,Other,,Non-Probability Sample,
4158,IRB 20-488,Observational,,,,Cohort,,Non-Probability Sample,
4159,Pro00037562,Observational,,,,Cohort,,Non-Probability Sample,
4160,16-010491,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4161,KSCM-CRD-001,Interventional,"Other, Experimental","Device, Other",Parallel Assignment,,,,Not Applicable
4162,829785,Observational,,Other,,Cohort,,Non-Probability Sample,
4163,INT17676,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4164,201707042,Interventional,"Experimental, Experimental",Device,Sequential Assignment,,,,Not Applicable
4165,20221202,Interventional,"Experimental, Experimental, No Intervention","Radiation, Procedure",Parallel Assignment,,,,Not Applicable
4166,GS-US-382-1587,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4167,BRCA-ACP.2022,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4168,GO-1,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Device",Single Group Assignment,,,,Phase 1
4169,GIHSYSU-26,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4170,1237087,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4171,P.T.REC/012/003747,Interventional,"Experimental, Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4172,JK08.1.01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4173,20,Observational,,Other,,Case-Only,,Non-Probability Sample,
4174,Klotho _ LRP-6 _ GC,Observational,,Other,,Cohort,,Non-Probability Sample,
4175,PARPA-293-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4176,Chemobrain Study,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4177,CEP1:4/2016,Interventional,"Experimental, No Intervention",Dietary Supplement,Parallel Assignment,,,,Not Applicable
4178,NC762-01,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4179,17237,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4180,MER-XMT-2056-1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4181,ZL-2306-912 ALTER-OC-02,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
4182,XB002-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4183,209514,Observational,,"Procedure, Procedure, Procedure, Procedure, Other",,Cohort,,Probability Sample,
4184,KlusPharma,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4185,20/PR/0222,Observational,,Genetic,,Cohort,,Probability Sample,
4186,INT 36/18,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4187,JTU-6H-20210227001,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
4188,CASE2117,Interventional,"Active Comparator, Active Comparator, Experimental","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4189,AJIRB-MED-THE-18-236,Interventional,"Experimental, Experimental","Biological, Biological",Single Group Assignment,,,,"Phase 1, Phase 2"
4190,69HCL22_0275,Interventional,Other,Biological,Single Group Assignment,,,,Not Applicable
4191,BTC-HER2,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4192,REPLAMOD,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4193,H-38855,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
4194,P2101,Observational,,Diagnostic Test,,Cohort,10 Years,Non-Probability Sample,
4195,GOUDET 2018,Observational,,Other,,Cohort,,Non-Probability Sample,
4196,4-2019-0648,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4197,2018-03,Observational,,,,Case-Control,,Probability Sample,
4198,TG-iConquerFear,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4199,FF-2018-084,Observational,,Procedure,,Cohort,2 Years,Probability Sample,
4200,TCM-padia001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4201,2018-003115-21,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4202,C/35/2017,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4203,GO43860,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4204,STUDY00023183,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4205,HS-10502-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4206,EC29,Interventional,"Placebo Comparator, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
4207,2021/117,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
4208,Health consortium maresme,Interventional,"Experimental, No Intervention",Other,Sequential Assignment,,,,Not Applicable
4209,201903142,Observational,,,,Cohort,,Non-Probability Sample,
4210,DCC-2036-01-003,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4211,CASE6118,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4212,E-19-3943,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4213,PRO1184-001,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4214,MCART-006,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4215,ONC-392-001,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4216,MC210302,Interventional,Experimental,"Procedure, Procedure, Drug, Procedure",Single Group Assignment,,,,Early Phase 1
4217,2021-04840,Observational,,"Other, Other, Other",,Cohort,,Non-Probability Sample,
4218,BPI-2358-105 phase 3,Interventional,"Active Comparator, Experimental","Drug, Drug, Other, Other",Parallel Assignment,,,,Phase 3
4219,SBT6050-201,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4220,HCC 20-064,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4221,MCART-002,Interventional,Experimental,Biological,Single Group Assignment,,,,Early Phase 1
4222,STUDY00003387,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Phase 2
4223,ARRAY-818-103,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4224,E-19-773,Interventional,"Experimental, Experimental, No Intervention","Other, Other",Parallel Assignment,,,,Not Applicable
4225,LINDA,Observational,,Device,,Cohort,,Probability Sample,
4226,The Swedish DIRECT study,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4227,CARTIER,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
4228,Niraparib-5001,Observational,,,,Cohort,,Non-Probability Sample,
4229,OCOG-2021-ELISA,Observational,,,,Cohort,,Probability Sample,
4230,QSPainRelief-patientCNS,Interventional,Experimental,"Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Other",Single Group Assignment,,,,Not Applicable
4231,Soh-Med-22-09-01,Observational,,Device,,Case-Only,,Probability Sample,
4232,MastoVit150,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 4
4233,B3271007,Observational,,Drug,,Case-Only,,Probability Sample,
4234,Elasto Trial,Interventional,"Active Comparator, Active Comparator","Diagnostic Test, Diagnostic Test",Sequential Assignment,,,,Not Applicable
4235,CKAF156A2104,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Combination Product, Drug, Drug, Drug, Combination Product",Sequential Assignment,,,,Phase 1
4236,N201810002,Interventional,"Other, Experimental, Experimental",Dietary Supplement,Parallel Assignment,,,,Not Applicable
4237,CASE1219,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4238,CHIRCOLREC-IPC 2018-017,Observational,,Other,,Cohort,,Non-Probability Sample,
4239,RELI/19/Der-Rdt/001,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
4240,GS-US-467-5643,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4241,PRO00031416,Interventional,"Experimental, Other",Behavioral,Parallel Assignment,,,,Not Applicable
4242,1407426,Interventional,"Other, Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4243,ONCB-006-19F,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4244,7635,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 2
4245,PRS-343-PCS_08_18,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4246,VAC for HPV,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4247,HCI105691,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Phase 2
4248,70781,Interventional,"Active Comparator, Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
4249,49/20 b,Observational,,Radiation,,Case-Control,,Probability Sample,
4250,NL72939.078.20,Interventional,"Other, Other",Procedure,Parallel Assignment,,,,Not Applicable
4251,AP2007-50104,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
4252,H00020209,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 4
4253,ROR2103,Observational,,"Other, Other, Other",,Cohort,,Non-Probability Sample,
4254,PRO00032593,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4255,KY-2021-012,Observational,,Drug,,Other,1 Year,Non-Probability Sample,
4256,BG01-2002,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4257,Rhomboid,Interventional,"Experimental, Experimental, Sham Comparator","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4258,GC101 TIL-ST-01,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
4259,49/20,Observational,,Radiation,,Case-Control,,Probability Sample,
4260,CEEGOG EX-02,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4261,IM014-032,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 1
4262,OTH267,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
4263,93 /1801/2021,Interventional,"Active Comparator, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4264,2020-3627-1407,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4265,Pro00054854,Observational,,Drug,,Cohort,,Non-Probability Sample,
4266,13022260-300-180785,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
4267,INCB 123667-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4268,BPX603-201A,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4269,2019-0989,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
4270,UCSD IIT 150729,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4271,MF 22-02,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4272,KEEP-G 07,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4273,2021-0611,Interventional,"Other, Other, Other","Drug, Drug",Single Group Assignment,,,,Phase 2
4274,ICO-2020-19,Interventional,"Experimental, Experimental, Experimental",Procedure,Parallel Assignment,,,,Not Applicable
4275,P.T.REC/012/003464,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4276,NU22-09-00539,Interventional,Experimental,"Diagnostic Test, Diagnostic Test, Procedure",Single Group Assignment,,,,Not Applicable
4277,CRUKD/21/004- Treatment Arm 4,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 2, Phase 3"
4278,2019-A03336-51,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
4279,09.2020.125,Interventional,"Active Comparator, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
4280,034-2020,Observational,,,,Cohort,,Non-Probability Sample,
4281,ANAE-341-19,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
4282,20-240,Interventional,"Experimental, Experimental","Radiation, Drug, Other",Parallel Assignment,,,,Phase 2
4283,01-2/141 27,Interventional,"Active Comparator, Active Comparator, Active Comparator",Diagnostic Test,Parallel Assignment,,,,Not Applicable
4284,D8410C00001,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4285,RG1006143,Interventional,Experimental,"Other, Other, Other",Single Group Assignment,,,,Not Applicable
4286,KF2019#1,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug, Drug",Crossover Assignment,,,,Phase 1
4287,Vein-project,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
4288,thoracic sympathectomy,Interventional,"Experimental, Active Comparator","Procedure, Drug",Parallel Assignment,,,,Not Applicable
4289,Debio 1143-106,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4290,457,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
4291,229510,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4292,YS-RVON-001,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4293,Estim Breast,Interventional,"Experimental, Placebo Comparator","Device, Procedure",Single Group Assignment,,,,Not Applicable
4294,228-17-EP,Observational,,,,Cohort,,Non-Probability Sample,
4295,38RC17.291,Observational,,Other,,Case-Control,,Non-Probability Sample,
4296,SNK01-102,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4297,2019-8890,Observational,,Device,,Case-Only,,Non-Probability Sample,
4298,2021-KY-073,Observational,,Procedure,,Cohort,,Probability Sample,
4299,ZL-2306-914,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4300,C4551001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4301,KCSG-ST18-20,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4302,HCC 20-117,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4303,EXGEFATU,Observational,,Genetic,,Cohort,,Probability Sample,
4304,ONT-380-011,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Crossover Assignment,,,,Phase 1
4305,STUDY00000334,Interventional,"Other, No Intervention",Device,Single Group Assignment,,,,Not Applicable
4306,22-501,Interventional,"Experimental, No Intervention, Experimental, Experimental","Other, Other",Factorial Assignment,,,,Not Applicable
4307,OPT-IN Research Protocol,Interventional,,Other,Single Group Assignment,,,,Not Applicable
4308,HEM-ONCO-013,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4309,FESPET,Observational,,Diagnostic Test,,Case-Only,,Non-Probability Sample,
4310,ELVN-002-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4311,OLATRA,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4312,STUDY00002021,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
4313,ILYAD1_2019,Observational,,Other,,Ecologic or Community,,Non-Probability Sample,
4314,FN-1501-UP1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4315,RBN-2397-19-001,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4316,CX-5461-04,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4317,MC16C2,Interventional,"Experimental, Placebo Comparator","Drug, Other, Other, Other",Crossover Assignment,,,,Early Phase 1
4318,2017-A02018-45,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
4319,NL75863.068.21,Interventional,"Experimental, Experimental",Device,Parallel Assignment,,,,Not Applicable
4320,20-009,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4321,919/2020/Oss/IOR,Observational,,"Other, Other",,Case-Control,4 Years,Non-Probability Sample,
4322,PUMCH-NM-11/041,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
4323,ISU104-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug",Parallel Assignment,,,,Phase 1
4324,BLU-222-1101,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4325,60116787-020/34123,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4326,CHUB-Hystocor,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
4327,BR/2019/487,Interventional,"No Intervention, Other, Other",Other,Parallel Assignment,,,,Not Applicable
4328,Shengjing-LJY05,Observational,,Other,,Cohort,,Probability Sample,
4329,ATADEK/2022.11,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4330,Soh-Med-22-09-16,Observational,,,,Other,5 Months,Non-Probability Sample,
4331,BARBEN 2020,Observational,,"Biological, Other",,Cohort,,Non-Probability Sample,
4332,NUV-868-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4333,CHUBX 2015/17,Interventional,"Other, Other",Procedure,Parallel Assignment,,,,Not Applicable
4334,1766419-7,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4335,200155,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Biological, Biological",Sequential Assignment,,,,"Phase 1, Phase 2"
4336,EJC001,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,"Phase 1, Phase 2"
4337,PREDICT,Observational,,,,Case-Only,,Non-Probability Sample,
4338,2021-BRV-004,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4339,436,Interventional,"Experimental, Experimental, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
4340,PHOX-CLI_001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4341,CHU-426,Observational,,Other,,Cohort,,Non-Probability Sample,
4342,A-ER-109-415,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4343,NICSO,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4344,BJK-Z-F18HN-202010-YZGK,Interventional,"Experimental, Active Comparator","Drug, Drug",Crossover Assignment,,,,Phase 3
4345,2-107-05-162,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 4
4346,20.60-onco20.07,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4347,20190131,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4348,IRAS307166,Observational,,Device,,Cohort,,Non-Probability Sample,
4349,YBCSG-21-04,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
4350,SamanRostambeigi,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4351,IRB00095260,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4352,999916161,Observational,,,,Other,,Non-Probability Sample,
4353,IRB00038262,Interventional,"Other, Active Comparator, Active Comparator, Active Comparator, Active Comparator, Active Comparator, Active Comparator, Active Comparator","Drug, Device, Other, Other",Factorial Assignment,,,,"Phase 2, Phase 3"
4354,29BRC18-0005 (VinMetAtezo),Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4355,OPTIMUM,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
4356,4397,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4357,2017-003582-10,Interventional,Experimental,"Drug, Drug, Radiation",Single Group Assignment,,,,Phase 2
4358,R-17-360,Observational,,Radiation,,Cohort,,Non-Probability Sample,
4359,TapeK_Gesso_ABM_PSO,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
4360,1000-1,Observational,,Device,,Cohort,,Non-Probability Sample,
4361,IRB-2019-118,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
4362,BIC4VMR,Observational,,"Other, Other, Other",,Other,,Non-Probability Sample,
4363,20-002000,Interventional,Experimental,"Behavioral, Other, Other, Other",Single Group Assignment,,,,Not Applicable
4364,2017_43,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4365,MT-5111_001,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4366,RGC-1501-001,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4367,19CX5601,Observational,,,,Other,,Probability Sample,
4368,00000001,Interventional,"Experimental, Other",Combination Product,Parallel Assignment,,,,Not Applicable
4369,210026,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4370,2020-1255,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
4371,20-03021615,Interventional,"Other, Other","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
4372,702576,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 4
4373,APHP180576,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
4374,RC2022_prg.15,Interventional,"Experimental, Active Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
4375,UW 19-436,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
4376,IEO 1740,Observational,,,,Other,,Probability Sample,
4377,2000031462,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4378,EDGE 000339,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4379,IMT-009-101,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4380,METCZ20210156,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
4381,CTM-N2D,Interventional,Experimental,Biological,Sequential Assignment,,,,Phase 1
4382,2017/184 HP,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
4383,SGNB7H4V-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4384,2020-3547,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Other",Crossover Assignment,,,,Not Applicable
4385,RTX-224-01,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4386,18.068,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Phase 3
4387,METCZ20210103,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
4388,CP-MGC018-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological",Sequential Assignment,,,,"Phase 1, Phase 2"
4389,Soh-Med-22-03-01,Observational,,,,Other,,Non-Probability Sample,
4390,B.30.2.ATA.0.01.00/1/6,Interventional,"Experimental, Active Comparator","Drug, Device, Drug, Drug",Parallel Assignment,,,,Phase 4
4391,SYSKY-2022-019-02,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
4392,2019-02Obs-CHRMT,Observational,,,,Cohort,,Non-Probability Sample,
4393,CHGH-IRB:(864)110-10,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4394,PROT-CI2021,Interventional,"Experimental, Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
4395,ShuangHoH,Observational,,Device,,Cohort,,Non-Probability Sample,
4396,2021-A01625-36,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
4397,P130935,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4398,2000029793,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4399,794/2020/Farm/IOR,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4400,CMUH109-REC2-101,Observational,,,,Cohort,,Probability Sample,
4401,RNI 2021 LEBRETON 3 (EVIGE),Observational,,,,Case-Control,,Probability Sample,
4402,MER-XMT-1660-1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4403,SBNK-YJ-2020-016-02,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4404,ThirdMMUb,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 2, Phase 3"
4405,STUDY00000224,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4406,2693-CL-0307,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 3
4407,2020NZKY-062-01,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
4408,2021-13614,Interventional,"Experimental, Experimental, No Intervention","Device, Device",Parallel Assignment,,,,Not Applicable
4409,DF1001-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4410,no: P.T.REC/012/002774,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4411,SBNK-YJ-2019-006-02,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4412,1648/2019,Observational,,Drug,,Cohort,6 Months,Non-Probability Sample,
4413,2020/900/88,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4414,2693-CL-0304,Interventional,"Experimental, Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4415,25922,Interventional,Experimental,Other,Sequential Assignment,,,,Not Applicable
4416,RG1001812,Interventional,Experimental,"Dietary Supplement, Procedure, Other",Single Group Assignment,,,,Not Applicable
4417,ZUH-ITP-MBCS,Interventional,"Experimental, Experimental",Drug,Crossover Assignment,,,,Phase 4
4418,CPI-006-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4419,1 TP2AH000076-01-00,Interventional,"Experimental, Sham Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4420,21-007867,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4421,Masters thesis,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4422,HKG-KZ-PRAD-103,Observational,,,,Case-Control,,Probability Sample,
4423,22072,Observational,,Drug,,Cohort,,Non-Probability Sample,
4424,PET/CT in malignancy,Observational,,Radiation,,Cohort,,Probability Sample,
4425,2693-CL-0305,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4426,2021-A01570-41,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4427,2693-CL-0302,Interventional,"Experimental, Experimental, Placebo Comparator, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
4428,2693-CL-0301,Interventional,"Placebo Comparator, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
4429,AssiutNT,Observational,,"Behavioral, Procedure",,Case-Only,,Probability Sample,
4430,PUMCH-NM-RR,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Single Group Assignment,,,,Early Phase 1
4431,IX-2021-DS-LEARN,Observational,,,,Cohort,,Non-Probability Sample,
4432,HKG-Bng-HCC-100,Observational,,Diagnostic Test,,Case-Control,,Non-Probability Sample,
4433,Pro00101102,Observational,,Other,,Cohort,,Non-Probability Sample,
4434,1-1-7-05-114,Interventional,"Experimental, No Intervention",Radiation,Parallel Assignment,,,,Not Applicable
4435,NCI-2020-01206,Interventional,Experimental,"Procedure, Procedure, Procedure, Procedure, Biological",Single Group Assignment,,,,Phase 1
4436,NL66650.041.18,Observational,,Radiation,,Cohort,2 Years,Non-Probability Sample,
4437,HALO Dx 001,Observational,,Other,,Cohort,,Non-Probability Sample,
4438,ALXN2040-HV-102,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
4439,21083,Interventional,Experimental,Other,Sequential Assignment,,,,Not Applicable
4440,STUDY00144314,Interventional,"Active Comparator, Experimental",Behavioral,Single Group Assignment,,,,Not Applicable
4441,19-068,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4442,69HCL21_0409,Interventional,"Experimental, Active Comparator","Other, Other, Other, Behavioral, Behavioral, Behavioral, Behavioral, Behavioral, Behavioral, Behavioral, Other",Parallel Assignment,,,,Not Applicable
4443,D8532C00003,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
4444,HSC-SPH-20-1117,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4445,UC-0107/1603,Interventional,"Experimental, No Intervention",Radiation,Parallel Assignment,,,,Not Applicable
4446,C4391001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Combination Product, Combination Product, Drug, Combination Product",Sequential Assignment,,,,Phase 1
4447,AK_2021_HP,Interventional,Experimental,"Drug, Drug, Procedure",Single Group Assignment,,,,Phase 2
4448,ICO-2020-14,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral, Drug",Parallel Assignment,,,,Not Applicable
4449,20-2458.cc,Interventional,"No Intervention, Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4450,659/2017BO1,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Radiation, Diagnostic Test",Single Group Assignment,,,,Not Applicable
4451,XL092-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4452,844554,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
4453,GCT1047-01,Interventional,Experimental,Biological,Sequential Assignment,,,,"Phase 1, Phase 2"
4454,SYSU_AI01,Observational,,,,Cohort,2 Years,Non-Probability Sample,
4455,B2017-113R,Observational,,Diagnostic Test,,Case-Control,3 Years,Non-Probability Sample,
4456,GCT1029-01,Interventional,Experimental,Biological,Sequential Assignment,,,,"Phase 1, Phase 2"
4457,PH-FAPGA-01/22,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
4458,HEALED_CPS3,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4459,FPA150-001,Interventional,Experimental,"Biological, Biological",Single Group Assignment,,,,Early Phase 1
4460,STU-2019-0522,Observational,,,,Cohort,,Probability Sample,
4461,PY314-1-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4462,PJ-KS-KY-2019-134,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
4463,DMT-2019.002,Observational,,Device,,Case-Control,,Probability Sample,
4464,DMT-2019.001,Observational,,Device,,Case-Control,,Probability Sample,
4465,LAUMCRH.YJ1.16/Jul/2019,Interventional,"Active Comparator, Experimental",Drug,Parallel Assignment,,,,Phase 4
4466,CASE7Y16,Observational,,Device,,Cohort,,Probability Sample,
4467,AD10,Observational,,Diagnostic Test,,Case-Control,1 Month,Probability Sample,
4468,1474/19,Interventional,"Active Comparator, Sham Comparator","Procedure, Procedure, Other",Parallel Assignment,,,,Phase 2
4469,CNZV930X2101,Interventional,"Experimental, Experimental, Experimental, Experimental","Other, Other, Drug",Parallel Assignment,,,,Phase 1
4470,TirolGESUND,Interventional,"Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4471,69HCL19_0992,Interventional,Other,Behavioral,Single Group Assignment,,,,Not Applicable
4472,2018-0075,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
4473,R20-3896L,Interventional,"Experimental, Sham Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4474,201805930,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4475,12345,Interventional,"Placebo Comparator, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4476,LOCAL/2020/DR-01,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
4477,PJ-KS-KY-2019-135,Observational,,,,Cohort,,Non-Probability Sample,
4478,IRB-300003680,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Early Phase 1
4479,HSC-MS-16-0467,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
4480,2021/03-12,Interventional,"Active Comparator, No Intervention",Procedure,Crossover Assignment,,,,Not Applicable
4481,D0817R00010,Observational,,,,Cohort,,Non-Probability Sample,
4482,201610,Observational,,,,Case-Control,,Non-Probability Sample,
4483,VAR-2021-12,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4484,WVU010518,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
4485,XmAb22841-01,Interventional,"Experimental, Experimental","Biological, Biological",Sequential Assignment,,,,Phase 1
4486,NUSMart NM,Interventional,"No Intervention, Experimental, Experimental","Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
4487,PREDAPT,Observational,,Diagnostic Test,,Case-Only,,Probability Sample,
4488,SC103,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4489,ACE1702-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4490,RG1005815,Interventional,"Active Comparator, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
4491,RP12146-2101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4492,HH-PRT-0001,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
4493,MP01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4494,RG1005140,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,Phase 1
4495,BT8009-100,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4496,00003543,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4497,AD07,Observational,,Diagnostic Test,,Case-Control,1 Month,Probability Sample,
4498,STUDY00018000,Interventional,"Experimental, Experimental, Experimental","Behavioral, Behavioral, Other, Other",Parallel Assignment,,,,Not Applicable
4499,5688,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
4500,OSU-19199,Interventional,Experimental,"Procedure, Other, Device",Single Group Assignment,,,,Not Applicable
4501,HN20190929,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4502,KB-0742-1001,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4503,21820,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4504,GQ1001X2101,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4505,NL 70691.091.19,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4506,NCI-2017-01232,Interventional,Experimental,"Drug, Other, Other, Drug",Single Group Assignment,,,,Phase 1
4507,ORM-5029-01-001,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4508,PRT3645-01,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4509,NCH04-2020,Observational,,"Radiation, Diagnostic Test",,Case-Control,,Non-Probability Sample,
4510,BakircayU/D208,Observational,,,,Cohort,,Non-Probability Sample,
4511,RG1121550,Interventional,Experimental,"Other, Other, Behavioral",Single Group Assignment,,,,Not Applicable
4512,HMBD-002-V4C26-01,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4513,123glioma,Observational,,,,Cohort,,Non-Probability Sample,
4514,AP1904-50102,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 4
4515,TJ004309STM103,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4516,KYL[2020091],Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
4517,GCT1044-01,Interventional,Experimental,Biological,Sequential Assignment,,,,"Phase 1, Phase 2"
4518,SZMC-0216-22,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
4519,7465-CL-202,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4520,ELU-FRÎ±-1,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4521,2000028592,Observational,,,,Cohort,,Non-Probability Sample,
4522,IMP7068 - 101,Interventional,Other,Drug,Sequential Assignment,,,,Phase 1
4523,D0818R00008,Observational,,Other,,Cohort,,Non-Probability Sample,
4524,SGNPDL1V-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4525,101,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 1
4526,D17062,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
4527,SAIL-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
4528,PREFER,Observational,,Diagnostic Test,,Cohort,2 Years,Probability Sample,
4529,22/006-P,Observational,,,,Other,1 Month,Non-Probability Sample,
4530,ASN004-101,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4531,C3881001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4532,TT420X1103,Interventional,"Experimental, Experimental, Experimental","Drug, Combination Product",Parallel Assignment,,,,"Phase 1, Phase 2"
4533,M18HAR,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
4534,20-458,Observational,,Other,,Cohort,,Non-Probability Sample,
4535,RP2-001-18,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological",Sequential Assignment,,,,Phase 1
4536,STUDY00020679,Interventional,Experimental,"Procedure, Procedure, Biological, Drug, Biological, Biological, Drug, Drug, Biological, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Other",Single Group Assignment,,,,Phase 2
4537,8259,Observational,,,,Cohort,,Probability Sample,
4538,21-508,Interventional,"Experimental, Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4539,M20COM,Observational,,Other,,Cohort,10 Years,Non-Probability Sample,
4540,CPG-01-001,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4541,S1714,Observational,,"Drug, Other, Other",,Cohort,,Non-Probability Sample,
4542,TJCC-LC-20190108,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 4
4543,2000026840,Interventional,Experimental,"Drug, Drug, Combination Product",Single Group Assignment,,,,Phase 2
4544,INCB 106385-102,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4545,2020/2706,Observational,,,,Cohort,,Probability Sample,
4546,GCT1046-01,Interventional,"Experimental, Experimental","Biological, Biological, Biological, Biological",Sequential Assignment,,,,"Phase 1, Phase 2"
4547,127-CL-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Combination Product, Combination Product",Sequential Assignment,,,,Phase 1
4548,Pro00077309,Observational,,,,Ecologic or Community,,Non-Probability Sample,
4549,Oncoplastic breast surgeries,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4550,105909,Observational,,,,Cohort,,Probability Sample,
4551,KY1044-CT01,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4552,UAB30,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4553,MCC-20086,Interventional,"No Intervention, Experimental, No Intervention",Behavioral,Sequential Assignment,,,,Not Applicable
4554,XmAb20717-01,Interventional,Experimental,Biological,Sequential Assignment,,,,Phase 1
4555,PBC017,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4556,NCI-2018-01375,Observational,,Procedure,,Cohort,,Non-Probability Sample,
4557,19ON033,Observational,,"Behavioral, Procedure, Procedure",,Case-Control,,Non-Probability Sample,
4558,NCI-2017-01979,Interventional,Experimental,"Drug, Biological, Other, Biological, Other",Single Group Assignment,,,,"Phase 1, Phase 2"
4559,Pro20170001392,Interventional,Experimental,"Other, Biological",Single Group Assignment,,,,Phase 2
4560,A005D-E01-201,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4561,Parameters of resistence,Observational,,Drug,,Cohort,3 Months,Probability Sample,
4562,A212102,Observational,,"Other, Procedure",,Case-Control,,Non-Probability Sample,
4563,TAP_Sett17,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
4564,CPO-100-US-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4565,20-117,Interventional,"Experimental, Experimental, Other","Radiation, Radiation, Other, Other",Parallel Assignment,,,,Phase 2
4566,IRB00058758,Observational,,"Other, Other, Other",,Cohort,,Probability Sample,
4567,19-002006,Interventional,Experimental,"Procedure, Other, Other, Other",Single Group Assignment,,,,Early Phase 1
4568,Plasticity Longitudinal cANcer,Interventional,"Experimental, Experimental, Experimental",Biological,Parallel Assignment,,,,Not Applicable
4569,2021-025,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4570,ST101-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4571,ATRC-101-A01,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological, Drug",Sequential Assignment,,,,Phase 1
4572,190143,Interventional,Experimental,"Drug, Drug, Drug, Biological",Single Group Assignment,,,,Phase 2
4573,CYT-0851-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4574,MC210102,Interventional,Experimental,"Drug, Biological, Biological, Biological",Single Group Assignment,,,,Phase 1
4575,NCI-2020-13883,Interventional,Experimental,"Drug, Biological",Single Group Assignment,,,,Phase 1
4576,TT00420CN04,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4577,2021-0299,Interventional,"Experimental, Experimental","Biological, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 1
4578,ONCR-177-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 1
4579,SGNSTNV-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4580,17573,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4581,ACE-Pan tumor-02,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4582,SKL27969C001,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4583,2019-0239,Observational,,"Other, Other, Other",,Cohort,,Non-Probability Sample,
4584,HCC 20-266,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
4585,17364,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4586,FT500-101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4587,NCI-2020-06906,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,,,,Phase 2
4588,D9090C00003,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4589,180043,Observational,,,,Cohort,,Non-Probability Sample,
4590,INT 48/21,Observational,,Other,,Case-Control,,Probability Sample,
4591,IDE161-001,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4592,AK2018_1,Interventional,Experimental,"Drug, Other",Single Group Assignment,,,,Phase 1
4593,FT536-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Combination Product, Combination Product, Combination Product, Combination Product, Combination Product, Combination Product, Combination Product, Drug",Sequential Assignment,,,,Phase 1
4594,IIBSP-ECV-2019-103,Observational,,,,Case-Control,,Non-Probability Sample,
4595,DV001,Observational,,"Diagnostic Test, Behavioral",,Cohort,,Probability Sample,
4596,STUDY00000719,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Sequential Assignment,,,,Not Applicable
4597,JZP712-201,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4598,TMPS-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4599,CancerDyads,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4600,CCI-2003,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4601,SGNB6A-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4602,2020-0439,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4603,XmAb23104-01,Interventional,"Experimental, Experimental","Biological, Biological",Sequential Assignment,,,,Phase 1
4604,00000441,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4605,MLB-PK-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
4606,20-410,Interventional,"Experimental, Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4607,NB-ND021 (NM21-1480)-101,Interventional,Experimental,Biological,Sequential Assignment,,,,"Phase 1, Phase 2"
4608,CYH33-G102,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4609,202101,Interventional,"Experimental, Other","Behavioral, Device",Crossover Assignment,,,,Not Applicable
4610,SBT6050-101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4611,17-262-01,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
4612,UC-IMM-2101,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 3
4613,ADCT-301-103,Interventional,"Experimental, Experimental, Experimental","Drug, Biological",Sequential Assignment,,,,Phase 1
4614,TPST-1120-001,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4615,170177,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 2
4616,180032,Interventional,"Experimental, Experimental","Biological, Biological, Biological",Sequential Assignment,,,,Phase 1
4617,VICC SUPP 2112,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4618,A9001502,Interventional,Other,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
4619,NCI-2020-05428,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4620,2020-117,Interventional,"Other, Other, Other","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4621,6B-20-1,Interventional,Experimental,"Procedure, Drug, Procedure, Procedure",Single Group Assignment,,,,Early Phase 1
4622,IB2022-03,Interventional,"Experimental, No Intervention",Other,Sequential Assignment,,,,Not Applicable
4623,PR148/21,Interventional,"Experimental, Active Comparator","Radiation, Procedure",Parallel Assignment,,,,Not Applicable
4624,2021-0175,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
4625,NRG-BN009,Interventional,"Experimental, Active Comparator","Drug, Other, Other, Radiation, Radiation",Parallel Assignment,,,,Phase 3
4626,TCR2-21-01,Interventional,Experimental,"Biological, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
4627,CCT303-406-mST01,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4628,2018-01,Observational,,Other,,Cohort,,Non-Probability Sample,
4629,NCI-2020-05956,Interventional,Experimental,"Procedure, Drug, Procedure, Procedure, Biological",Single Group Assignment,,,,Phase 1
4630,CA052-002,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4631,Pro9646,Observational,,"Other, Other, Other, Other",,Case-Control,,Non-Probability Sample,
4632,IMX-110-001,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4633,WPH 2201,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4634,IIR 17-127,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4635,02-MX-003,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
4636,2019-1091,Interventional,Experimental,"Drug, Drug, Other",Single Group Assignment,,,,"Phase 1, Phase 2"
4637,XmAb808-01,Interventional,Experimental,"Biological, Biological",Sequential Assignment,,,,Phase 1
4638,IRB20-0462,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
4639,INT156-19,Observational,,Drug,,Cohort,,Non-Probability Sample,
4640,VAR-2022-04,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4641,NYPC ERC# 2019-002,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, No Intervention",Radiation,Single Group Assignment,,,,Not Applicable
4642,Phase 1 SV-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4643,TTX-080-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4644,0752-20-HMO,Interventional,Experimental,"Drug, Drug, Biological, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
4645,OCEL-01,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
4646,P.T.REC/012/003744,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
4647,P.T.REC/012/004199,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
4648,Doaa Atef,Interventional,"Active Comparator, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
4649,09.2018.466,Observational,,Diagnostic Test,,Other,,Probability Sample,
4650,NuTide:303,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4651,ILBS-VASMPCa-103,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4652,NU04,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4653,IC 2020-11_ALCINA4,Interventional,"Other, Other, Other, Other","Other, Other",Parallel Assignment,,,,Not Applicable
4654,AMT-151-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4655,MDNA11-01,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4656,SGNTGT-001,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4657,STUDY00001436,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
4658,PT199X1101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4659,IB2022-02,Observational,,,,Cohort,,Non-Probability Sample,
4660,GB1275-1101 (KEYNOTE-A36),Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4661,INCAGN 2385-101,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4662,IB 2017-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4663,INCAGN 2390-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4664,20430,Interventional,"Active Comparator, Experimental, Experimental","Other, Other, Other, Procedure, Other",Parallel Assignment,,,,Not Applicable
4665,IRB00092505,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Sequential Assignment,,,,Not Applicable
4666,STUDY00015588,Interventional,Experimental,"Drug, Drug, Drug, Biological, Drug, Procedure, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Biological, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Biological, Drug, Drug, Drug, Drug, Drug, Drug, Biological, Drug, Drug, Drug, Drug, Biological, Biological, Drug, Other, Drug, Drug, Drug, Drug, Drug, Drug, Biological, Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
4667,NX-1607-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4668,0S-17-4,Observational,,"Other, Other",,Case-Only,,Non-Probability Sample,
4669,GLP-CDK-1009,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4670,Teleclub_cam,Interventional,"Experimental, No Intervention",Other,Crossover Assignment,,,,Not Applicable
4671,AS-IRB-BM-17056,Observational,,,,Cohort,4 Years,Probability Sample,
4672,HZDH20-002,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 1
4673,Pro00100029,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
4674,2022-0712,Interventional,"No Intervention, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
4675,2018-0439,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4676,2020-0079-E,Interventional,"Experimental, Other","Other, Behavioral",Parallel Assignment,,,,Not Applicable
4677,GIMI-IRB-20004,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4678,CR109080,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
4679,EOC317X1101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4680,IRB00056774,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
4681,EAQ202,Interventional,"Other, Other",Other,Parallel Assignment,,,,Early Phase 1
4682,10000045,Interventional,Experimental,"Drug, Drug, Biological, Drug",Single Group Assignment,,,,Phase 1
4683,SYNERGY-AI,Observational,,Other,,Cohort,36 Months,Non-Probability Sample,
4684,V937-013,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4685,19-006717,Interventional,Experimental,"Procedure, Other",Single Group Assignment,,,,Not Applicable
4686,ATLAS-101,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4687,19-151,Interventional,"No Intervention, Active Comparator",Behavioral,Parallel Assignment,,,,Not Applicable
4688,H19-04010,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4689,F/N-R19-3893L,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
4690,21-00715,Interventional,"Active Comparator, Active Comparator, Placebo Comparator","Drug, Drug, Other",Parallel Assignment,,,,Phase 3
4691,TAC01-HER2-03,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4692,UW17009,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Radiation",Single Group Assignment,,,,Early Phase 1
4693,UMCC 2021.076,Interventional,"Active Comparator, Experimental, Experimental","Other, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4694,Adela-EDMRD-001,Observational,,,,Case-Control,,Non-Probability Sample,
4695,CRUKD/21/005,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4696,IPO/PI134,Interventional,"Experimental, Experimental, Other","Behavioral, Behavioral, Other",Parallel Assignment,,,,Not Applicable
4697,YXLL-KY-2022(057),Interventional,"Active Comparator, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4698,ISI dV Xi-NSM,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4699,16712,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4700,HREBA.CC-20-0098,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4701,Cancer Genetic Counseling.PSI,Observational,,Other,,Cohort,,Non-Probability Sample,
4702,IMM2520-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4703,17493,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4704,OM-GRPR-02,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4705,LOXO-IDH-20002,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
4706,1,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4707,PACT-0101,Interventional,"Experimental, Experimental, Experimental","Biological, Biological, Biological",Sequential Assignment,,,,Phase 1
4708,11190071,Observational,,,,Cohort,3 Months,Non-Probability Sample,
4709,1623168,Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4710,PROICM 2021-05 SER,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
4711,IRB-300002068,Interventional,"Experimental, Experimental, Experimental","Behavioral, Other, Other, Other",Parallel Assignment,,,,Not Applicable
4712,0000-0001-5580-7256,Interventional,"Experimental, No Intervention",Other,Crossover Assignment,,,,Not Applicable
4713,2017-0319,Interventional,Experimental,"Procedure, Procedure, Radiation, Radiation, Procedure, Procedure",Single Group Assignment,,,,Phase 1
4714,TRV-003,Observational,,,,Cohort,,Probability Sample,
4715,ATOS-016R,Interventional,"Placebo Comparator, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
4716,HSP70CTC,Observational,,Diagnostic Test,,Cohort,3 Months,Probability Sample,
4717,Pro00104093,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4718,VNC-236-101,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4719,Metabolic Cancer 001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 3
4720,19-000756,Interventional,Experimental,"Procedure, Radiation, Radiation, Procedure, Radiation",Single Group Assignment,,,,Early Phase 1
4721,7339-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4722,2018-001744-62,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
4723,20-533,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4724,19-011472,Interventional,Experimental,"Procedure, Other, Other, Other",Single Group Assignment,,,,Phase 1
4725,D9950C00001,Interventional,"Experimental, Experimental","Drug, Biological",Sequential Assignment,,,,Phase 1
4726,7684A-005,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
4727,2017-0719,Interventional,Experimental,"Drug, Biological, Drug",Single Group Assignment,,,,Phase 1
4728,1801,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
4729,MOHCCN-O,Observational,,,,Cohort,,Non-Probability Sample,
4730,STU00209558,Observational,,Device,,Cohort,,Non-Probability Sample,
4731,IJB-IRAES-2020,Interventional,,Drug,Single Group Assignment,,,,Phase 2
4732,IRB00229163,Interventional,"Other, Other, Other","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4733,ON-1002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4734,SGN47M-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4735,TP-CA-001,Observational,,Other,,Cohort,,Non-Probability Sample,
4736,NTI1GSA,Interventional,"Experimental, Experimental, Experimental","Biological, Drug",Sequential Assignment,,,,Phase 1
4737,P-MUC1C-ALLO1-001,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Drug",Sequential Assignment,,,,Phase 1
4738,FT538-102,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Combination Product, Combination Product",Sequential Assignment,,,,Phase 1
4739,CBX-12-101,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4740,H-43405 VISTA,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4741,202211038RINA,Observational,,,,Case-Control,5 Years,Non-Probability Sample,
4742,OHSN-REB#20170381-01H,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4743,20201421,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4744,QUILT-2.025,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4745,ZZTIL-012,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4746,YSCH-01-0000,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
4747,SNB101P01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4748,1224/2018,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
4749,438-IO-101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4750,831-IO-101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
4751,BHP0120,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Phase 2
4752,CDX527-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4753,HREBA.CC-22-0196,Observational,,,,Family-Based,,Non-Probability Sample,
4754,Meet-URO 12,Interventional,"Experimental, Other","Drug, Other",Parallel Assignment,,,,Phase 2
4755,NC318-01,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4756,STR-004-001,Interventional,"Other, Other, Other, Other, Other","Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
4757,Pro00103249,Interventional,"Experimental, Active Comparator",Behavioral,Crossover Assignment,,,,Not Applicable
4758,180049,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Biological, Drug",Parallel Assignment,,,,Phase 2
4759,21850,Interventional,"Experimental, Experimental, Experimental, Experimental","Device, Drug, Drug",Parallel Assignment,,,,Phase 1
4760,ARC-5 (AB928CSP0005),Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4761,AVS4TL - 0921,Observational,,,,Other,,Probability Sample,
4762,201809177,Interventional,"Experimental, Active Comparator",Device,Parallel Assignment,,,,Phase 2
4763,IIT2020-24-SHIRAZIP-BURN,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4764,2020-2110,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
4765,PY159-2-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4766,C3651010,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Sequential Assignment,,,,Phase 1
4767,Palliach,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
4768,DPM401,Observational,,,,Cohort,,Non-Probability Sample,
4769,BR-DTX-OS-401,Observational,,,,Cohort,,Non-Probability Sample,
4770,TAK-500-1001,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4771,PRT1419-02,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4772,IIT2020-13-GRESHAM-ELLY,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4773,2018-0663,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,,,,Phase 1
4774,APHP190973,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
4775,C3441037,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Crossover Assignment,,,,Phase 1
4776,143631,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4777,CE 07-14-2020,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
4778,ELVCAP-001-01,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4779,202100484,Observational,,Procedure,,Cohort,,Probability Sample,
4780,ZZITICI-004,Interventional,"Experimental, Active Comparator",Drug,Parallel Assignment,,,,"Phase 2, Phase 3"
4781,QBS-72S-1001,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4782,MX-011-219,Observational,,,,Cohort,,Non-Probability Sample,
4783,DB-1303-O-1001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4784,2440LM-002,Interventional,"Experimental, Experimental, Experimental",Biological,Sequential Assignment,,,,Phase 1
4785,VISTA-101,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4786,ZZICI3-015,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4787,ALS-6000-101,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4788,AA1809,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4789,PMV-586-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4790,AMXT1501-102,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4791,201909133,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4792,ROOT,Observational,,"Diagnostic Test, Drug, Other",,Cohort,5 Years,Non-Probability Sample,
4793,R231-A14057,Observational,,Genetic,,Other,6 Months,Non-Probability Sample,
4794,FPI-1966-101,Interventional,"Experimental, Experimental","Drug, Drug, Biological",Sequential Assignment,,,,"Phase 1, Phase 2"
4795,MYCT001,Observational,,,,Case-Only,,Non-Probability Sample,
4796,JAB-3312-1002,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4797,707-IO-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Factorial Assignment,,,,"Phase 1, Phase 2"
4798,UW18101,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Phase 3
4799,JAB-3312-1001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4800,PAL-E602-001,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological",Sequential Assignment,,,,"Phase 1, Phase 2"
4801,05-2019,Observational,,Other,,Cohort,,Non-Probability Sample,
4802,PRO17070414,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4803,340-74,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4804,MFLeong,Interventional,"Experimental, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4805,MAPreminder1,Interventional,"No Intervention, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4806,1100,Interventional,Experimental,"Drug, Radiation, Drug, Drug",Sequential Assignment,,,,Phase 1
4807,MAPinitial,Interventional,"Experimental, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4808,MAPreminder2,Interventional,"No Intervention, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4809,G190165,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4810,JSKN003-102,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4811,56160922.7.3001.5274,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
4812,RAIN-3202,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4813,PN #1082409C,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
4814,A222001,Interventional,"Experimental, Experimental, Placebo Comparator, Placebo Comparator","Drug, Drug, Other, Other",Crossover Assignment,,,,Phase 2
4815,CH1701,Interventional,"Placebo Comparator, Placebo Comparator, Active Comparator, Placebo Comparator, Placebo Comparator, Placebo Comparator, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4816,D0816C00020,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 3
4817,K01CA190659,Interventional,"Active Comparator, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
4818,UW19-183,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4819,TOS-358-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4820,202006168,Interventional,"No Intervention, Experimental",Other,Sequential Assignment,,,,Not Applicable
4821,2011P002580-207,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
4822,EK 1612/2018,Interventional,"Other, Other",Procedure,Parallel Assignment,,,,Not Applicable
4823,SI-B003-101,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4824,PROT004,Interventional,"Active Comparator, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
4825,FT-003,Observational,,Genetic,,Case-Only,,Non-Probability Sample,
4826,BO41929,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4827,STUDY00020629,Interventional,Other,"Procedure, Other, Other, Other",Single Group Assignment,,,,Not Applicable
4828,IRB202201399 -N-R,Interventional,"Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
4829,FLX475-02,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4830,2019-A02135-52,Interventional,"Other, Other, Other, Other, Other, Other, Other, Other",Genetic,Single Group Assignment,,,,Phase 2
4831,18-504,Interventional,Other,Behavioral,Single Group Assignment,,,,Not Applicable
4832,DB-1305-O-1001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4833,TAS0612-101,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,,,,Phase 1
4834,IIT2021-07-Atkins-CARMA,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4835,1948-CL-0101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4836,CO-338-100,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4837,NRG-GU006,Interventional,"Placebo Comparator, Experimental","Drug, Radiation, Other",Parallel Assignment,,,,Phase 2
4838,E7766-G000-101,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4839,BBI-20201001,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4840,SAHoWMU-CR2021-02-404,Observational,,Other,,Cohort,1 Day,Probability Sample,
4841,ZWI-ZW49-101,Interventional,Experimental,Drug,Parallel Assignment,,,,Phase 1
4842,BVAC-B-P1,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4843,19-011444,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
4844,IDE397-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4845,MDK-703-102,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4846,ATTCK-34-01,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,Phase 1
4847,BDTX-189-01,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4848,DB-1310-O-1001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4849,NRG-GU009,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Other, Other, Radiation, Drug",Parallel Assignment,,,,Phase 3
4850,7101,Observational,,,,Cohort,,Non-Probability Sample,
4851,17504,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4852,DGD-44-065,Interventional,"Experimental, Experimental, Other","Procedure, Procedure, Procedure, Procedure, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
4853,22-OBU-SH-CA-II-019,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
4854,20220586-01H,Interventional,"Experimental, No Intervention",Diagnostic Test,Parallel Assignment,,,,Not Applicable
4855,D8532C00004,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4856,CLIN-17-008,Interventional,"Other, Other, Other, Other",Device,Single Group Assignment,,,,Not Applicable
4857,200-04,Observational,,Procedure,,Cohort,,Non-Probability Sample,
4858,01GS,Observational,,,,Cohort,,Non-Probability Sample,
4859,Ad-p53-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4860,TUMAGNOSTIC(CP506-001),Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4861,20210104,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4862,217228,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4863,FT516-102,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4864,19-110,Observational,,"Other, Other",,Cohort,,Non-Probability Sample,
4865,IMC-F106C-101,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4866,TK-Onko,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4867,Pro00103812,Interventional,"No Intervention, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 2
4868,17894,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4869,M19-345,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4870,21-00072,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
4871,UW21090,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4872,18-222,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4873,20246,Interventional,"Experimental, Experimental","Drug, Drug",Crossover Assignment,,,,Phase 1
4874,17-01135,Observational,,Other,,Family-Based,,Probability Sample,
4875,4830-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Biological",Parallel Assignment,,,,Phase 1
4876,2020-002766-14,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
4877,2019-00134,Observational,,,,Cohort,,Non-Probability Sample,
4878,AG0315OG/CTC0140,Interventional,"Experimental, Active Comparator","Drug, Biological, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
4879,201617079.3,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
4880,63646,Interventional,"Active Comparator, Experimental","Other, Behavioral",Parallel Assignment,,,,Not Applicable
4881,19-007,Observational,,"Behavioral, Behavioral, Behavioral, Behavioral, Behavioral, Behavioral",,Cohort,,Probability Sample,
4882,2018-01B,Observational,,Other,,Cohort,,Non-Probability Sample,
4883,IOSI-COVID19-001,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
4884,C4221015,Interventional,"Experimental, Experimental, Experimental, Experimental, Active Comparator, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
4885,ARRAY-818-202,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4886,03.CP.0.3,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4887,0482-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4888,Ordu55,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
4889,ORDU551,Interventional,"Other, Other, Other, Other","Other, Other, Other, Other",Crossover Assignment,,,,Not Applicable
4890,GO42144,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4891,GOG-8030,Observational,,"Procedure, Other, Other",,,,Non-Probability Sample,
4892,ONO-4059-09,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
4893,19741,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4894,LCH-112020,Interventional,,Procedure,Single Group Assignment,,,,Phase 2
4895,JTX-8064-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4896,18HLGENE03,Observational,,Genetic,,Ecologic or Community,1 Day,Non-Probability Sample,
4897,IBC0966-I/IIa,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Biological,Sequential Assignment,,,,"Phase 1, Phase 2"
4898,"019/026/ICI, CEI/1330/18",Interventional,"Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
4899,HP-00070946,Interventional,"Other, Experimental, Experimental","Behavioral, Other, Behavioral",Parallel Assignment,,,,Not Applicable
4900,FGCL-4592-898,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4901,2000034075,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4902,CR108454,Observational,,Other,,Cohort,,Non-Probability Sample,
4903,APHP180586,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4904,T30-0002,Interventional,Experimental,Device,Single Group Assignment,,,,"Phase 1, Phase 2"
4905,CAMH2_1001,Interventional,Experimental,Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4906,NCI-2020-07841,Interventional,Experimental,"Procedure, Procedure, Drug, Biological",Single Group Assignment,,,,Phase 1
4907,CIRB Ref. No: 2019/2135,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Phase 2
4908,Nigeria World Cancer Walk 2022,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4909,S60857,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4910,WP-2021-03,Observational,,Other,,Cohort,,Probability Sample,
4911,RPCR-breast 01,Observational,,Radiation,,Case-Only,5 Years,Non-Probability Sample,
4912,MO19/127559,Observational,,,,Cohort,,Probability Sample,
4913,NRG-HN010,Interventional,"Active Comparator, Experimental","Drug, Other, Biological, Biological",Parallel Assignment,,,,Phase 2
4914,D081SC00001Sub,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4915,D081SC00001,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4916,FatebenefratelliH,Observational,,"Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",,Case-Only,5 Years,Non-Probability Sample,
4917,2019P001434-2,Observational,,,,Other,,Non-Probability Sample,
4918,H18-02052,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Device, Device, Device, Device",Parallel Assignment,,,,Not Applicable
4919,REG-114-2019,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
4920,PRO00104179,Interventional,"Experimental, Experimental","Behavioral, Behavioral, Behavioral",Sequential Assignment,,,,Not Applicable
4921,20-0270-E,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
4922,SJHH_PSPM,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4923,823871-iGame,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4924,2018-0419,Interventional,"Experimental, Experimental, Active Comparator","Genetic, Genetic, Genetic",Parallel Assignment,,,,Early Phase 1
4925,2019-00965,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4926,COALESE/2021/103,Interventional,"Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4927,BC 09915,Observational,,Device,,Cohort,,Non-Probability Sample,
4928,7013,Observational,,,,Cohort,,Non-Probability Sample,
4929,2017_71,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4930,22-200,Observational,,Other,,Cohort,20 Years,Probability Sample,
4931,PYC001,Interventional,"Experimental, Experimental, Experimental, Experimental","Dietary Supplement, Dietary Supplement, Dietary Supplement, Dietary Supplement",Crossover Assignment,,,,Not Applicable
4932,22-01516,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4933,2U01HG007292-05,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4934,CTMS# 19-0069,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
4935,E2019453,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4936,20201224,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
4937,21-103,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Early Phase 1
4938,ABCSG C08,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
4939,CASE1121,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4940,PCA001,Interventional,,"Biological, Biological",Single Group Assignment,,,,"Phase 1, Phase 2"
4941,Nigeria Cancer Walk,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4942,20172841,Observational,,Other,,Cohort,10 Years,Non-Probability Sample,
4943,RC31/18/0440,Observational,,Drug,,Cohort,,Non-Probability Sample,
4944,SDLNOC,Observational,,Procedure,,Cohort,,Non-Probability Sample,
4945,20-565,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Phase 3
4946,UPCC 11919,Interventional,"Experimental, Experimental, Experimental, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
4947,Arabic BREAST-Q,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
4948,2021-1211,Observational,,Other,,Cohort,,Probability Sample,
4949,segmental thoracic TEA-spinal,Interventional,"Active Comparator, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
4950,IRB-22-34,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4951,PSCI-19-112,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4952,LSHBSWMBC,Observational,,Diagnostic Test,,Case-Control,,Non-Probability Sample,
4953,2016-0463,Interventional,"Experimental, Experimental","Other, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4954,IIT-0013,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4955,BND and RND,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
4956,TheNethersole,Interventional,"Experimental, No Intervention","Other, Other",Parallel Assignment,,,,Not Applicable
4957,1655,Observational,,Genetic,,Cohort,,Probability Sample,
4958,N-111012422,Interventional,"Active Comparator, Active Comparator, Placebo Comparator, Placebo Comparator, No Intervention, No Intervention","Dietary Supplement, Other",Parallel Assignment,,,,Phase 1
4959,302,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4960,MC01/01/19,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
4961,Colorectal Cancer,Observational,,Other,,Other,,Non-Probability Sample,
4962,LCCC1748,Interventional,"Experimental, Experimental","Device, Drug",Sequential Assignment,,,,Phase 4
4963,1992110-1,Observational,,Behavioral,,Other,,Non-Probability Sample,
4964,CSC-20200324,Observational,,Procedure,,Cohort,,Non-Probability Sample,
4965,69HCL22_0466,Interventional,Experimental,"Behavioral, Other",Single Group Assignment,,,,Not Applicable
4966,IMPACNEO,Interventional,"Active Comparator, Experimental","Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
4967,0029-20-ZIV,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
4968,HKG-KZ-LNG-102,Observational,,,,Case-Control,,Non-Probability Sample,
4969,GCO 19-2707,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
4970,LIFT project,Observational,,,,Cohort,,Probability Sample,
4971,RECO_CT29A,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4972,INT 292/20,Interventional,"Experimental, Experimental","Diagnostic Test, Other",Parallel Assignment,,,,Not Applicable
4973,STUDY21020095,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4974,D967MC00001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4975,UHHeidelberg,Interventional,"No Intervention, Other",Other,Sequential Assignment,,,,Not Applicable
4976,R01CA205025,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4977,2019-PVSEP,Observational,,Other,,Case-Control,,Non-Probability Sample,
4978,HCB/2021/0130,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4979,S1614,Interventional,"Experimental, Experimental, Experimental","Other, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
4980,TMHPO1763,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
4981,002.1,Observational,,Other,,Cohort,,Non-Probability Sample,
4982,LIFT,Observational,,,,Cohort,,Probability Sample,
4983,2767,Observational,,Diagnostic Test,,Cohort,2 Years,Probability Sample,
4984,APHP210359,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
4985,M16VIB,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4986,EPOC1903,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4987,CASE2118,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4988,PARALUC,Interventional,Experimental,"Diagnostic Test, Other",Single Group Assignment,,,,Not Applicable
4989,CTC20200417,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4990,09.2019.1026,Observational,,Other,,Cohort,,Non-Probability Sample,
4991,CASE4119,Interventional,"Active Comparator, Experimental","Procedure, Behavioral",Parallel Assignment,,,,Not Applicable
4992,EC/GOVT/24/IRB23,Observational,,,,Case-Only,,Non-Probability Sample,
4993,CFTSp195,Observational,,,,Cohort,,Non-Probability Sample,
4994,04/20,Observational,,"Drug, Drug",,Cohort,,Probability Sample,
4995,29BRC20.0021,Interventional,"Active Comparator, Experimental","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
4996,MRI in urinary bladder tumors,Observational,,Device,,Case-Only,,Non-Probability Sample,
4997,CRUKD/21/004 - Treatment Arm 2,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 2, Phase 3"
4998,20201491,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4999,32900654326,Interventional,"Placebo Comparator, Active Comparator, Active Comparator, Active Comparator","Procedure, Drug",Parallel Assignment,,,,Not Applicable
5000,ReDA 13176,Interventional,"Active Comparator, Experimental","Radiation, Drug, Drug, Drug, Drug, Other, Radiation, Procedure, Other, Radiation",Parallel Assignment,,,,Phase 3
5001,64121317.4.1001.5330,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
5002,3-2020-0038,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
5003,INST UNM 2104,Interventional,"Other, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
5004,2018-A00260-55,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
5005,200013,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
5006,P/2017/317,Interventional,"Experimental, Experimental, No Intervention","Other, Other",Parallel Assignment,,,,Not Applicable
5007,FP2CLI001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Biological,Sequential Assignment,,,,"Phase 1, Phase 2"
5008,10000491,Observational,,,,Cohort,,Probability Sample,
5009,NCI-2022-02915,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
5010,4-2017-0840,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
5011,21953,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
5012,J1940,Observational,,Other,,Cohort,3 Years,Probability Sample,
5013,2018PS02,Observational,,Behavioral,,Ecologic or Community,,Non-Probability Sample,
